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This thesis begins by overviewing the literature around the design, synthesis and 
application of molecular switches with a focus on the field of azobenzene switches, their 
isomerisation mechanisms and their value as control units on biological molecules. 
The introductory chapter is followed three synthesis chapters reporting on the 
application of copper promoted azide alkyne and uncatalysed nitrile oxide alkyne 
cycloadditions for conjugation of azobenzenes initially with small molecule test case 
substrates, followed by the synthesis of carbohydrate, peptide and nucleic acid 
conjugates. The preparation of range of monosaccaride, disaccharide and nucleoside 
azobenzene conjugates are detailed. 
The synthesis of a number of new azobenzenes bearing either 1,3-dipoles or their 
precursors, or dipolarophiles is described. Biomolecules bearing the complementary 
functionality are reported. The formation of isoxazole, triazole and ether linked 
biomolecule conjugates is demonstrated. Peptide conjugates have been prepared by 
cycloaddition in solution and on the solid phase. Formation of both mono- and divalent 
conjugates is demonstrated and a range of regioisomeric structures formed. All new 
compounds have been characterised by a variety of techniques including NMR 
spectroscopy, IR and UV/Vis spectroscopy, as well as HRMS. The structures of some 
compounds have been determined by x-ray crystal analysis. 
The photophysical properties of a selected range of bioconjugates has been explored: 
the photostationary states were determined using NMR spectroscopy and the kinetic 
parameters of the cis to trans relaxation process determined by a UV spectroscopy study. 
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The 2016 Nobel award in chemistry to Jean-Pierre Sauvage, Sir J. Fraser Stoddart and 
Bernard L. Feringa for the design and synthesis of molecular machines demonstrates the 
importance of molecules that can exhibit a mechanical response to external stimuli. 
Molecular switches can be considered as simple machines in that they are compounds 
that can reversibly respond to external stimuli.1 The stimuli can be virtually anything 
e.g. changes in pH, temperature, the concentration of recognised guest molecules or ions, 
or light of a specific wavelength.2,3 Common  responses include changes in colour, 
fluorescence behaviour, ion or molecule capture or release, and changes in molecular 
geometry or dipole moment.4 The scope for utility is massive and molecular switches 
have commonly been employed in molecular recognition,4  studies of drug delivery 
systems,5 data storage and nanotechnology.6 
In one example, Harai et al. created a pH probe where fluorescent output was controlled 
by the alteration of molecular shape in response to pH.7 Above pH 9, there was no 
interaction between the pendant anthracene units of the sensor 1, in figure 1, and 
monomer emission was observed. Upon lowering of the pH, the structure bent allowing 
interaction between the anthracene centres, causing an excimer emission to be observed. 
 
 




This introduction will review the incorporation of molecular switches to biomolecules 
including carbohydrates, nucleic acids and peptides, and the utility of such derivatisation 
in controlling their function. 
 
1.1.2 Biomolecular switches 
 
The structure of biomolecules is intrinsic to their function. The change of a single amino 
acid can drastically affect the folding of an entire protein, rendering it inactive. Similarly, 
the change of a single nucleobase can prevent DNA helix formation, making it defunct. 
The interaction between biomolecules and their substrates is highly specific.8 Often the 
lock and key analogy is used to demonstrate the way that biomolecules respond to the 
specific characteristics of a given substrate. The three dimensional shape, layout and 
available functionality control interactions between the guest molecule and the host 
biomolecule, as depicted in figure 2.  
 
 
Figure 2: An illustration of the specificity of biomolecular interactions, so-called ‘lock and key’.8 
 
The design of biomolecular switches tend to be based around units which show, upon 
external stimulation, significant changes in shape and dipole moment. The choice of 
stimulus is also an important factor. It is preferable that external stimuli affect switching 
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on demand but otherwise do not interfere with the biomolecule or its environment. The 




Photoswitching is particularly attractive for biomolecular applications due to the 
possibility for non-invasive, controlled triggering and inertness to biological conditions. 
That is to say, that apart from those specialised to do so, cells are generally unaffected 
by light irradiation and have moderate permeability to lower energy wavelengths, i.e. 
between 650 nm and 950 nm.9 Light also gives excellent switching control in terms of 
its near instantaneous turning on and off.  
The vitamin A derivative retinal is a naturally occurring photoswitch. It is a key 
molecule in translating light into vision in the human eye.  The mechanism of this 
translation is based upon geometric isomerisation of an extended unsaturated 
hydrocarbon chain. As shown in figure 3, upon irradiation the single cis bond (2) 
isomerises to give the all trans form (3). Only when in the all trans form can the retinal 
take part in the metabolic pathway which results in the interpretation of light as vision.10 
The wavelength of retinal absorption is dependent on the binding sites of the different 
opsin proteins, and the on pH of the environment. 
 
 




Spiropyrans, diarylethenes, and azobenzenes are three leading classes of photoswitch. 
Each has a different response to light stimuli, which in turn has led to different potential 
applications. 
In the early 1950s Fischer and Hirshberg observed that following irradiation with light 
the C-O bond of spiropyrans could be reversibly broken and reformed.11  Irradiation in 
the UV region, typically between 270-380 nm, triggers ring opening, with the reverse 
process occurring thermally or with irradiation in the visible region, typically between 
500-600 nm.10 For example, the propanol functionalised spiropyran,  4, shown in figure 
4, was opened to its merocyanine form, 5, with irradiation at 312 nm; it reverted to the 
ring closed form following irradiation at 590 nm.12 It was already known that spiropyran-
merocyanine isomerisation could occur in both directions thermally, but the observation 
that it could be photochemically induced caused a rapid growth in the photochromic 
application of spiropyran containing molecules. 
 
 
Figure 4: Photoisomerisation between a spiropyran (left) and a merocyanine (right).12 
 
The ring closed (spiropyran) and ring open (merocyanine) forms exhibit very different 
chemical and physical properties. Isomerisation usually coincides with a striking colour 
change, from the colourless spiroform to the deep blue of the open form. Merocyanines 
exhibit emission between 600-700 nm whilst spiropyrans display no emission.13 
Geometrically,  the merocyanine form is elongated compared to the spiroform.13 A 
notable shift in dipole moment also occurs upon photoisomerisation, typically going 
from 4-6 D in the spiropyran to 14-16 D in the merocyanine form. The merocyanine has 
a single conjugated system, in contrast the spiroform has two conjugated systems 
separated at the central, spiro carbon atom.  
These dramatic, yet controllable property changes have facilitated a wide range of 
applications. The incorporation of spiropyran units within photochromic materials is 
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extremely common. They offer smart materials a range of  interesting property changes 
upon isomersiation, including changes in structure,14 solubility,15 colour and 
spectroscopic behaviour e.g. fluorescence.16 Applications include controlled release of 
guest molecules/ions17, visualisation of stress14,18 and photoresponsive surfaces.19 
Spiropyrans are especially popular switches for fluorescent imaging.20,21 They have also 
been used for ion detection as the merocyanine form strongly coordinates to metals ions, 
particularly through the phenolate oxygen atom, whereas the spiropyran form 
demonstrates little coordination potential.22-24  
There are many applications of spiropyran photoswitching in biological settings, for 
example, as fluorescent imaging probes,25,26 with the greatest interest being in peptide 
and protein chemistry.27,28 The functionalisation of peptides with spiropyrans has been 
particularly successful in facilitating control of tertiary structure. In one example Lenci 
et al. show that spiropyran-merocyanine, 5↔6, switching of the modified polyglutamic 
acid, shown in figure 5, allows turning on and off peptide helical formation.29,30 Inouye 
et al. also demonstrated photocontrol of peptide helix formation through incorporation 
of spiropyran units into the peptide chain.30  Marriott et al. have demonstrated that 
modified spiropyrans can be used to control activity in regulatory proteins. In the ring 
closed spiropryan form the peptide retains its native activity but the dipolar character of 
the merocyanine form actively inhibits the function of the protein.31 
 
Figure 5: A spiropyran modified polyglutamic acid used to study photo-controlled folding.29 
Diarylethenes are more recent additions than spiropryans or azobenzenes to the 
photoswitching family.32 They share many characteristics with spiropryans. 
Photoisomerisation, centring upon the opening and closing of a 6-membered ring, as 
shown for 8↔9 in figure 6, coincides with changes in absorption and other physical 
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properties of the molecules. The nature of the substituent on the diarylethene is 
especially important to ensure stability of the ring closed form. Generally, heterocyclic 
groups are incorporated, particularly thiophenes, and most examples incorporate methyl 
groups at the 2-positon to avoid oxidation of the central ring.33,34 Geometrically, the 
changes induced by photoisomerisation are modest, but significant changes are noted 
between the absorption spectra of the two forms. The ring open form usually absorbs 
between 200-350 nm, with the ring-closed form absorbing at around 600 nm. It should 
be noted that these values may vary significantly depending upon the identity of the 
aromatic rings and the nature and pattern of their substituents. One drawback of these 
molecules is a low quantum yield of isomerisation.35 
 
 
Figure 6: Photoisomerisation between the two forms of  a diarylethene.35 
 
Diarylethenes differ from many other photoswitches in two major ways: firstly, both 
forms can exhibit long-term stability, meaning both directions of isomerisation can only 
be induced by light. Secondly, photoisomerisation does not cause major 
geometrical/structural changes.36 These features have led to applications as optical 
memory devices as photoswitching at a particular wavelength allows for non-destructive 
reading of optical data.37 For example, targeted photoswitching was used to write a 
message on a surface functionalised with a diarylethene based film. Irie et al. could 
observe the image visually and through the change in IR absorbance for the two different 
forms, as shown in figure 7.38 Diarylethenes are also attractive for incorporation into 
materials where photoisomerisation triggered changes in magnetism,39 or in electronic 




Figure 7:Visual (left) and IR (right) images of a message written into a diarylethene containing photochromic 
film.38 
 
Due to the modest changes in shape and dipole moment between the two isomers 
relatively few biomolecular applications have been reported for diarylethene switches. 
In one example, a two-part inhibitor of human carbonic anhydrase I designed around a 
diarylethene core, figure 8,42 was shown in the open form, 10, to be ineffective: in this 
form it is understood that it was not possible for the two required inhibiting moieties to 
fit into the active site of the target enzyme. However, upon photoswitching the topology 
of the molecule changed sufficiently and the ring closed form, 11, fitted the active site, 
causing enzyme activity to be switched off. 
 
 
Figure 8: Two part human carbonic anhydrase I inhibitor based around a diarylethene.42 
 
Diarylethene switching has also been used to execute light controlled paralysis in simple 
organisms. It is believed that the electron accepting ability of the closed system 
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facilitates a disruption of the metabolic pathways. The open ring form does not affect 
the organism.43  
The only examples of the incorporation of diarylethene units directly into biomolecules 
are Singer and Jäschke’s examples of nucleoside derivatives 12↔13, where the 
nucleobase was substituted by a diarylethene unit, as shown in figure 9.44 It was 
proposed that this approach offered a potential opportunity to introduce a photoswitch 








Azobenzenes may be photoisomerised around the azo double bond linkage, going from 
the thermodynamically more stable trans form, 14, to the cis form, 15, as shown in figure 
10. Unlike spiropyrans and diarylethenes, there is no colour change upon isomerisation 
and azobenzenes retain their characteristic orange colour in both forms. Subtle 
differences are observed in the absorption and emission profile of the two forms; a 
decrease in the intensity of the peak at ~300 nm and an increase in intensity of the peak 
at ~450 nm is observed in going from the trans form to cis form. However, 
photoisomeriation causes significant changes in shape and dipole moment of 
azobenzene. The trans form is planar and non-polar whilst the cis form exhibits a 
significant dipole moment (~3 D). The trans form of the parent molecule is ≈ 42-50 kJ 
mol-1 more stable than the cis form and in the dark the trans form dominates approaching 
100%.45 The energy barrier for trans to cis conversion in the parent molecule is around 
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100 kJ mol-1. Thermal relaxation generally has a half-life in the order of days, but is 
dependent on factors such as solvent, temperature and substitution.  
 
 
Figure 10: Photoisomerisation of azobenzene  
 
1.2.1 Azobenzene isomerisation mechanism. 
 
The mechanism of azobenzene photoisomerisation has long been a topic of debate with 
several routes proposed and many reviews published on the subject.46-50 The main 
proposals are: inversion, rotation, concerted inversion, and inversion assisted rotation, 
as summarised in figure 11. Rotational theories suggest that the N=N double bond 
partially breaks, allowing free rotation around the N-N bond. In contrast, the inversion 
mechanism maintains the N=N bond and has one of the C-N=N bond angles increasing 
to 180˚ in the transition state; the concerted inversion route has both C-N=N bonds 
angles going to 180˚. The inversion assisted rotation mechanism has both twisting of the 





Figure 11: Mechanistic routes proposed for azobenzene photoisomerisation51 
 
The absorption profile of the ground state trans azobenzene has two well defined bands 
with the first, and most intense, usually appearing around 310-330 nm, the second, a 
weaker band usually appears around 440-460 nm, as shown for the parent azobenzene 
in figure 12 (red trace). The first absorbance corresponds to the symmetry allowed π → 
π* transition, and the later band to a symmetry forbidden n → π* transition.52 As a 
forbidden transition the intensity of the n → π* transition will always be lower than that 
of the π → π* transition. As the percentage of cis form increases the absorption of the π 
→ π* transition becomes weaker and that of the n → π* transition becomes stronger. 
Data for the parent azobenzene going from the trans dominating red trace (t = 0) to the 
cis dominating yellow trace (t = 60 min), can be seen in the figure 12. The π → π* 
absorption represents the transition to the S2 (ππ*) energy state and the n → π* to the 
S1 (nπ*) state.53 Excitation to either state affords isomerisation in both directions.54 
Ultimately this means that whilst irradiation at 320 nm will favour conversion of the 
trans to cis it also facilitate the reverse process meaning complete conversion to one 
geometrical form is not possible, thus conversion to the cis form usually peaks at around 
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90%. Conversely irradiation at the n → π* band, typically around 440 nm, will facilitate 
cis to trans conversion, commonly maximising around 80% conversion to the trans 
form.  
 
Figure 12: Absorption spectra of azobenzene following irradiation at 316 nm over a 60 min period.51 
 
The quantum yield of the n → π*  is more efficient than the π → π* transition for both 
the trans to cis, and the cis to trans conversions.51 The π → π*  transition involves the 
cleavage of the azo bond to a single N-N bond, making it compatible with a  rotational 
mechanism, whereas the n → π* transition is compatible with an inversion pathway.55 
Recent mechanistic studies favour the rotational or inversion assisted rotational 
pathways as the primary mechanisms,56-59 with inversion being a possible, but 
energetically unfavourable route.60 It is significant that the quantum yield does not equal 
1 for either conversion as it infers that more than one isomerisation pathway is in 
operation 
Generally speaking with more polar solvents the quantum yield for the trans to cis 
conversion is higher. In contrast, the quantum efficiency of the reverse process is optimal 
in non-polar solvents.51  
The trans to cis conversion is thermally independent and occurs solely upon irradiation. 
The cis to trans transformation can be affected thermally or upon photo-activation. 
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Quantum efficiency is reduced at lower temperatures for isomerisation under both 
passive relaxation and active irradiation.61,62 
Photoisomerisation of functionalised azobenzene derivatives is affected by several 
factors, including: irradiation wavelength, solvent, temperature and substituent nature 
and pattern. Thus by targeting appropriate experimental conditions a given azobenzene 
derivative can be isomerised to favour one geometric form. Practically, this is usually 
achieved by irradiating at a wavelength which has maximum absorption by the trans-
form and minimal absorption by the cis-form or the reverse. 
Azobenzenes have been traditionally categorised into three classes, azobenzenes, 
aminoazobenzenes and pseudostilbenes, based upon the nature of their substituents, as 
shown in figure 13.  
 
 
Figure 13: Examples of the three different classes of azobenzenes: azobenzenes, aminoazobenzenes and 
pseudostilbenes 
 
Azobenzenes, 16, comprises those structures that retain the absorption characteristics of 
the parent molecule. Typical substituents for this group are alkyl, aryl, amide, carbonyl 
and ester. The UV/Vis spectra for this family appear as two well defined bands: a strong 
π → π* absorption and a weak n → π* band. Similar quantum yields are observed for 
both directions of isomerisation. On the other hand they exhibit quicker cis to trans 
thermal relaxation when compared to that of the parent molecule. This is especially the 





Aminoazobenzenes, 17, typically have strong electron donating groups, such as amino 
or hydroxyl, ortho or para to the azo group. As the number of electron donating groups 
increases the UV spectra shows a shift of the π → π* band to a higher wavelength, 
consequently, the π → π* and n → π* absorption bands become closer.64 The shift in 
absorbance coincides with an increase in quantum yield. Electron rich azobenzenes 
usually demonstrate significantly quicker thermal relaxation than the parent molecule. 
They have been used by industry as dyes due to their bright colour, for example ‘Aniline 
Yellow’, [4-(phenyldiazenyl)aniline], 19, is a commonly used brightly coloured yellow 
dye, figure 14.  
 
 
Figure 14: Aniline Yellow, a common commercial dye 
 
The pseudostilbene class, 18, are often referred to as push-pull systems as they contain 
electron donating groups on one ring and electron withdrawing groups on the other. 
Typically both the substituents are para to the azo group. The effect of such substituents 
is the creation of a significant dipole moment, up to 9.8 D in extreme examples, such as 
the pseudostilbene 18 in figure 13.63 Like aminoazobenzenes, pseudostilbenes are often 
strongly coloured. The electronic imbalance of pseudostilbenes results in a shift of the 
absorption band of the π → π* transition to a longer wavelength, to the region typically 
occupied by the n → π* transition.65 Thermal relaxation rates for the pseudostilbene 
class are typically extremely fast; this can make the determination of quantum yields 
difficult. However, where quantum yields have been measured they are often lower than 
those observed for the parent molecule.  
 
1.2.2 Isomerisation effects 
 
The primary changes observed upon photoisomerisation of the trans-form to the cis-
form are in the geometry and in the dipole moments of the molecules. Whilst for 
azobenzene the change from zero dipole for the trans-form to ~3 D for the cis-form is 
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14 - trans-azobenzene 
15 - cis-azobenzene 
significant, it is generally the geometric changes that are the ‘mechanics’ behind the 
switching operation, figure 15. The trans-form is a planar molecule, with recent work 
identifying it as having C2h symmetry.
66,67 The photoisomerised cis form has a bent azo 
linkage and a twist of one of the aryl rings to around 55˚ out of the plane of the azo 
bond.67 These distinct orientations result in considerable differences in distance 
between, and relative orientation of, substituents on the individual phenyl rings of the 
cis and trans isomers of substituted azobenzenes. The extent of such changes for any 
given molecule can be extrapolated from the observation that the distance between the 
carbons atoms para to the azo linkage (end to end distance) differ by 3.5 Å upon 
isomersation of the trans form to the cis form of azobenzene.68  
 
 
Figure 15: Electrostatic potential maps of both geometrical forms of azobenzene (positive = red and negative = 
blue).69 
 
1.2.3 Application of azobenzene photoswitching in biological materials and in 
biomolecular settings  
 
1.2.3.1 Carbohydrate substrates 
 
Azobenzene-carbohydrate conjugates can broadly be separated into those where 
properties of the carbohydrate are being exploited in modification of the azobenzene unit 
or those that employ an azobenzene unit to control carbohydrate function. In the case of 
the former different sugars have been appended to azobenzenes to create desired 
spectroscopic responses. For example, Shinkai et al. created two different amphiphilic 
azobenzene glycosides, varying only in the choice of glucose or galactose heads.70 When 
compressed into films, both molecules experienced shifts in their UV-Vis absorption 
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behaviour with respect to the uncompressed films, with the glucose form red shifting 
and the galactose adduct blue shifting. 
A second series of amphiphilic conjugates synthesised by Laurent et al., e.g. 20,  figure 
16, were  found to differ in their ability to pack as liquid crystals.71 It was found that a 
change in the orientation of a single hydroxyl group of the sugar resulted in significant 
change to the packing properties of the azobenzene-sugar adducts.  
 
 
Figure 16: Example of an amphiphilic carbohydrate azobenzene conjugate synthesised by Laurent et al.71 
 
‘Methyl Yellow’ is one example of an azobenzene dye about which there are long term 
concerns about toxicity. This problem was addressed by Valldeperas et al.72 through its 
functionalisation with a simple monosaccharide. The resulting glucose adduct, 21 in 
figure 17, had a much reduced toxicity with respect to its parent.73 
 
 
Figure 17: ‘Methyl Yellow’ functionalised with glucose.73 
 
Carbohydrate based amphiphilic fluorosurfactants, exemplified by compound 22 in 
figure 18, have exploited azobenzenes to give control of surface tension and antibacterial 
properties.74 Photoisomerisation altered the efficiency of micelle formation, which in 
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Figure 18: Photoswitchable fluorosurfactants with controllable surface tension and antibacterial properties.74 
 
The rigid structure of saccharides makes it difficult to directly alter the geometry of 
individual sugar units. However, azobenzene photoisomerisation offers the potential to 
change the relative orientation of saccharide units and so to control their interactions 
with other molecules. Srinivas et al. have demonstrated this by examining the interaction 
between azobenzene bearing glycoclusters and lectins.75 They were able to observe that 
both the trans and the cis forms of glycocluster 23 had a higher binding affinity for the 
lectin than the lone saccharide unit, figure 19. Of the two glycocluster forms the cis had 
the highest lectin binding affinity. It was proposed that lectin binding affinity was 
influenced by the geometry of the azobenzene core, the valence of the glycoclusters, and 
by the relative orientation of the saccharide units. 
 




Surface bound carbohydrate-azobenzene adducts have been used to explore potential 
photocontrol of bacterial adhesion to sugar units.76 An azobenzene unit has been used to 
functionalise a surface with mannose. When in the trans form the saccharide was capable 
of interacting with the bacteria. When in the cis form no adhesion occurred, as 
summarised in figure 20. The same group have also demonstrated the photo-control of 
bacterial adhesion to the surface of a human cell.77 
 
 
Figure 20: Photocontrol of bacteria surface adhesion.76 
 
There have also been applications of azobenzene carbohydrate conjugates in the sensor 
field. It has been shown that azobenzenes can interact with cyclodextrins, fitting 
comfortably in the ring cavity.78 Toda et al. exploited this host-guest  relationship to 
create a molecular recognition system.79 The azobenzene pH indicator Methyl Red was 
guested into a cyclodextrin ring and so protected from protonation by the bulk medium. 
Upon addition of a ‘suitable’ organic molecule, the azobenzene was displaced and the 
Methyl Red became available for protonation, causing the system to go from yellow to 
red. Thus, the system acted like a sensor for the ‘suitable’ organic compound. 
With the appropriate linkers, dimeric systems can be created between cyclodextrins 
covalently modified with azobenzene moieties. The azobenzene unit of each 
cyclodextrin sits into the cavity of the other, as in figure 21.  Described as 
‘pseudorotaxanes’, the dimeric structures disrupt upon photoisomerisation, as the ‘guest-








Functionalisation of peptides with azobenzene units is perhaps the best studied class of 
biomolecule photoswitch conjugates. This is mostly likely due to the great diversity of 
peptides and proteins and their important biochemical roles. The wide variety of amino 
acid sidechain functionalities facilitates targeted, or site specific functionalisation. This 
is in stark contrast to DNA with its limit of four nucleotide building blocks, or the 
chemically similar structures of carbohydrates. Secondary, tertiary and quaternary 
structure is of vital importance to peptide and protein function, and all of these could 
potentially be photochemically controlled by integration of an azobenzene unit into the 
biomolecule. 
Functionalisation of peptides can be divided into side chain derivatisation and backbone 
modification. In early work side chain functionalisation was popular as it allowed for 
the modification of proteins from natural sources. For example, Riklin et al. 
demonstrated the attachment of several azobenzene units to the enzyme papain.81 The 
azobenzene units were not regiospecifically introduced at the active site of the enzyme, 
rather any available lysine residues were functionalised. The derivatised protein, 24 in 
figure 22, maintained 80% of enzymatic activity when in the trans form; upon 
photoswitching to the cis form activity was reduced to 30%.  Although somewhat 
‘simplistic’ in approach, this experiment demonstrates that even without targeting a 
specific site, the structural and dipolar changes accompanying isomerisation of 
azobenzene units incorporated at the sidechains can have a significant influence on the 





Figure 22: Section of papain incorporating an azobenzene functionality.81 
 
With the advancement of sophisticated molecular modelling and of synthetic peptide 
chemistry it became possible to target the introduction of azobenzene units to specific 
sites within a protein. Amongst the most elegant examples is Kramer et al.’s 
functionalisation of a potassium channel.82 An azobenzene unit is tethered near the 
mouth of the ion channel via reaction between the thiol group of a cysteine residue and 
the maleimide bearing azobenzene 25. When in the trans form, the unit is positioned 
such that its ammonium functionality covers the opening of the channel. Electrostatic 
repulsion between the ammonium group and potassium ions effectively blocks the 
movement of potassium ions across the channel. When the azobenzene core is 
photoisomerised to the cis form the ammonium functionality is pulled away from the 
opening, allowing the flow of potassium ions, as summarised in figure 23. Further 
development of this work demonstrated that the azobenzene photoswitches could be 
used to control neurological activity. This approach has been successful in controlling 






Figure 23: Azobenzene 'arm' developed by Kramer et al. for photo-control of potassium transportation.82 
 
Azobenzenes have also been used as cross-linking units in the modification of peptides. 
The azobenzene unit is attached at two points on the protein through side chain 
modification and upon photoisomerisation the folding of the protein is disrupted. The 
distortion in the azobenzene shape is relayed to the peptide, generally the modified 
conformation is biochemically ineffective. Instructive papers by Woolley et al. 
demonstrate the effects of such cross linking, for example it can be seen that the number 
of helices in an azobenzene cross-linked protein can be controlled through 
photoisomerisation.87,88 In another example Pingoud et al. introduced azobenzene cross-
linkers to a restriction enzyme and upon photoisomerisation they saw up to 16 fold 
improvement in DNA cleavage.89 
In terms of backbone functionalisation, cyclic peptides incorporating azobenzenes have 
been prepared from azobenzenes bearing both amine and carboxylic acid functionalities. 
These derivatives are suited to integration through standard peptide coupling. Cyclic 
peptides constructed with this unit demonstrate different conformational preferences 
depending on whether the azobenzene unit has trans or cis geometry.90,91  
Azobenzenes with amine and carboxylic acid functional groups have also been used to 
generate synthetic peptides with an azobenzene within the backbone, for example 26, 
figure 24, created by Renner et al.; 92 β-hairpin folding resulted when 26 was in cis form, 





Figure 24: Peptide incorporating azobenzene: cis geometry mimics β-hairpin folding92 
 
1.2.3.3 Nucleic acids 
 
The DNA double helix is arguably the most recognisable of all biological structures; its 
sequence and shape are critical to its function; the effects of DNA sequence mutation, 
even the change of a single nucleotide can have dramatic consequences from 
evolutionary change to cancer causing diseases. Although RNA is more commonly 
found as a single chain, it still forms complex tertiary structures. These are often helices 
but folded structures akin to peptides also occur with features such as loops and hairpin 
folds.93,94 Azobenzene photoswitches have been exploited in studying the structure and 
function of DNA and RNA in a manner similar to that demonstrated for peptide studies. 
A range of azobenzene photoswitches capable of interacting non-covalently with DNA 
and RNA have been reported. Applications include control of conformation95 or 
interstrand interaction: in one example a bis-1,8-naphthyridine appended azobenzene 
intercalated DNA as demonstrated in figure 25.96 The changes to DNA structure 
resulting from photoisomerisation of the complex 27 can be monitored by changes in 





Figure 25: DNA intercalating bis-1,8-naphthyridine appended azobenzene developed by Nakatani et al.96  
 
By the mid-1990s, DNA sequences incorporating azobenzene motifs capable being 
photoisomerised were synthesised, this gave greater control of DNA duplex 
formation/disruption. Introduction of a photoswitchable azobenzene into the DNA 
phosphate backbone has been demonstrated by Komiyama et al.98 The modified DNA, 
28↔29 shown in figure 26, retained its ability to form duplexes when the azobenzene 
was in the trans form, 28, however upon photoisomerisation to the cis form, 29, 
dissociation into single chains was observed. The switching was observed to be 
reversible. It was later shown azobenzene modification of the phosphate chain helps to 
stabilise duplex formation in the trans form through π-stacking interactions.99 In another 
example, Liu and Sen demonstrated the integration of azobenzene units into a 
deoxyribozyme, via phosphate backbone modification.100 The RNA cleaving DNA was 
found to be between 5-6 times more effective when the azobenzene unit was in the cis 
form than in the trans form.  
The integration of azobenzene units into DNA has facilitated control over its interaction 
with cleavage enzymes. Komiyama et al. reported that Ribonuclease H was more 
effective at digesting modified DNA sequences when the introduced azobenzene had cis 





Figure 26: Photoisomerisation of an azobenzene unit integrated along the phosphodiester backbone of a DNA 
sequence used to control duplex formation.98 
 
An interesting approach to incorporate azobenzene units into nucleic acids developed by 
Heckel et al. involved replacement of the nucleobase from a thymidine residue with an 
azobenzene unit, i.e. 30 in figure 27.102 It was found that incorporating this building 
block into RNA disrupted duplex formation when the azobenzene unit was in the cis 
form. However, whilst in the trans form no disruption was observed. 
 
 





1.2.4 Introduction of azobenzenes to biomolecules 
 
1.2.4.1 Introduction of azobenzenes to carbohydrates 
 
1.2.4.1.1 Glyosidic bond formation with azobenzene acceptors 
 
The majority of carbohydrate derivatives bearing azobenzene units have been 
synthesised through direct glycosidic bond formation between a suitably functionalised 
sugar and azobenzene units.73,76  
Glycosidic bond formation has many attractions as a synthetic approach; the C-1 
position can be specifically functionalised without the need for the extensive protecting 
group manipulation that is often be required for modification at other saccharide 
positions. For example, pentaacetates, such as 31, can be reacted with a range of suitable 
glycosyl acceptors, for example 32-34, in the presence of carefully selected activating 
agents to form a variety of glycosides, e.g. 35-37 as shown in scheme 1. 
 
Scheme 1: Representative carbohydrate functionalisation through glyosidic bond formation 
 
Glycosidic bond forming chemistry for the introduction of azobenzene units is well 
demonstrated by Lindhorst et al., where the simple azobenzene-mannose adduct, 40, is 
easily formed in a single step following reaction of 1-O-trichloroacetimidoyl-mannose, 
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38, with 4,4’-dihydroxylazobenzene, 39, boron trifloride is the activating agent. The 
adduct was formed in 41 % yield, as shown in scheme 2.103 
 
 
Scheme 2: Azobenzene-mannose conjugate constructed by glycosidic bond formation.103 
 
The drawback to glycosidic bond formation is the lack of generality; success is highly 
dependent upon the choice of saccharide, the protecting groups, glycosidic acceptor and 
donor and the activation agent. For example, the success of the reaction between 
protected N-pentenyl glucose, 41, and methanol, depends on the choice of protecting 
group. Benzyl groups activate the saccharide and the reaction works well. In contrast, 
protection with benzoyl groups deactivate the saccharide and the reaction fails to 
proceed.104 The stereochemical outcome of the reaction is also sensitive to reaction 
conditions, with the β-isomer, 42, favoured with iodine dicollidine perchlorate (IDCP) 
as the activating reagent, whereas activation by a combination of N-iodosuccinimide 
(NIS) and triethylsilyl trifluoromethanesulfonate (Et3SiOTf) results in a dominance of 




Scheme 3: Sensitivity of glycosylation chemistry to the nature of protecting groups and activating agents. 
 
1.2.4.1.2 Manipulation of C-1 nitrophenyl glycosides 
 
An alternative approach to the synthesis of azobenzene conjugates has involved 
manipulation of C-1 p-nitrophenyl substituted sugars. The nitro functionality of the aryl 
has served as a precursor to an amino group, which has subsequently been used either 
to link an azobenzene by condensation chemistry as in the formation of 5270,79 or to 
directly form an azo linkage, via an intermediate diazonium as in the formation of 50, 
shown in scheme 4.71,77 In this example, 4-nitrophenol, 45, was initally coupled with a 
glucopyranosyl bromide to give the p-nitrophenyl glycoside 46.105 Reduction yielded 
the anilino glycoside, 47.71 Conversion to the diazonium salt, 48, followed by reaction 
with phenol afforded the azobenzene-carbohydrate conjugate 50, scheme 4 path A.77 
Alternatively the aminoglycoside, 47, could be coupled to an azobenzene bearing 





Scheme 4: Formation of azobenzene glycoside derivatives via C-1-p-nitrophenyl glycoside building block. 
 
1.2.4.2 Introduction of azobenzenes to peptides 
 
1.2.4.2.1 Azobenzene units introduced as backbone functionalities 
 
Amide bond formation is the dominant chemistry of peptide functionalisation, 
particularly for building functionality into the backbone. Therefore, the formation of 
azobenzenes which bear either, or, both amino or carboxylic acid groups are highly 
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desirable. One attractive example is 3-[(3-N-Fmoc-
aminomethyl)phenylazo]phenylacetic acid, 55, synthesised by Renner et al., from Fmoc 
protected 3-aminobenzylamine, 53 and nitrosophenylacetic acid, 54, through a Mills 
reaction, shown in scheme 5.92 With Fmoc protection, this derivative is an ideal 
candidate for both manual and automated solid phase peptide synthesis. 
 
Scheme 5: Synthesis of 3-[(3-N-Fmoc-aminomethyl)phenylazo]phenylacetic acid. 92 
 
It should be noted that due to their poor nucleophilicity aromatic amines do not easily 
undergo amide bond formation and linkers between azobenzene and amine 
functionalities are generally required, however, there are some examples of direct 
reactions. In one example, 4-aminophenylazobenzoic acid, 58, synthesed from reaction 
between nitrobenzoic acid 56 and 57,  scheme 6, was coupled through its carboxylic acid 
under standard solid phase conditions. The aromatic amine did not require protection 
and remained unreacted. However, it was subsequently coupled under much more 
forcing conditions (N,O-bis(trimethylsilyl)acetamide, DIEA, THF, 40 ˚C) to create an 
azobenzene linker in the backbone of a peptide.91   
 
 
Scheme 6: Synthesis of 4-aminophenylazobenzoic acid.91 
 
1.2.4.2.2 Azobenzene units introduced as side-chain functionalities 
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The chemistry for modification of peptide side chains has largely focused on lysine and 
cysteine residues. Typically, lysine has been targeted with amide bond formation 
through reaction with activated esters, but urea and amine bond forming chemistries are 
also utilised.106 However, due its unique chemistry and its infrequency in protein 
sequences cysteine is the most commonly selected residue for side chain modification. 
The ‘thiol-maleimide’ reaction has been designated ‘click’ status due to its efficiency 
and reliability.107 Both mono- and bis- maleimide functionalised azobenzenes have been 
introduced by this approach.89,108,109 The simplest mono-substituted azobenzene 
maleimide, (4-phenylazophenyl)maleimide 61, has been synthesised in one-step from 4-
aminoazobenzene, 59, and maleic anhydride, 60, as shown in scheme 7.110 this derivative 
has, site specifically, been introduced into calcium binding proteins.109  
 
 
Scheme 7: Synthesis of (4-phenylazophenyl)maleimide.110 
 
Functionalisation of tyrosine residues offers an alternative approach to azobenzene 
functionalised peptides. For example, a tyrosine residue in peptide 62 has been reacted 
directly with a nitrobenzene diazonium salt, 63, resulting in the formation of 64 with the 
azo linkage ortho to the tyrosine hydroxyl as shown in scheme 8.111,112 
 





1.2.4.3 Introduction of azobenzenes to nucleic acids 
 
The introduction of azobenzene units into DNA and RNA strands via automated 
synthesis is an attractive approach. Therefore, azobenzenes with both a phosphoramidite 
functionality and a protected alcohol have been important synthetic targets. Although it 
dates from the late 1990s, the derivatisation of 2,2-bis(hydroxymethyl)propanoic acid, 
66, with 4-aminoazobenzene, 65, by amide bond formation, remains popular. 113 This 
reaction forming 67 is shown in scheme 9. One of the equivalent alcohol functional 
groups of 67 is protected by reaction with 4,4′-dimethoxytrityl chloride. Conversion of 
the remaining alcohol to a phosphoramidite is typically achieved by reaction with 2-
cyanoethyl N,N-diisopropylchlorophosphoramidite. The resulting compound 69 has 
been be used in standard automated oligonucleotide synthesis. 
 





A significant drawback of this approach is that two diastereoisomers of the 
phosphoramidite result. As the two diastereoisomers have different stabilising effects on 
the resultant DNA duplexes, they must be separated before incorporation into 
oligonucleotides. Komiyama et al. by-passed this problem by following a set of 
reactions similar to those shown in scheme 9, but starting from the optically active D-
threoninol, 71, as shown in scheme 10. Reaction with 4-(phenylazo)benzoic acid, 70, 
gave the diol functionalised azobenzene as a signal enantiomer. A series of 
transformations the phosphoramidite 73, was obtained as a single diasterioisomer.114 
 Starting from L-threoninol the corresponding azobenzene bearing phosphoramidite 
could be constructed diastereoselectivity. The DNA constructed from the L-
phosphoramidite was destabilised with respect to the native form irrespective of the 
geometry of the azobenzene unit. Whereas DNA constructed using compound 73 created 
from D-threoninol showed preferential destabilisation when in the cis geometry. 
 
Scheme 10: Diastereoselectivite synthesis of  the azobenzene phosphoramidite 73 starting from D-threoninol.114 
 
As was previously described by Heckel et al. substitution of the nucleobase with an 
azobenzene unit has been achieved. Cleavage of the nucleobase from thymidine by 
reaction with hexamethlydisilazane and ammonium sulphate resulted in formation of a 
ribose glycal, 75,115 Subsequent Heck reaction with iodo-azobenzene, 74, resulted in 




Scheme 11: Synthesis of a nucleoside analogue, where an azobenzene unit replaces the nucleobase.102 
 
1.2.4.4 Azobenzene-biomolecule conjugation: closing remarks. 
 
As presented in the previous three sections, the introduction of an azobenzene 
functionality into biomolecules is most commonly achieved through the traditional 
chemistry of that particular class of molecule, whether it is glycosidic bond formation 
for carbohydrates, amide bond formation for peptides/proteins or phosphoramidite 
chemistry for nucleic acids. This means that methodologies may not be easily 
transferable from one class to another, and knowledge of the individual chemistry of 
each biomolecule class is required if azobenzene biomolecule conjugation is to be easily 
accessed. 
Whilst introduction of  azobenzene functionalities is well demonstrated for all three 
classes of biomolecules, there are limitations to the current approaches for example, 
amide bonds suffer from relatively easy hydrolysis, making them sensitive to water, 
acids, bases and heat. Drawbacks to other approaches include the necessity to utilise 
protecting groups. Functionalisation of biomolecules by 1,3 dipolar cycloaddition 
chemistry could avoid many of these issues, accordingly the following sections will 
disscuss this class of ring forming reaction.  
 
1.3 Click chemistry 
 
The term click chemistry was coined by Barry Sharpless in the late 1990s, reactions 
which merit this classification offer high yields, wide substrate scope, inoffensive 
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byproducts, stereospecificity, simple conditions, and easy separation and purification.116 
Those reaction classifications commonly cited as fulfilling the conditions include: 
cycloadditions including Diels-Alder cycloadditions and alkyne-azide cycloadditions, 
nucleophilic substitution of strained rings, and carbonyl chemistry of a non-aldol type, 
epoxide opening reactions. These reactions are often described as being ‘spring loaded’ 
as they have strong thermodynamic driving forces and their use in syntheses has been 
prolific, for example, entering ‘click chemistry’ in the literature search engine SciFinder 
in 2017 generates nearly 15,000 unique citations.   
 
1.3.1 1,3-Dipolar cycloaddition chemistry  
 
Within the broader scope of click chemistry, this work will focus on the use of 1,3-
dipolar cycloaddition reactions as a method for conjugating biomolecules with 
azobenzene photoswitches. As well as the copper cataylsed azide-alkyne cycloaddition 
(CuAAC), nitrile oxide-alkyne cycloadditions (NOAC) will be explored117  
1.3.2 Copper catalysed azide-alkyne cycloaddition (CuAAC) 
 
The azide-alkyne cycloaddition, shown in scheme 12, is the best known example of click 
chemistry. It is renowned for its reliability and effectiveness in connecting two units 
together. The resulting triazole, 79, is extremely stable and substitution patterns are 
highly predictable. However, perhaps the greatest asset of the reaction is the inertness 
of the starting azide, 78, and alkyne, 77, to other modes of reaction. This lack of 
reactivity allows the groups to be easily introduced into complex substrates where they 
will lie dormant until the conditions promoting the cycloaddition are provided.  Whilst 
the reaction can occur upon heating, it may be extremely slow and lead to undesirable 
by-products. However, in the presence of a copper I catalyst, the so called CuAAC 
(copper catalysted azide alkyne cycloaddition) proceeds rapidly.118 The active catalyst 
is often generated in situ by reduction of a copper II salt. Typically copper sulphate is 
used with sodium ascorbate or ascorbic acid. However, it is not uncommon for a copper 
I salt to be used, such as cuprous bromide. Other catalysts such as ruthenium119 and 





Scheme 12: Copper catalysed azide alkyne cycloaddition (CuAAC). 
 
The reaction mechanism has been studied in detail both experimentally and 
computationally.121-123 Recent studies have favoured a dinuclear copper mechanism, as 
shown in scheme 13.122,123 Two copper centres coordinate to the alkyne, one adjacent to 
the π-bond, the other replacing the terminal hydrogen generating species A. The azide 
coordinates to the copper centre engaged with the alkyne, B, and a six-membered ring 
system, C, is created. Subsequent ring collapse generates a five-membered ring, D, with 
ejection of one of the copper centres. In the final step, the remaining copper centre is 
replaced by a proton, furnishing the final cycloaddition product. 
 
 
Scheme 13: Mechanism proposed by Worrell and Fokin for CuAAC reaction.123 
 
The scope of the CuAAC reaction for derivatisation of carbohydrate substrates is 
demonstrated in a recent Chemical Reviews article.124 It relates a huge range of ‘clicked’ 
glycosides, with applications spanning conjugation to proteins, peptides and lipids, as 
well as formation of glycoclusters, macromolecules and polymers. A wide range of 
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carbohydrate substrates bearing the alkyne or azide groups, in a variety of positions have 
been reported. However, the application the CuAAC to the synthesis of photoswitchable 
bio-adducts is still underexploited. In particular, there are limited reports of the 
generation of azobenzene bioconjugates by CuAAC chemistry.  
A review by Toth et al. demonstrates the diversity of the CuAAC reaction with peptide 
substrates.125 Alkyne and azide functionalities have been introduced to the side chain of 
a range of different amino acids and amongst other reactions CuAAC chemistry has been 
used for cross-linking proteins, labelling and tagging proteins and cyclising peptides. 
Ghadiri et al. have found that a triazole unit can be tolerated in place of a dipeptide e.g. 
the triazole containing 80 can replace the lysine-leucine unit 81 without effecting α-helix 
formation of the resulting peptide, figure 28.126 
 
 
Figure 28: Triazole mimic,81, of peptide, 80.126 
 
The CuAAC reaction has also been applied extensively to the functionalisation of DNA 
and RNA. There are examples where either the azide or the alkyne have been introduced 
into the ribose, the nucleobase or the phosphate chain.127,128 Typically triazole formation 
is used for labelling DNA or  connecting DNA strands.128 
To date azide-alkyne click chemistry has rarely been applied for the conjugation of 
azobenzenes to biomolecules. Lindhorst and Chandrasekaran have linked C1-linked 
azido-monosaccharides, 82, to azobenzene alkynes, 83, to create mono and oligovalent 
glycosides, 84, as shown in scheme 14.129 Azide functionalised cyclodextrins have also 
been used as substrates in the CuAAC reaction with azobenzene alkynes. The resulting 
conjugates were used to investigate the effects of isomerisation on the conformational 




Scheme 14: Azobenzene-glycoside conjugate formed by CuAAC chemistry.129 
 
CuAAC chemistry remains unexploited for the formation of azobenzene peptide or 
nucleic acid conjugates. However, there is some interest in the field. In a recent 
publication Muller and Lindhorst developed several azobenzene glycosides with azide, 
alkyne and alkene functionalities with the intention of creating protein cross-linkers 
through triazole formation, one such building block 85, is shown in figure 29.132 
 
 
Figure 29: Azide/alkene functionalised azobenzene glycoside designed for future protein cross-linking studies.132 
 
Whilst the CuAAC reaction is often considered the best ‘click’ reaction, it is not without 
its drawbacks. These are often associated with the potential toxicity and the potential 
explosive nature of azides. The requirement for a copper catalyst can be a major obstacle 
in biological and pharmacological settings, where residual ions can be detrimental. One 
approach to avoiding the need for the copper catalyst is to use more reactive strained 
alkynes, typically cyclooctynes. However, these substrates generally lack functionality 
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and introduce large rings to the final conjugate which maybe undesirable in future 
applications. Therefore, reactive dipoles such as nitrile oxides that can readily react with 
alkenes and alkynes without the need for catalysts are an attractive alternative to azide 
cycloadditions. 
 
1.3.2 Nitrile oxide alkyne cycloaddition reactions (NOAC) 
 
In comparison to the azide-alkyne cycloaddition reaction, the isoxazole forming nitrile 
oxide-alkyne cycloaddition (NOAC) can be considered a more classic 1,3-dipolar 
cycloaddition. The mechanism was initially debated between a pericyclic concerted 
reaction and diradical route, however, work by Huisgen helped established the pericyclic 
route as the preferred mechanism.133 Nitrile oxides tend to be extremely reactive, short 
lived species. Thus, conditions for cycloaddition need to be carefully considered to avoid 
dimerisation134 or reaction with nucleophilic elements present in the reaction mixture.135 
Nitrile oxides are generally formed in situ from oximes, 86, hydroximinoyl halides, 88, 
or nitro groups, 90, as summarised in scheme 15.136 Conversion directly from an oxime 
to a nitrile oxide through reaction with chloramine-T, (Ch-T), is the most commonly 
reported route.137 Another major other route involves inital conversion of an oxime to a 
hydroximoyl chloride through treatment with N-chlorosuccinimide, which subsequently 
forms the nitrile oxide upon addition of a suitable base138,139 Alternative reagents for 
conversion of an oxime to a nitrile oxide include reaction with chlorine gas,140 sodium 
hypochlorite141 or tert-butyl hypochlorite.142 Examples involving nitrile oxime 
formation from hydroximinoyl bromides are also reported; oxime bromination can be a 





Scheme 15: Nitrile oxide formation and isoxazole formation by cycloaddition of a nitrile oxide with a terminal 
alkyne 
 
NOAC is popular for its rapid reaction, ease of access to the required oxime precursor 
and the high degree of regioselectivity. It also avoids the potential safety risks associated 
with azide dipoles and the need for a metal catalyst associated with the CuAAC 
chemistry. The isoxazole rings (92) formed in the reactions can also be of interest either 
for incorporation into the final molecules144,145 or for its potential to ring open and 
provide further useful functionality, for examples the α–ketonitriles 94 and the highly 
substituted 95, which are illustrated in scheme 16.146-148    
 
 




Although NOAC reactions are less common than their CuAAC counterpart, they have 
been used successfully in a range of biomolecular applications. Functionalisation of 
oligonucleotides, and to a lesser extent peptides and carbohydrates has been reported.149-
151 
The application of nitrile oxide cycloaddition chemistry with carbohydrate substrates 
includes isoxazoline forming reactions. For example, methylene exo-glucals, 96, have 
been reacted with nitrile oxides to generate spiro structures like 98 with potential enzyme 
inhibition activity, scheme 17.149  
 
 
Scheme 17: Nitrile oxide cycloaddition chemistry generating spiro-isoxazoline carbohydrate derivatives.149 
 
Methylene exo-glucals have also been used in intramolecular cycloaddition reactions 
forming bicyclic systems. In these examples it has been demonstrated that the reaction 
is tolerant to both protected.152,153 and unprotected saccharides154 
Bhoseker et al. used a nitrile oxide-alkene cycloaddition to form disaccharide and 
trisaccharide macrocyclic molecules, including 99. The isoxazoline ring was then 
opened to give a less rigid macrocyclic structure, 100, which has additional 
aminoalcohol functionality, scheme 18.153 
 
 




The highly reactive nature of nitrile oxides and therefore the potential for undesirable 
side reactions, has somewhat limited the attractiveness of their application in the 
derivatisation of peptide and protein substrates. In one example, Delft et al. report nitrile 
oxide cycloaddition to the N-terminal modified peptide, 101. Their approach involved 
adding of the dipole precursor, 103, in six equal portions over the 12 hours reaction 
duration. Their reaction resulted in the formation of the isoxazole terminated peptide 
104, shown in scheme 19.150 The reactive benzonitrile oxide was generated in situ from 
the parent oxime by reaction with the hypervalent iodine reagent 102. 
 
 
Scheme 19: NOAC between an alkyne functionalised peptide and nitrile oxide generated from benzaldehyde oxime. 
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In another report, Neumair et al. reacted a 18F labelled 4-fluorobenzonitrile oxide with 
peptides bearing a range of strained and activated alkynes and alkenes, including 
cyclooctynes, norbornenes and succinimides to great effect.155  
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Delft et al. were able to mitigate against the potential difficulties of nitrile oxide self 
reaction by using reactive strained alkynes and a less reactive nitrone  dipole in place of 
a nitrile oxide.156 The nitrone was introduced onto the N-terminus of a deprotected 
peptide and successful cycloaddition reactions were achieved under ambient conditions. 
In contrast to peptides, nucleic acid substrates have frequently been derivatised by 
NOAC chemistry. Again, strained alkynes and alkenes are popular dipolarophiles, but 
terminal alkynes are also utilised. In one example, Carell et al. functionalised a 
nucleoside with a norborene, once built into an oligonucleotide the strained alkene was 
trapped with a range of functionalised nitrile oxides, including one bearing  an 
azobenzene.157 Heaney and Singh introduced a cyclooctyne at the terminus of a DNA 
sequence, 105, which they used to trap a serval different tags by NOAC chemistry, 
scheme 20.158 Further work from the group also demonstrated introduction of an oxime 
functionality to a phosphoramidite, subsequent conversion to nitrile oxide proceeded 
cycloaddition to a terminal alkyne.159 The resulting isoxazole-phosphoramidite was then 
introduced into a growing oligonucleotide by standard solid phase synthesis. There are 
a many more examples of the application nitrile oxide-alkyne cycloaddition chemistry 
in nucleic acid modification included in the microreview by Heaney.151 
 
 




2. Azobenzenes with dipole and dipolarophile functionalities: 




The objective of this project was to develop a robust and generally applicable 
methodology for the conjugation of photoresponsive azobenzene units to biomolecular 
substrates. To this end, a range of azobenzenes bearing either an azide or a nitrile oxide 
precursor, or an alkyne dipolarophile were desired. Creation of azobenzenes bearing 
either a dipole or dipolarophile functionality, offered flexibility for the conjugation 
process in that the azobenzene or the biomolecule could have either of the reciprocal 
functionalities. Perhaps more importantly, it also offered the possibility of a range of 
physical and geometric properties to the resulting cycloadducts. As the 3D properties of 
the cycloadducts were of interest, the potential to prepare regioisomeric azobenzene 
conjugates was recognised as one important way to create structural diversity. Varying 
the valency of the azobenzene core further offered access to cycloadducts where one or 
more individual biomolecule units could be appended.  
After designing the range of azobenzenes bearing dipole or dipolarophile functionalities 
the optimal conditions for cycloaddition were to be investigated. The objective was 
development of a high yielding reaction, which could be reliably delivered regardless of 
the nature of the particular biomolecule being ligated. To this end, a number of test case 
reactions between suitably functionalised azobenzenes with simple aryl dipoles and 
dipolarophiles were investigated prior to experimentation with biomolecule partners. 
The geometric changes affected by photoisomerisation of a functionalised  azobenzene 
derivative are expected to vary depending upon the nature and position of its 
substituents. Photochemical properties, such as the wavelength of the absorption bands, 
the quantum yield and rate of the cis to trans thermal relaxation are also affected by the 
substituents pattern. As such, it was desired to create a range of functionalised 
azobenzenes carrying 1,3-dipolar or dipolarophile functionalities in positions ortho, 
meta and para to the azo functionality, examples shown in figure 30. In search of 
polyvalent derivatives bis substituted compounds, specifically including those with two 





Figure 30: Selection of functionalised azobenzene structures targeted in this research. 
 
Initial target compounds bore an alkyne (107-109), an oxime (110-112) or a 
hydroximinoyl chloride functionality ortho, meta or para to the azo linkage (figure 30). 
Azobenzenes with either a hydroxyl, 119, or an aldehyde functionality, 123, were 
identified as key synthetic precursors to these targets. The synthetic routes to be adopted 
are shown retrosynthetically in scheme 21. It was anticipated that the phenolic 
functionality of 119 would react with propargyl bromide to give easy access to the 
azobenzene-dipolarophile family (107-109) and that the aldehyde 123 would react with 
hydroxylamine (124) to give the azobenzene-oxime family (110-112) which would act 
as precursors to the corresponding nitrile oxides (121). 
 
 




It was envisaged that some of the targeted molecules could be accessed by modification 
of commercially available azobenzenes. However, for most formation of the azo linkage 
would an important first step in the synthesis. 
 
2.1.1 Major synthetic routes to azobenzenes. 
 
Several routes are available for the formation of an azo bond. Those commonly utilised 
include the Mills reaction, reductive coupling, oxidative coupling and azo coupling; 
these approaches are summarised in scheme 22.160  
 
Scheme 22: Major synthetic routes to access azobenzenes. 
 
The ‘azo coupling’ reaction is the most popular for synthesising azobenzenes. It is 
compatible with a range of functionalities and is generally high yielding and fast. It 
involves formation of an intermediate diazonium salt, formed by nucleophilic attack 
from an aniline derivative onto nitrosonium ion, generated in situ from the reaction of 
sodium nitrite with an acid, typically HCl. The partnering aryl generally requires at least 
one electron donating group (EDG) to facilitate the electrophilic attack on the diazonium 
salt. Substitution para to the EDG is the favoured regiochemical outcome. However, if 
this site is blocked reaction will occur at the ortho position. Apart from the electronic 
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requirements, the reaction is also sensitive to temperature and pH.  The pH of the 
reaction must initially be acidic enough to facilitate the formation of  nitrous acid; later 
it must not impede the electrophilic substitution by protonation of the EDG on the aryl 
partner. For example, often a diazonium salt will be reacted with a phenolate, so in the 
course of the reaction the pH has to be adjusted from acidic to basic.  Particular care 
must also be taken to control the temperature as diazonium salts are known to be unstable 
above 5 °C. However, these low reaction temperatures often result in poor solubility of 
the reactants in the aqueous media commonly used. The mechanism for the reaction is 
demonstrated in scheme 23. Nitrite, 129, protonation gives rise to nitrous acid, which is 
further protonated before dehydration to generate NO+. Attack by aniline, 126, and a 
series of proton transfers steps affords diazonium 127. Attack by phenol and proton 
elimination gives the final hydroxyazobenzene 131. 
 
 
Scheme 23: Mechanism of azo bond formation by the azo coupling reaction. 
 
The Mills reaction is also popular for formation of azobenzene derivatives. The 
mechanism of this reaction involves nucleophilic attack by an aniline derivative on a 
nitroso functionality followed by proton transfer and elimination of a water molecule, 
as shown in scheme 24. 
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While the reaction is usually quick and high yielding, its attractiveness as a synthetic 
route is can be limited by the range of suitable nitroso species. Whilst nitrosobenzene is 
commercially available, more highly substituted nitrosoaryls can be challenging to 
access. Preparation of nitrosoaryls is typically achieved by hydroxylamine oxidation, a 
reaction that needs to be carefully controlled to prevent over oxidation and which is often 
poor yielding. The Mills reaction can also be limited by difficulties in product 
purification with the potential for a variety of by-products to be formed. 
 
 
Scheme 24: Mechanism of azo bond formation by the Mills reaction 
 
Reductive couplings offer an efficient route to symmetrically functionalised 
azobenzenes. In situ generation of nitroso and hydroxylamine species during the 
reduction of nitro compounds allows for azo bond formation. The key intermediates in 
the reaction are shown in scheme 25.  
 
 
Scheme 25: Key intermediates of azo bond formation by the reductive coupling approaches. 
 




Zn/NaOH165 have been reported to be suitable for the transformation. The synthesis of 
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the parent azobenzene 14 and a selection of substituted derivatives 132-134 by this 
approach, and the respective reducing conditions, are summarised in scheme 26.  
 
 
Scheme 26: Reductive routes to symmetric azobenzene derivatives 
 
An alternative route to symmetrically functionalised azobenzenes involves oxidative 
coupling of anilines. A range of oxidising agents have been shown to be effective; these 
include HgO,166 MnO4,
166 Pb(OAc)4
167 and hypervalent iodine species.168 Oxidative 
coupling has also been achieved electrochemically169 and with O2 in the presence of 
various metal catalysts. Oxidative azo bond formation is generally a low yielding 
reaction. It is thought to proceed via a radical mechanism,170 as shown for the formation 
of azobenzene 14 in scheme 27. The key step in the mechanism, coupling of the ArNHˑ 




Scheme 27: Mechanism of azo bond formation by oxidative coupling. 
 
2.2 Synthesis of azobenzenes bearing alkyne dipolarophiles at the ortho, 
meta and para positions 
 
The mono- and bis-p-propargyloxyazobenzenes 107171 and 113,129 both known in the 
literature were the initial azobenzene-dipolarophile targets. The corresponding hydroxy 
parents 131 and 133 were identified as key starting materials. The symmetric 4,4’-
hydroxyazobenzene, 133, was prepared by the reductive route starting from 4-
nitrophenol, 137, according to a literature procedure.172,173 4-Nitrophenol was added to 
potassium hydroxide in a minimum amount of distilled water. The reaction slurry was 
heated to 300 °C. After several dramatic colour changes, suggestive of a radical 
mechanism, the product was produced as a yellow solid in 37% yield.174 Subsequent 
reaction with propargyl bromide in the presence of potassium carbonate in dry 
acetonitrile gave the desired bis-ether 113 as a golden coloured crystalline solid, in 95% 
yield. The 1H-NMR spectral data of 133 and 113 agreed with that reported in the 
literature.129 For both compounds, a pair of doublets (J = 8.0 Hz) were observed in the 
aromatic region. For 113 a doublet (2H) and triplet (1H) with reciprocal coupling 
constants (J = 2.5 Hz) represented the propargyl group. The 1H-NMR spectrum showed 
113 presented exclusively in the trans form at room temperature in CDCl3. 
p-Hydroxyazobenzene, 131, the precursor to 107, was formed by an azo reaction. 
Aniline, 126, and sodium nitrite were reacted in the presence of hydrochloric acid to 
form benzenediazonium chloride. A solution of phenol in aqueous sodium hydroxide 
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was subsequently added.175  Electrophilic aromatic substitution resulted in the formation 
of 131 in 57% yield.  The 1H-NMR spectroscopic data of 131 was in agreement with 
that reported in the literature.176 Alkylation with propargyl bromide in anhydrous 
acetonitrile in the presence of potassium carbonate, gave 107 as an orange solid in 88% 
yield. NMR characterisation data match that reported by Yao et al.171 Like its di-
substituted version 113, the 1H-NMR spectrum showed evidence of the trans isomer 
only (r.t., CDCl3). 
 
 
Scheme 28: Synthetic of 113 and 107. 
 
Azo coupling chemistry was not used to target either the o- (138) or the m-
hydroxyazobenzene (141) regioisomers of 131 were targeted through as the electronics 
of this reaction are known to favour the para regioisomer. However, their syntheses have 
been reported in the literature through a range of other methods. The difficulty with 
many of the reported routes is that they proceed from starting materials which are 
themselves difficult to access, or they involve the use of unconventional reagents. 
However, Wachtveitl et al. have reported synthesis of 138 and 141 in reasonable yield 
via the Mills coupling of nitrosobenzene, 125, with either o- or m-aminophenol, 
139/140, in glacial acetic acid (51% and 73% respectively).177 
Attempts to reproduce either of Wachtveitl’s reactions progressed poorly in our hands 
and the 1H-NMR spectra of the crude products in each case showed a complex mixture. 
No pure sample of 138 could be isolated from the reaction of o-aminophenol, 139, with 
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nitrosobenzene, 125. However, after a difficult separation by flash chromatography the 
meta 141 was isolated in 6% yield from reaction with 140. Despite the low yield, 141 
was reacted with propargyl bromide in the presence of potassium carbonate and the 
novel 108 was obtained as an orange solid in 87% yield.  
 
 
Scheme 29: Attempted synthesis of azobenzenes bearing an ortho or meta dipolarophile.. 
 
The 1H-NMR signals arising from the propargyl functionality of 108 mirrored those 
observed for its para regioisomer 107. The OCH2 signal occurred at close to 4.8 ppm 
(d, J = 2.5 Hz) and the terminal alkyne proton was observed at ~2.5 ppm (t, J = 2.5 Hz). 
Signals representing the aryl protons suggested it presents as 10:1 mixture of trans and 
cis geometrical isomers. The signals for the trans isomers, which like the resonances of 
107, appear between 7-8 ppm. A second set of low intensity signals represent the aryl 
protons of the cis isomer were present between ~8.3 and 6.4 ppm. The OCH2 protons of 





Figure 31: Aromatic region of the 1H-NMR spectrum of 108; resonances attributed to the cis isomer are boxed in 
red (CDCl3, 500 MHz). 
 
The 1H-NMR spectra of a number of compounds in this series provide evidence of a 
small amount of the cis isomer in equilibrium with the major product having trans 
geometry about the azo double bond. In such cases, a second set of low intensity peaks 
are observed. The aryl protons nearest the azo bond are those which most frequently 
appear as separate resonances, distinct from their trans counterparts. The signals arising 
from the cis isomer span a wider range of chemical shifts than the corresponding protons 
of their trans counterparts. In particular, a number of resonances of the cis isomer appear 
upfield of the corresponding trans protons.178,179 In the case of 108 the downfield 
resonances of some of the aryl protons of the cis- isomer whilst not rare is less common. 
Following the failure to prepare the ortho substituted 138 and in continued pursuit of an 
azobenzene bearing a propargylic dipolarophile ortho to the azo linkage, it was proposed 
to prepare 144. Although the methyl group at the 5-position limits direct comparisons of 
the chemical and photophysical behaviour of this compound to its ‘regioisomers’ 107 
and 108, it does offer an azobenzene with a dipolarophile in the ortho position 
Since p-cresol, 142, has a ‘blocked’ para position it was believed that an azo coupling 
with aniline may occur at the ortho position, providing 143 as a key intermediate en 
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route to 144. A review of the literature shows that p-cresol reacts with benzenediazonium 
chloride to give the 2-hydroxy-5-methylazobenzene 143.180 We repeated Black’s 
reaction (65% yield) and the NMR spectral data of the orange solid agreed with that 
reported. It presented predominantly in the trans form with extremely low intensity 
signals consistent with the presence of a small amount of the cis form (CDCl3, r.t.). 
To access the novel compound 144 propargyl bromide was reacted with the 143 in the 
presence of K2CO3 in dry acetonitrile. After reaction work up the orange/red product 
was isolated in 79% yield, scheme 30. The 1H-NMR spectrum of 144 (CDCl3), shown 
in figure 32, indicates the product was present almost exclusively in the trans form with 
very low intensity signals attributed to trace amounts of the cis isomer.    
 
Scheme 30: Synthesis of 2-propargyloxy-5-methlyazobenzene, 144 
 




The symmetrical o,o- and m,m-dihydroxyazobenzenes 115 and 114 were the next 
synthetic targets. Reductive coupling of o-nitrophenol and m-nitrophenol were explored 
in turn. A solution of the substrate in diethyl ether was added to a stirring suspension of 
LiAlH4 (5 eq.) in diethyl ether.  In both cases a complex mixture resulted. 
1H-NMR 
spectroscopy and TLC analysis suggested formation of a number of species with no 
dominance of the desired product.  
Reaction of either of the nitrophenols with a potassium hydroxide slurry (300 ˚C) also 
failed to yield the desired compounds.174 In both cases over reduction was observed and 
the aminophenols 147 and 148 were found in good yield. An alternative experiment 
employing sodium hydroxide in ethanol returned, in both cases, the starting materials in 
quantitative yield.181 The failure of these reactions, summarised in scheme 31, led to an 
abandonment of the search for the o,o- and m,m-dihydroxyazobenzenes 114 and 115.  
 
 
Scheme 31: Attempted reductive coupling routes to 114 and 115. 
 
The final azobenzene alkynes targeted were the known 151 and 152; 151 has two 
potential sites for cycloaddition, one alkyne is ether linked and the other ester linked. In 
contrast, 152 only has the ether linked alkyne. p-(p-Hydroxyphenylazo)benzoic acid, 
150, was synthesised according to the literature,182 through azo coupling of p-
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aminobenzoic acid, 149, and phenol, 130, in the presence of sodium nitrite and 
hydrochloric acid. The alcohol and carboxylic acid groups of 150 were converted to the 
corresponding ether and ester functionalities respectively through reaction with 
propargyl bromide in the presence of potassium carbonate in dry acetonitrile. The ester 
linkage was hydrolysed by treatment with sodium hydroxide to give monovalent 152, 
scheme 32. The 1H-NMR data for both the ester 151 and the acid 152 were in agreement 
with that reported in the literature.182  
 
 
Scheme 32: Synthesis of 4-(4-propargyloxyphenylazo)benzoic acid 152 
 
2.3 Preliminarily cycloadditions to azobenzenes bearing one or two 
dipolarophiles: test case reactions 
 
As previously discussed in section 1.3.2, the generation of nitrile oxides for NOAC 
reactions can be achieved under a range of conditions. One option involves direct 
conversion of an oxime to a nitrile oxide by treatment with chloramine-T hydrate (Ch-
T). Alternatively the oxime can initially be converted to its chlorinated derivative by 
treatment with N-chlorosuccinimide (NCS) prior to dipole generation following 
treatment with base. Whilst the direct conversion is often a more straightforward and 
efficient process, its attractiveness is limited by the poor solubility of Ch-T in organic 
solvents and reactions generally require aqueous alcohol media. In comparison 
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conversion of oximes to chlorooximes (or hydroximinoyl chlorides) with NCS is 
typically undertaken in DMF. The chlorooxime can be isolated and subsequent 
cycloaddition, if required, can be conducted in solvents other than DMF. The conversion 
from the hydroximinoyl chloride to the nitrile oxide is extremely rapid upon addition of 
base whereas dipole formation from reaction of oximes with Ch-T, generally involves 
premixing of the reactants. 
To determine the suitability of either or both the Ch-T or NCS routes for the generation 
of nitrile oxides and cycloaddition to alkyne bearing azobenzenes, the p-propargylated 
107 and 116 were reacted in turn with commercially available benzaldehyde oxime, 103, 
in the presence of Ch-T, or with the preformed hydroximinoyl chloride 97 .  
The isoxazole forming reaction between 107 and the nitrile oxide generated through the 
treatment of benzaldehyde oxime with Ch-T in ethanol/water was previously known in 
the group, scheme 33, route A.183,184 The trapping of transient dipole yielded the 
cycloadduct 153 in 88%.  
It was characterised by the appearance of a singlet diagnostic of the isoxazole C-4 
proton, at 6.69 ppm in the 1H-NMR spectrum (CDCl3). A shift in resonance of the OCH2 
protons from 4.68 ppm in the starting alkyne to 5.30 ppm also accompanies cycloadduct 
formation. The aryl proton resonances (CDCl3, 500 MHz) of the azobenzene core of 153 
were complex signals. This is due to the magnetic inequivalence of the protons 6 and 6a, 





Figure 33: Aromatic region of 1H-NMR spectrum of 153 CDCl3 500 MHz. 
 
To evaluate the chlorooxime route to 153, scheme 33 route B, benzaldehyde oxime was 
initially converted to its hydroximinoyl chloride, 97, by reaction with NCS in DMF. The 
success of the reaction was confirmed by the disappearance of the C-H singlet of the 
imine, at 8.04 ppm, in the 1H-NMR spectrum (CDCl3) of the starting oxime and by a 
downfield shift in the OH resonance from within the multiplet at 7.49-7.58 ppm to a 
sharp singlet at 8.13 ppm in the chlorooxime. The hydroximinoyl chloride under the 
influence of triethylamine in ethyl acetate generated the transient nitrile oxide which 
reacted in situ with the p-propargylated azobenzene 107 to afford the cycloadduct 153 





Scheme 33: NOAC leading to 153; exploring two routes for dipole formation: Ch-T (route A) and NCS/ NEt3 (route 
B). 
 
In conclusion, both Ch-T and NCS/NEt3 approaches were effective in generating nitrile 
oxides which could be trapped in situ by the propargyloxyazobenzene 107. Starting from 
benzaldehyde oxime in reaction with Ch-T, the cycloadduct 153 formed in higher yield 
(88%). The two step oxime to chlorooxime to cycloadduct yields 153 in 48% over the 
two steps. The lower yield of the cycloaddition step in going from 97 to 157 is possibly 
due to the faster formation of the nitrile oxide, which facilitates self-reaction of the 
dipole. 
The p,p-bis-azobenzene dipolarophile, 116, had poor solubility in aqueous ethanol and 
thus cycloadditions utilising Ch-T were not attempted and the hydroximinoyl chloride 
97 was used as a precursor to the nitrile oxide. 
Dipolarophile 116 was poorly soluble in many common solvents. DMF, DMSO, EtOAc 
and CHCl3 were found to be the best for solubilising it. DMSO and DMF were 
unattractive due high boiling points and miscibility with water, therefore, CHCl3 and 
EtOAc were selected as solvents for cycloadditions leading to 154. The dipole was 
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formed in situ by the addition of NEt3 to a solution containing 116 and 6 equivalents of 
the chlorooxime 97.  
The success of the reaction was initially estimated by comparing the relative integration 
of the signals of the isoxazole (6.69 ppm) and OCH2 protons of the cycloadduct 154 (s, 
5.31 ppm) with that of the starting material OCH2 protons (t, 4.78 ppm). Following 
purification by flash chromatography the desired cycloadduct 154 was isolated in 81% 
yield when the reaction was undertaken in chloroform and in 74% yield when ethyl 
acetate was selected as solvent, scheme 34. The 1H-NMR spectrum of purified 154 
(CDCl3, 500 MHz) also suggested restricted rotation about the single bonds, as seen for 
its monovalent analogue 153. The aryl protons of the azobenzene unit were second order 
multiplets due to their magnetic inequivalence.  
 
 
Scheme 34: NOAC leading to divalent cycloadduct 154 
 
The potential for the azobenzene dipolarophiles to be trapped with azide dipoles in 
CuAAC reactions was also of interest. Therefore the cycloadditions of 107 and 116 with 
benzyl azide were investigated in turn. The dipolarophile and benzyl azide, 155, were 
dissolved in a DMSO/H2O mixture prior to the addition of CuSO4.5H2O and sodium 
ascorbate, followed by stirring for 16 hours at room temperature. 
The mono alkyne, 107 was reacted with two equivalents of the azide. The catalyst 
loading was 20 mol % with respect to the alkyne. The cycloadduct 156 was isolated in 
89% yield. The bis propargyl azobenzene, 116, was reacted with two equivalents of 
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azide per alkyne functional group, i.e. four molar equivalents. Catalyst loading was 40 
mol % loading per alkyne functional group and the cycloadduct 157 was isolated in 87% 
yield, scheme 35. The catalyst loading is high, however, it is cheap and readily accessible 
and the project did not test the loading limits. 
 
Scheme 35: CuAAC leading to the mono- and divalent triazoles 156 and 157. 
 
The 1H-NMR spectra of the cycloadducts 156 and 157 indicate the compounds presents 
mainly as the trans isomers, with low intensity signals for the cis isomer in both cases. 
The ratio of the cis to trans isomer for 156, shown in figure 34, was roughly 1:13. The 
most shielded aryl protons of cis form of 156 were observed as far upfield as 6.8 ppm, 
whilst the most shielded aryl proton of trans isomer appears at 7.2 ppm (DMSO-d6).  
The triazole CH (8.3 ppm) is much more deshielded than is typically observed for an 
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isoxazole CH (7.3 ppm) (DMSO-d6). Both 156 and 157 show the aryl protons of the 












Figure 34: Region of the 1H-NMR spectrum of cycloadduct 156 showing the dominance of the trans isomer; signals 
attributed to the cis isomer are identified in red boxes (500 MHz DMSO-d6) 
 
2.4 Synthesis of azobenzenes bearing a 1,3-dipole functionality 
 
Following on from the successful synthesis and preliminary cycloaddition reactions of 
azobenzenes bearing dipolarophile functionalities, the next objective was to develop a 
range of substrates bearing one or more 1,3-dipole functionalities. The first targets were 
azobenzenes bearing oxime or chlorooxime groups as precursors to nitrile oxide dipoles. 
The development of azobenzenes with an azide functionality was also explored. 
The first synthetic target was the oxime, 110, a compound previously synthesised in the 
group. As summarised in scheme 36, it was accessed from 4-phenylazobenzoic acid, 
158.184 The carboxylic acid was reduced to the primary alcohol, 159, (LiAlH4, diethyl 
ether) followed by controlled oxidation to the aldehyde, 160, with PCC in DCM in the 
presence of molecular sieves. The molecular sieves are an important additive since 





purified. For example, when the reaction was conducted in the presence of molecular 
sieves purification by passing the mixture through a silica plug yielded the compound in 
81% yield. In contrast, following reaction in the absence of molecular sieves 160 could 
be isolated in only 65% yield.  
Successful oxidation of 159 was also achieved with catalytic amounts (5 mol %) of 
tetrapropylammonium perruthenate (TPAP) in the presence of N-methylmorpholine 
(NMM) and 160 was isolated in 78% yield. The catalyst was not recovered. 
The oxime, 110, was generated from the aldehyde 160 by reaction with hydroxylamine 
hydrochloride in ethanol, pyridine was added to liberate the free hydroxylamine.185 
Reaction was initially carried out on a small scale (1.25 mmol) in a Scientific Microwave 
((T= 125 ˚C, P = 300 W, t = 1 hr) furnished 110 in 87% yield. However, the reaction 
scale was limited due to size of the microwave vessels. 
The reaction was also successful of a larger scale (9.4 mmol) with conventional heating. 
The reaction mixture was heated to reflux for 4 hours, the oxime 110 was furnished in 
83% yield. Satisfyingly, regardless of the heating method, the oxime 110 was easily 
isolated by precipitation following the addition of water to reaction solution. It was 
readily characterised by 1H-NMR spectroscopy (300 MHz, CDCl3); the imine proton 
resonated at 8.20 ppm. 
The Ar-H resonances of 110 overlapped and signals for the and the individual aromatic 
hydrogens could not be unambiguously assigned. The sample presented as a single 
isomer about both the azo and oxime functional groups. Oxime stereochemistry is 
unconfirmed but on steric grounds is assumed to be anti, as shown in scheme 36, (as is 





Scheme 36: Synthesis of the oxime 110. 
 
The meta oxime 111 was also known in the group.184 It was synthesised, as shown in 
scheme 37, starting with a Mills coupling between 3-aminobenzyl alcohol, 161, and 
nitrosobenzene in the presence of glacial acetic acid to give 3-(phenylazo)benzyl 
alcohol, 162. Oxidation to the aldehyde 163 was achieved with PCC in DCM in the 
presence of molecular sieves. Finally reaction of 163 with hydroxylamine hydrochloride 
in ethanol in the presence of pyridine yielded the desired oxime 111 as an orange solid, 
in 82%.184  
 
 




To synthesise the symmetrical bis-oxime 116, 4-nitrobenzaldehyde, 164, was protected 
with ethylene glycol in the presence catalytic amount of p-TsOH.186 The condensation 
reaction was conducted in toluene and a Dean-Stark trap was used to remove the water 
as formed so driving acetal formation to completion. The protected 165, formed in 84% 
yield, was subjected to reductive coupling following reaction with  LiAlH4 (5eq.) in 
diethyl ether and 166 was formed in 86 % yield.187 Deprotection and oxime formation 
were achieved in one step following treatment of 166 with hydroxylamine hydrochloride 
in ethanol in the presence of pyridine. Oximation was successful by both microwave 
(0.74 mmol scale, 53% yield) and conventional heating approaches (4 mmol scale, 44% 
yield). The compound 116 was found to be insoluble in chloroform, therefore NMR 
spectra were recorded in DMSO-d6. The symmetrical compound showed two doublets 
for the aromatic protons; the imine resonance occurred at 8.26 ppm and the hydroxyl 
resonance at 11.57 ppm. 
 
Scheme 38: Synthesis of bis oxime 116. 
 
The only preparation of the m,m-bis-oxime 117 recorded in the literature involves the 
reduction of m-nitrobenzaldehyde, 167 using Zn power.188 The paper is ambiguous about 
the exact reaction conditions, therefore the reported approach was not adopted for this 
work and a reaction sequence parallel to that used to synthesise p,p-dioxime 116 was 
explored in search of 117 (scheme 39). m-Nitrobenzaldehyde was protected with 
ethylene glycol in the presence of p-TsOH,189 subsequently the nitro groups were 




Direct conversation to the oxime 117 was effected by treatment with NH2OH. However, 
unlike its p,p-derivative 116, the pure product did not precipitate on addition of water. 
Instead, purification by flash chromatography was required to separate several minor 
by-products and 117 was isolated in a modest 48% yield. 
 
 
Scheme 39: Synthesis of m,m-bis-oxime 117. 
 
4-Azidoazobenzene, 171, known in the literature,190 is an attractive target for facilitating 
direct comparison of the cycloaddition potential of azobenzene azides with azobenzene 
nitrile oxides. Its structure ‘parallels’ that of the nitrile oxide accessible from oxime 110. 
Potential cycloadducts arising from both the dipoles would have the heterocycle attached 
directly to the azobenzene unit in the para position. 
The azide 171 was synthesised from aminoazobenzene, 170, in a one pot reaction with 
water as the solvent.190 The intermediate diazonium salt, generated by reaction with 
sodium nitrite in the presence of p-TsOH, was directly reacted with sodium azide giving 




Scheme 40: Synthesis of the azidoazobenzene 171. 
 
2.5 Preliminary cycloadditions of azobenzenes bearing a 1,3-dipole 
functionality  
 
Propargyloxybenzene, 173, was selected as a simple dipolarophile for investigating 
reaction conditions suitable for cycloaddition to azobenzene 1,3-dipoles. Its reaction 
with the para and meta azobenzene oximes 110 and 111 were previously known in the 
group;184 5 equivalents of either oxime was allowed to mix with chloramine-T in 
aqueous ethanol for 10 minutes at room temperature before addition of the alkyne and 
warming to 40 ˚C. A product yield of 89% was reported for the formation of 172 and 
46% yield for its meta analogue formed via route B1, scheme 41. 
The reaction of 110 with 173 was revisited to explore the effectiveness of dipole 
generation by the NCS/NEt3 approach. Initially a one pot reaction was conducted, route 
B2, scheme 41. Initial conversion of oxime 110 to the hydroximinoyl chloride effected 
by treatment with NCS in DMF. After 1 hour NEt3 was added to effect the conversion 
to the nitrile oxide. The resulting mixture was stirred at room temperature for eight 
hours. The cycloadduct 172 was ultimately isolated in 73% yield. which is slightly less 
than the 89% achieved by the Ch-T approach. 
In a second experiment (route A, scheme 41), the hydroximinoyl chloride 174 was 
preformed and isolated (81%) prior to dipole formation (NEt3) and reaction with the 
alkyne 173. In this case, the cycloadduct 172 was isolated in 76%. This corresponds to 
a reduced 62% yield over the two steps starting from oxime 110. 
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The 1H and 13C-NMR spectral data for 174 are interesting and show both cis and trans 
isomers (CDCl3, 500 MHz). The 
13C NMR spectrum of 174 is expected to show nine 
resonances, five Ar-C and four quaternary carbon signals. Ar-CH signals are seen for 
the major isomer at 122.9, 123.1, 128.0, 129.2 and 131.6 ppm and for the minor isomer 
at 120.5, 120.7, 127.8, 128.1 and 128.9 ppm. The quaternary carbons appear at 134.4, 
139.4, 152.6 and 153.7 ppm for the major isomer. The quaternary signals for the minor 
isomer were not observed. The 1H-NMR data suggests two isomers are present in a 5:1 
trans to cis ratio . 
 
 





Scheme 41: Synthesis of the cycloadduct 172. 
 
The p,p-bis oxime 116 was selected as a test case compound to study the potential for 
formation of divalent conjugates. Substrates with two nitrile oxide functionalities are 
potentially difficult to work with. To promote good cycloadduct yields from NOAC 
reactions, in particular to negate any loss of dipole due to dimerization side reactions, 
the nitrile oxide is generally used in excess. Substrates with two nitrile oxide groups 
have a much greater propensity for side reactions including dimerization and 
polymerisation. To minimise self-reaction of the dipole during cycloaddions, an excess 
of the dipolarophile is generally used.191,192  
The bis-oxime 116 was treated with chloramine-T in an ethanol/water mixture, followed 
by addition of three equivalents of propargyloxybenzene, 173, i.e. 50% excess per 
dipole. The reaction solution was warmed to 40 ˚C for four hours ,table 1, A1. Analysis 
of the crude product by 1H-NMR spectroscopy revealed a complex mixture with no 
evidence for the formation of the desired bis isoxazole 175, scheme 42. 
The reaction was repeated and the dipolarophile excess increased to six molar 
equivalents (i.e. 3 functional group equivalents) (A2). However, the reaction still 
resulted in formation of a complex mixture. In a third attempt more forcing conditions 
were applied and the reaction mixture was heated to reflux (A3). Again no evidence of 
the formation of cycloadduct 175 was observed in the 1H-NMR spectrum of the crude 
product mixture, scheme 42. 
The failure to produce 175, from the reaction between oxime 116 and Ch-T lead us to 
explore reaction with the bis-hydroximinoyl chloride 176, was synthesised in 72% yield 
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from 116 by the additions of six molar equivalents (or three functional group 
equivalents), of NCS in DMF.  
The 1H-NMR spectrium of 176, like its precursor 116, shows it exists as a single 
geometric isomer with a pair of AB doublets for the aromatic protons. The hydroxyl 
proton appears at 12.75 ppm, figure 35.  
 
Figure 36: Overlaid 1H-HMR spectra of the bis-oxime 116 (upper) and its chlorooxime derivative 176 (lower) 
(DMSO-d6, 500 MHz). 
 
The bis-chlorooxime 176 was reacted with a six molar equivalents of 173, i.e. a 3:1 
functional group ratio, in the presence of triethylamine, scheme 42 and table 1, route B1. 
Analysis of the 1H-NMR spectrum of the crude material indicated a complex mixture 
with limited evidence of the desired product 175, which was finally isolated in just 2% 




Scheme 42: Attempted synthesis of 175 with Ch-T and successful synthesis of 175 via 176, details of explored 
conditions for route A and B shown in table 1. 
 
A search of the literature for NOAC reactions with substrates bearing two or more 
hydroximinoyl chlorides revealed that slow addition of base reduces the rate at which 
the nitrile oxide forms and so limits side reactions e.g. dimerization or polymerisation.191  
In an attempt to optimise the reaction leading to 175, a solution of NEt3 in ethanol was 
slowly added over 40 minutes to the bis-hydroximinoyl chloride 176 and the alkyne 173 
(B2). This revised protocol, resulted in a much improved 21% yield. 
Another publication suggested the yields of NOAC reactions may be increased by 
conducting the reaction under more forcing conditions such as heating to reflux in 
toluene.193 All the reagents 176, 173 (3 mol eq.) and NEt3 were combined at once and 
heated to reflux in toluene, after 24 hours 175 was isolated in an increased 32% yield 
(B3).  
In an attempt to further increase the yield of 175 an experiment was designed which 
combined elements of both these approaches. A solution of NEt3 in ethanol was slowly 
added to 176 and 173 (3 mol eq.), followed by heating to reflux for 20 hours (B4). In 
this case, 175 was obtained 46% yield. 
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The appearance of a isoxazole proton resonance, assigned as the singlet at 6.73 ppm, 
together with the shift in the resonance of the OCH2 protons, from 4.70 ppm in the 
starting alkyne to 5.25 ppm in the cycloadduct are consistent with regiospecific 
formation of the 5-substituted isoxazole at each end of the molecule.  
 























EtOH 0.11 1:3 4 40 No 175  
A.2 Oxime 
116 
EtOH 0.11 1:6 4 40 No 175 
A.3 Oxime 
116 








EtOH 0.046 1:6 20* 
 








EtOH 0.046 1:6 20* 
 
83 175 - 46% yield 
 
ǂ Dipole precursor: alkyne ratio is the number of mole equivalents of alkyne to 
each dipole precursor. Since the oxime 116 or chlorooxime 176 potentially furnish 2 
equivalents of nitrile oxide,  a 1:3 molar ratio of ratio implies a ratio of 2:3 alkyne to 
dipole precursor in terms of functional groups,  




2.6 Attempted synthesis of o-azobenzene oximes and resulting indazole 
formation 
 
With the p- and m-azobenzene oximes 110 and 111 successfully synthesised, the o-
isomer 112 was targeted to complete the regiosomeric series. At the outset of this 
investigation, it was known that the route developed for the p- and m-derivatives was 
not suited to the generation of 112.  
It had been noted in the group, the aldehyde 179 could not be obtained by oxidation of 
the hydroxymethyl precursor and reaction with DMP resulted in formation of a 
colourless compound, scheme 43. The loss of colour indicated a reaction in which the 
azo group had been consumed. Subsequently analysis by X-ray crystallography showed 







Scheme 43: Synthetic route planned to access 112; formation of the indazole 180.184 
 
Whilst the mechanistic details for the generation of 180 from 178 are unknown, several 
papers report indazole formation from azo substrates. For example, Xi created the same 
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indazole 180 in a reaction involving an initial rhodium catalysed insertion of an olefin 
ortho to the azo linkage, prior to cyclisation as shown in scheme 44, route A.195 An 
second group report I2 mediated attack of the azo linkage on an ortho methyl group 
route B, as shown in scheme 44, Route B.196 
 
 
Scheme 44: Indazole formation from azobenzene substrates.195,196 
 
It is further reported that nucleophilic azo attack of azobenzenes bearing adjacent 
electrophilic centres readily furnishes the indazole skeleton.197,198 In particular, Hecht et 
al. observed cyclisation of the acetal 182 during an attempted deprotection with 1M HCl 
in acetone, scheme 45. They proposed indazoles 183 and 184 arose by pathways A and 
B respectively involving attack of the azo group on an adjacent oxonium species (route 
A) or on a protonated aldehyde (route B).199  
 
 
Scheme 45: Mechanism of formation of indazoles 183 and 184 from acid induced reactions of 182. 
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With Hecht’s work in mind, we sought a new synthetic route to oxime 112 which would 
avoid the potential incompatibility between the proximate aldehyde and the azo 
functional group of 179. A Mills coupling between nitrosobenzene 125 and 2-amino 
benzaldehyde oxime 186 was planned, as shown in scheme 46. 
 
 
Scheme 46: Attempted synthesis of oxime 112 and isolated by-products. 
 
2-Aminobenzaldehyde 185 was converted in good yield to the required oxime 186.200 It 
was subsequently treated with nitrosobenzene 125 under typical Mills coupling reaction 
conditions.201,202  
Initially oxime 186 was added to nitrosobenzene, 125, in glacial acetic acid. After an 
hour at 0 °C, followed by 3 hours at room temperature, the crude mixture was analysed 
by 1H-NMR spectroscopy.201 The data failed to support the formation of the desired 
product, there was no peak observed for the expected aryl aldoxime CH=NOH which 
would typically be a singlet between 7.5-8.5 ppm. The following compounds were 
isolated following separation by flash chromatography: o-cyanoazobenzene 187 (9%), 
azoxybenzene 188 (6%) and unreacted oxime 186 (28%).  The  cyanoazobenzene 187203 
and azoxybenzenes 188198 are known compounds and the 1H NMR spectra of the 
isolated materials match those reported in the literature. 
The mechanistic origins considered for formation of 187 are summarised in scheme 47; 
it may have arisen either from the dehydration of the starting oxime leading initially to 
the aminonitrile 189 followed by Mills coupling (path A) or by dehydration from the 
targeted product 112, path B scheme 47.204-206 There is literature precedence for the 
dehydration of an aryl aldoxime following heating first to reflux in acetic acid, and then 
in acetic acid in the presence of hydrochloric acid.207 Aldoxime dehydration has also 
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been observed under basic conditions208 and has been promoted by a variety of 
catalysts.209,210 In one example dehydration of a dimethlyamino analogue of 112, has 
been observed upon treatment with CuSO4, NEt3 and DCC in chloroform.
211 
To explore the possibility that 187 involved initial oxime dehydration, a solution of 
oxime 186 was stirred at room temperature in glacial acetic acid for 3 hours (73 mmolar, 
0.73 mmol scale). After this time, the oxime was returned in quantitative yield, ruling 
out the possibility that 189 was an intermediate en route to the cyanoazobenzene 187, 
path A, scheme 47. 
 
    
Scheme 47: Possible routes to o-cyanazobenzene 187 from the reaction between aminobenzadehyde oxime and 
nitrosobenzene. 
 
The failure of 186 to dehydrate on exposure to acetic acid may be explained by the 
examining the relative pKas of its amine and the oxime functional groups.212,213 It is 
likely that the more basic amine is the preferred site of protonation, making acid induced 
oxime dehydration of 186 unlikely. It remains possible that the reaction between 125 
and 186 did lead to 112 and that it its dehydration accounts for the failure to isolate 112.  
In considering the origin of azoxybenzene 189, we have found that there is precedence 
for formation azoxy products from the coupling of anilines and nitrosobenzenes under 
typical Mills coupling conditions, for example, the highly substituted 192 resulted from 
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the reaction between diaminodurol and 4-(dimethylamino)nitrosobenzene, as shown in 
scheme 48.214 However, the origin of the azoxy derivative 189, from the reaction 
between 186 and nitrosobenzene is not easily accounted for since in addition to coupling, 
the mechanism must account for loss of the oxime functional group for 193 or one of its 
derivatives as shown in scheme 49, route A. However, whilst the elimination of oxime 
functional groups under flash vacuum pyrolysis has been observed215 such as reaction is 
not likely under the conditions employed in this experiment. 
 
 
Scheme 48: Reaction between diaminodurol and 4-(dimethylamino)nitrosobenzene under Mills conditions leading 
to the azoxy dervitive 192. 
 
It could also be considered that azoxybenzene 189 may have resulted from self-reaction 
of nitrosobenzene, scheme 49 route B.216,217 However, such couplings normally require 
drastic conditions,  for example, treatment with elemental carbon in an arc reactor.218 
These conditions are very forcing compared to those employed in our experiments and 
nitrosobenzene dimerization is not the likely origin of the unsubstituted azoxybenzene 
189. 
Finally, 189 may be considered to arise from reaction between one molecule of 
nitrosobenzene with a molecule of phenyl hydroxylamine 194, generated in situ by 




Scheme 49: Proposed mechanistic origins of azoxyazobenzene 189. 
 
In a second experiment targeting the ortho substituted azobenzene aldoxime 112, the 
Mills coupling reaction between the amino oxime 186 and nitroso benzene was repeated 
and its duration was extended to 14 hours. Following flash chromatography the reaction 
products were the starting oxime 186 (15%), azoxybenzene 187 (28%), and o-
cyanoazobenzene 188 (24%). The desired product was not found in the mixture. 
The failure of the Mills approach to furnish 112 prompted a change in direction and the 
symmetrical dioxime 118 was the new target. The approach to 118 was centred around 
a reductive coupling of the acetal protected nitrobenzaldehyde 196, shown 
retrosynthetically in scheme 50. Aldehyde protection was used to avoid potential 
cyclization between azo and aldehyde functionalities. It was hoped that direct 
conversion from the acetal 197 to the bis-oxime 118 would be possible. If the oxime was 
insufficiently electrophilic indazole formation could be prevented and 118 could be 




Scheme 50: Retrosynthetic route and proposed forward reaction for formation of the bis-oxime 118. 
 
Treatment of o-nitrobenzaldehyde 197 with ethylene glycol in the presence of an acid 
catalyst gave the acetal protected 196 in 64% yield.186 LiAlH4 in diethyl ether was used 
in the attempted reductive coupling of 196187 and reaction work up involved the addition 
of dilute sulphuric acid. 1H-NMR spectroscopic analysis of the orange coloured crude 
products showed a complex mixture. However, a singlet at 5.55 ppm (CDCl3) was 
interpreted as potentially representing the acetal CH proton of 195. The upfield shift of 
this signal compaired to the corresponding proton in the starting 196 (6.32 ppm in 
CDCl3) was thought to be in keeping with transformation of the nitro group of 196 to 
the less electron withdrawing azo group of 195.217  Encouraged by the orange colour and 
the appearance of the new ‘acetal CH singlet’ in 1H NMR spectrum, the product mixture 
was treated with hydroxylamine hydrochloride without purification in an attempted one 
step deprotection/oximation sequence.185 The crude mixture from this reaction was 
analysed by 1H NMR spectroscopy and was found to comprise of one major, asymmetric 
product, which was isolated as a colourless solid following trituration with diethyl ether 
and pet. ether.  
The 1H-NMR spectral data of this colourless product included singlets at 7.79 and 11.52 
ppm, characteristic of the CH and OH resonances of an oxime.  A further 1H singlet 
resonance at 8.73 ppm and 13C resonances at 122.4, 128.8, 139.4 and 149.4 ppm, 
together with the lack of colour a suggested the product may have been the oxime 














Figure 37: 1H-NMR spectrum of indazole 198 (DMSO-d6, 500MHz). 
 
The structure was unambiguously identified as 198 following analysis by x-ray 
crystallography, figure 37. Crystals were grown by the vapour diffusion technique. The 
compound was dissolved in methanol and slow diffusion of chloroform allowed quality 
crystals to be obtained. The crystallographic data showed that the phenyl ring is rotated 
roughly 35˚ out of the plane of the bicycle. The packing diagram shows intermolecular 
hydrogen bonding between the hydroxyl of one oxime and the N-2 nitrogen atom of the 
indazole of another molecule (NˑˑˑH-O distance 2.785 Å). 
To avoid the possibility that 198 resulted from cyclisation of 195 induced by the acid 
used in work up of the LiAlH4 reduction reaction, the coupling experiment was repeated 
and the reaction work up based around the Fieser method of quenching.219 involving 
quenching of excess LiAlH4 by slow addition of water and NaOH followed by removal 
of the salts by filtration. Surprisingly, under the modified experimental conditions the 









Figure 38: Left: Molecular structure of 198 with atomic displacement parameters shown at 50% probability; right: 
Packing diagram of 198 viewed down the a-axis. Hydrogen atoms omitted for clarity. 
 
It is difficult to be unambiguous about the mechanistic origin of indazole 198, however, 
the lack of a 2-oxo or a 2-hydroxyethoxy substituent suggests it did not form by 
mechanisms parallel to those suggested by Hecht et al. for the mono-protected analogue 
182, scheme 45. 
To reduce the potential for azo-cyclization and to promote formation of 118, we wanted 
to avoid intermediates bearing aldehyde functional groups. Direct reductive coupling of 
o-nitrobenzaldehyde oxime 199 was investigated.  
o-Nitrobenzaldehyde, 197, was converted to oxime 199 and its potential as a precursor 
to 118 was explored under a range of conditions, scheme 51.185 LiAlH4 promoted 
reductive coupling of 199 in diethyl ether produced a complex mixture of products, the 
1H-NMR spectrum was not consistent with survival of the oxime group, scheme 51 (ii). 
In a second experiment KOH was used as the coupling promotor and the reaction was 
conducted using the conditions which had been successful in the reduction producing 
113 (300 ˚C).220 Analysis of the resulting complex mixture by 1H-NMR spectroscopy 








Scheme 51:  Attempted formation of bis-oxime 118 by reductive coupling of 2-nitrobenzaldehyde oxime. 
 
The reductive coupling of 199 was further explored with NaBH4, scheme 51 (iv). The 
reduction was first attempted at low temperature (-82 °C) in diethyl ether. Under these 
conditions unreacted oxime was returned. There is literature precedence for NaBH4 
promoted azobenzene formation in DMSO at 80 °C from a wide range of aromatic nitro 
compounds.221 Reaction of 199 with NaBH4 was repeated at 80 ˚C (DMSO). At shorter 
reaction times (t = 5 mins - 1.5 hrs ), the starting oxime was returned, at longer times (t 
= 6-24 hrs ) complex mixtures were produced. 1H NMR spectral data of a number of 
isolated products supported the presence of the starting oxime 199, 2-
aminobenzaldehyde oxime, 186200 and benzaldehyde oxime, 103, as the main 
contributors in the product mixtures.222 
In a further attempt to access 118, a final year student doing a research project in the 
laboratory explored a reductive coupling of 196 employing zinc and hydroxide, scheme 
52 (ii, a).223 After flash chromatography of the complex product mixture, small orange 
crystal were isolated directly from the column fractions (diethyl ether : pet. ether, 1:1). 
Analysis by x-ray crystallography unambiguously identified the structure as 2,2’-(1,3-
dioxolane)azobenzene (195). The structure, shown in figure 38, indicates in the solid 
state, as expected, the azo functional group adopts the trans geometry. Disappointingly 





Figure 39: Molecular structure of 195 with atomic displacement parameters shown at 50% probability. 
 
The 1H-NMR spectrum of 195 showed the acetal proton resonance ~0.5 ppm downfield 
of the corresponding signal in the starting material 196. Thus negating the earlier 
interpretation that the azoacetal 195 was an intermediate species present amongst the 
products of LiAlH4 reduction of 196, (scheme 50) the species identified in that reaction, 
with the upfield singlet resonance remains unidentified. 
 
Scheme 52: Attempted synthesis of the bis-oxime 118. 
 
The reductive coupling of nitroaryl compounds was also reported with Mg in MeOH.224 
In an attempt to access 195 in higher yields, 196 was heated to reflux with five mole 
equivalents of magnesium (30 mins) scheme 52 (ii, b), the masked aldehyde 195 was 
isolated in 14%. To try to improve the yield further, the reaction was repeated on the 
same scale but was heated to reflux and left at this temprature overnight, scheme 52 (ii, 
c), however, the yield did not improve. The reaction was also repeated with double the 
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quantity of magnesium, scheme 52, (ii, d) however in this case over reduction of the 
nitro group occurred and protected aminobenzaldehyde oxime was observed as the 
major product. In this case none of the desired 195 could be isolated from the 
experiment. 
Since the yields of 195  isolated from the magnesium induced reductions were so 
modest, the reduction of 196 was repeated with an increased quantity of zinc (10 
eq.).225,226 Following 3 hours of reaction time, the 1H-NMR spectrum indicated the 
starting material was completely consumed, however the known azoxy product, 200,225 
dominated the product mixture. In a subsequent experiment, the reaction was repeated 
with 20 equivalents of zinc to facilitate the conversion of any of the intermediate azoxy 
200. The 1H-NMR spectrum showed a complex mixture formed with no identifiable 
products. 
The protected azoxy 200 was successfully converted to the novel di-oxime 201 by 
treatment with hydroxylamine in the presence of pyridine in ethanol when the solution 
was heated to 125 ˚C in a Scientific Microwave, scheme 53. The bis oxime, isolated in 
86% yield does not undergo intramolecular cyclisation as azoxy groups have quite 
different reactivity to their azo analogues.226,227  
 
 
Scheme 53: Reductive coupling leading to the azoxybenznene 200 and its subsequent conversion to bis-oxime 201. 
  
Due to the failure of the various experiments designed to access either the o-oxime 112 
and the o,o-bis-oxime 118 and because of the potential problems of intramolecular 
cyclisation or possible issues with intermolecular cycloaddition of an azobenzene 
bearing in ortho substituted nitrile oxide (scheme 54), a decision was made to abandon 
the pursuit of azobenzenes with oxime functional groups in the positions ortho to the 




Scheme 54: Potential intramolecular cyclisation and intermolecular cycloaddition reactions of an azobenzene with 
ortho substituted nitrile oxide. 
 
It was noticed during TLC analysis that the indazole oxime 198 was weakly fluorescent 
and its fluorescence emission spectrum was recorded in THF (12 μM), figure 39. 
 
  
Figure 40: Fluorescence emission spectrum of Indazole 198 (12 μM, THF, ex. 295 nm). 
 
It was proposed that the oxime of 198 might provide handle to introduce a fluorescent 
indazole tag on a substrate of interest. Several attempts were made to promote NOAC 





























treated with Ch-T in ethanol before addition of the alkyne and stirring for 16hrs. The 
resulting product was dominated by the starting oxime 198. In a second experiment, 
chlorination of 198 with NCS in DMF was attempted, however, a complex mixture 
resulted. In a final experiment a one pot chlorination/dehydrochlorination cycloaddition 
sequence was explored. Treatment with NCS in DMF for an hour followed addition of 
the alkyne 173 and finally the slow addition of triethylamine also resulted in a complex 










 A range of azobenzenes bearing 1,3-dipoles, precursors to 1,3-dipoles or 
dipolarphilic functionalities were synthesised 
 An alkyne functionality was introduced ortho, meta or para to the azo-linkage; 
a symmetrical p,p-disubstiuted azobenzene bearing two alkyne groups was also 
successfully synthesised. 
 Azobenzene-alkynes were successfully reacted with simple “1,3-dipole 
partners”; several routes were found effective for formation of putative nitrile 
oxides from precursor oximes. 
 Azobenzenes with an oxime functionality in the para or meta position were 
synthesised; symmetrical m,m- and p,p-bisoximes were also accessed.  
 Test case reactions showed cycloaddition with monofunctional oximes could be 
effected by multiple routes, but that those azobenzenes with two oximes 
requiredmore specific reaction conditions. 
 Synthesis of an azobenzene bearing an oxime functionality in the ortho position 
was difficult. In particular, cyclisation between the azo functionality and any 










Following the successful synthesis of a range of azobenzenes bearing either 1,3-dipole 
or dipolarophile functionalities and the subsequent exploration of conditions suitable for 
their cycloaddition  to ‘simple’ partners, the next aim was to apply this knowledge to 
form azobenzene-biomolecule conjugates. 
The biomolecules desired for conjugation included peptides, nucleic acids and 
carbohydrates. Structures of a diverse range of azobenzene appended biomolecules can 
be found in the introduction of this thesis. These molecules, with wide rangeing 
applications have been accessed by a variety of chemistries. In this research we aimed 
to develop cycloaddition chemistry as a general route to form azobenzene-biomolecule 
conjugates.  
In this work the biomolecule targets were split into two categories: carbohydrates and 
nucleic acids, and peptides. The peptide substrates offered very different synthetic 
challenges and will be considered separately from the carbohydrate and nucleic acid 
class which would be functionalised by the introduction of cycloaddition handles to 
hexose and deoxyribose units respectively. 
 
3.1 Carbohydrates functionalised with azobenzenes 
 
3.1.1 Synthesis of and cycloaddition to carbohydrate dipolarophiles  
 
Galactose, 204, mannose, 205, and lactose, 206, were selected as the representative 
saccharide units to be conjugated with an azobenzene unit. Their structures are shown 





Figure 41: The structures of galactose, mannose and lactose, with undefined stereochemistry at the anomeric 
position. 
 
Galactose, the C-4 epimer of glucose, is commonly found in the human body in 
glycolipids, glycoproteins and antigens. It plays an important role in cell recognition 
processes. Mannose, the C-2 epimer of glucose, is also an important biological molecule. 
In particular it has been a popular choice for studying carbohydrates-lectin interactions. 
The disaccharide lactose is a major component of milk, metabolically it is broken down 
into its constituent galactose and glucose units, which are consumed for energy. It has 
various applications in the food industry. 
The multitude of hydroxyl functional groups on a carbohydrate substrate means 
protecting group chemistry is often extensively utilised in accessing selectively 
functionalised derivatives. Several protection and deprotection steps can make syntheses 
somewhat laborious. In this project we wished to use the C-1 position as the anchor point 
for sugar conjugation and acetyl protection was an attractive choice. Galactose and 
mannose pentaacetates, and lactose octaacetate are reliable substrates capable of 
controlled glycosidic bond formation. 
2-Propynyl-tetra-O-acetyl-β-D-galactopyranoside, 209, 2-propynyl-tetra-O-acetyl-α-D-
mannopyranoside, 211, and 2-propynyl-octa-O-acetyl-β-D-lactose, 213, were the initial 
target carbohydrate bearing dipolarophile compounds. They were accessed through a 
two-step synthesis, which has been applied to a wide range of related carbohydrate 
substrates. 
Galactose, mannose and lactose were fully protected by heating to reflux in acetic 
anhydride in the presence of sodium acetate. The products were purified by 
crystallisation. Acetylation of saccharides generally favours formation of the β-
isomer.228 The reaction between the hydroxyls and anhydride in the presence of a weak 
base, typically sodium acetate, is slow and anomerization occurs more rapidly and 
reaction by the more nucleophilic β-hydroxyl is favourable so resolving the α/β mixture 
towards the β-isomer.  
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Following protection, glycosidic bond formation was achieved by reaction with 
propargyl alcohol. Boron triflouride ethrate (BF3.OEt2) was selected as the activating 
agent as the activating agent and anhydrous DCM as the solvent.229 The reaction product 
was isolated exclusively as the β-isomer for the galactose and lactose substrates. The 
mannose derivative was isolated as the α-isomer. The synthesis of the galactose and 
mannose substrates are shown in scheme 56. The yields for the propargylated sugars 
were 73% for the galactose derivative 209, 83% for the mannose counterpart 211 and 
74% for lactose analogue 213. 
 
 
Scheme 56: Synthesis of 2-propynyl-tetra-O-acetyl-β-D-galactopyranoside, 2-propynyl-tetra-O-acetyl-α-D-
mannopyranoside and 2-propynyl-octa-O-acetyl-β-D-lactose. 
 
The stereochemistry of the propargylation reaction can be explained by examining the 
reaction mechanism.  The acetyl at the 2-postion of acetylated sugars is important for 
controlling the stereochemistry of reactions at the anomeric centre. Reactions are 
typically promoted by a Lewis acid, which facilitates the leaving of the anomeric acetyl. 
Attack by the 2-postion acetyl on the adjacent electrophilic centre forms a cyclic 
oxonium. The cyclic oxonium species then undergoes SN2 nucleophilic attack resulting 
in inversion of stereochemistry, as shown in scheme 57. Therefore, if the substituent at 
the 2-position is equatorial, as in glucose or galactose, the β-product is favoured. 
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Conversely where the 2-postion substituent is axial, as in mannose, the α-product is 
favoured.    
 
 
Scheme 57: Mechanism of stereocontrolled glycosylation of a galactose pentaacetate. 
 
Attempted formation of 214 by cycloaddition between the propargylated galactose 209 
and the nitrile oxide derived from the oxime 106 was initially conducted by both the 
chloramine-T route and by the transient hydroximinoyl chloride route. The same 
reaction conditions which had been successful in the cycloaddition between 106 and the 
test case dipolarophile propargyloxybenzene were employed, scheme 58. Complex 
mixtures resulted from both reactions, with only limited evidence of isoxazole formation 
evident in the 1H-NMR spectrum of the crude reaction products. TLC analysis indicated 
several different products containing azobenzene and carbohydrates units were present 
in the mixture – the former can be visualised as orange coloured spots and the latter by 
the appearance of dark spots upon charring (heat gun) of the plates. 
 
 
Scheme 58: Attempted synthesis of carbohydrate-azobenzene adduct 214 
 
In a subsequent attempt to form the adduct 214 the hydroximinoyl chloride 174 was 
performed. Triethylamine was added over the course of 4 hours with a syringe pump to 
a solution of 174 and propargyl galactose 209 in an approximately 3:1 molar ratio. The 
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resulting solution was heated to reflux for a further 16 hours. Following purification by 
flash chromatography the desired adduct 214 was isolated in 79% yield, scheme 59. The 
1H-NMR spectrum of this protected compound showed the trans form dominated and 
only low intensity signals could be seen for the cis form. The OCH2-isoxazole protons 
of 214 are diastereotopic and present as a pair of doublets (at 4.84 and 5.02 ppm, J = 
14.0 Hz, 500 Hz, CDCl3), which contrasts to the starting galactose dipolarophile, 209, 
where the OCH2 presents as a singlet. 
 
 
Scheme 59: Synthesis of the galactose-azobenzene cycloadduct 215. 
 
During the purification of the cycloadduct 214 by flash chromatography, another orange 
coloured product was isolated. It crystallised via the vapour diffusion technique. It was 
dissolved in DCM and pet ether was allowed to diffuse into the solution. Upon standing 
for three days orange needles formed. They were analysed by X-ray diffraction and the 
solved structure was found to be the furoxan 216, as shown in figure 42. The formation 
of furoxans is the common result of nitrile oxide dimerization and its formation could 





Figure 42: Structure of the furoxan 216, solved by X-ray crystallography. 
 
The mannose adduct 217 was also formed starting from the preformed chlorooxime 174, 
again the sugar alkyne was used in approximately 3 fold excess, scheme 60. The slightly 
reduced yield of 73% for the mannose adduct with respect to its galactose analogue 214, 
is attributed to mechanical loss rather than a lower conversion of the reaction, as both 
the starting material and product were very difficult to handle due to their sticky nature. 
The 1H-NMR spectrum for the mannose derivative shows very low intensity signals for 
the cis isomer and the major adduct is the trans-azobenzene conjugate 217. 
 




Following their successful cycloaddition reactions the conjugates 214 and 217 were 
deprotected. Deprotection of the galactose cycloadduct 214 was attempted using the 
Zemplén method. The adduct in aqueous methanol was treated by a catalytic amount of 
sodium methoxide at room temperature for 16 hrs.231 After which the product, only 
partially soluble, was found to be incompletely deprotected. TLC analysis showed a 
variety of products likely material in various stages of deprotection.  
In a second reaction, the protected cycloadduct was initially dissolved in THF before the 
addition of methanol and finally water. The conjugate remained in solution in the three 
component mixture and sodium methoxide was added in catalytic amounts. After 
stirring overnight, the pH of the reaction solution was adjusted with addition of acidic 
Dowex resin. When the mixture became slightly acidic an orange precipitate formed. 
The solid product together with the resin beads was collected by filtration and washed 
with aqueous methanol. The product was separated from the resin by washing with 
DMF. The resulting solution was concentrated to provide the pure cycloadduct 215 as 
an orange solid in 79% yield. 
The 1H-NMR spectrum of the deprotected product 215 presented as an all trans form. 
Unfortunately, some of the CH signals of the galactose unit are obscured by the residual 
H2O in the solvent. However, the spectrum was extremely well resolved, and showed 
each OH resonance as a doublet or triplet. When partially exchanged with deuterium 





Figure 43:1H-NMR spectrum of 215 in DMSO-d6 (top) and DMSO-d6 with D2O added (bottom), showing reduced 
intensity of partially exchanged OH signals; 500 MHz. 
 
Deprotection of the mannose derivative 217 was approached in the same way, however 
no precipitate formed upon acidification of the crude products. TLC analysis of the 
solution indicated the reaction had been a success. Therefore the solution was 
concentrated under vacuum until a precipitate did form. Work up following the usual 
way yielded the deprotected product 218 in 87% yield. 
With successful formation of the monosaccharide-azobenzene conjugate demonstrated, 
the next objective was to prepare the disaccharide analogues. Reaction between the 
chlorooxime 174 and the propargylated lactose 213 (3 eq.) was conducted using the same 
conditions as had been successful in synthesising the adducts 214 and 217, scheme 61. 
Purification proved difficult and the cycloadduct product 219 could not be completely 
isolated from the propargylated lactose starting material. The partially purified material 
was deprotected with sodium methoxide in a THF/MeOH/H2O mixture. The deprotected 




Scheme 61: Synthesis of the lactose-azobenzene conjugate 220. 
 
The 1H-NMR spectra of the mannose and lactose conjugates 218 and 220 are rather 
typical of unprotected carbohydrates, unlike the galactose analogue 215 (figure 42), no 
defined hydroxyl resonances can be seen. Instead a broad peak appears between ~3.0-
4.0 ppm representative of the residual water and various OH protons. Often obscuring 
many of the C-H resonances of the carbohydrate, which can be seen the 1H-NMR 
spectrum of the lactose adduct 220 is shown in figure 44.  
Several attempts were made to crystallise the deprotected conjugates. The galactose and 
mannose cycloadducts 215 and 218 but not the lactose conjugate 220 crystallised under 
the conditions explored. The compounds were dissolved in methanol and chloroform 
was allowed to slowly diffuse into the solution, which was left to stand at room 
temperature. Both 215 and 218 presented as small cubic crystals after a period of weeks. 
Unfortunately, those of the galactose adduct 215 proved unsuitable for X-ray analysis 
due to twinning. Despite a small amount of disorder, the crystals of the mannose 
cycloadduct 218 were solved by Dr Brendan Twamley, TCD. Significant images are 





Figure 44: 1H-NMR spectrum of 220 in DMSO-d6 (500 Mz), showing broad OH signal at ~3.5 ppm obscuring C-H 
resonances, 500 MHz. 
 
 
Figure 45 Disordered moieties of 218 as separate images (A) 78 and 70% and (B) 22 and 30% occupied. Sugar 





The crystal data shows the molecules present as two district dimer units, labelled A and 
B in figure 45. The key difference between the two dimers is the relative orientation of 
the isoxazole and the azo linkage about the aryl ring that connects them. In dimer unit 
A, the C=N bond of the isoxazole has a trans-relationship to the azo bond across the aryl 
ring, we label this conformation transoid. In contrast, in dimer unit B unit there is a cis-
relationship between the isoxazole C=N and the azo bond and the aryl ring that connects 
them. We described presentation B as having a cisoid conformation. A report by Sharma 
and Bharadwaj, discusses potential limitations on rotational freedom (about both sigma 
and N=N bonds) of divalent imidazole-appended azobenzenes, creating cisoid and 
transoid conformations. They describe how rotational motions in the structure create 
disorder, which can be observed in crystal structures.232 
The isoxazoles in both the A and B dimer units are only slightly out of plane with 
adjacent azobenzene aryl ring, interplane angles of 3 degrees and 7 degrees suggest 
partial conjugation between the heterocycle and the azobenzene.  
The basic packing unit of the crystals was based around an asymmetric dimer of the two 
geometric forms. Two hydrogen bonds occurred between the saccharides of the dimer 





Figure 46: Packing diagram of 218 viewed down the a-axis. Dashed lines indicate strong hydrogen 
bonding. Hydrogen atoms omitted for clarity. 
 
distance 2.947 Å). The azobenzene and isoxazole units do not show any π-stacking, with 
only weak intermolecular interactions observed. Overall the packing structure is based 
around interlocking azobenzene units between saccharide walls, as shown in figure 46.  
The saccharide unit in the X-ray structure was observed to be in the favourable chair 
conformation. The crystal structure also confirms the α-glycosidic linkage. An 




Figure 47: Expanded saccharide region of the X-ray structure of 218. Hydrogen atoms omitted for clarity 
 
An expansion of the aromatic region of the 1H NMR spectrum of 218, figure 48, shows 
the signals are the expected second order multiplets due to the magnetic non-equivalence 
of the chemically equivalent protons  
 




Conjugates with one azobenzene unit separating two carbohydrate moieties were the 
next synthetic targets. The p,p-bishydroximinoyl chloride 176 and the propargylated 
galactose 209, in a 1:2 molar ratio or 1:1 functional group ratio, were dissolved EtOH at 
room temperature before the slow addition of triethylamine, followed by heating to 
reflux overnight. Following work-up the cycloadduct 221 was obtained in a modest 34% 
yield. Poor solubility of the starting chlorooxime in EtOH was viewed as limiting the 
success of the reaction and it was subsequently repeated in ethyl acetate, scheme 61. 
This reaction gave the product in a much improved 69% yield. Like its mono ligated 
analogue 214, 1H-NMR spectrum of 221 shows it presenting mainly as the trans isomer 
in solution (CDCl3).  
 
 
Scheme 62: Synthesis of galactose-azobenzene conjugate 222. 
 
Whilst the isolated yield of 221 for the reaction in EtOAc (20 hrs., 77 ˚C) was 
satisfactory, options to further increase the yield were explored. A review of the 
literature suggested NOAC reactions might proceed faster under microwave 
activation.233,234  
The reaction between the chlorooxime 176 and 209 was repeated with heating in a 
scientific microwave (80 ˚C, 30 mins). The potential to use a syringe pump to facilitate 
a slow addition of the base is problematic with microwave vessels and an all in approach 
was adopted. After work up the product was isolated in 53% yield. In an attempt to 
control the effective concentration of nitrile oxide, the reaction was repeated and the 
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NEt3 was added in 6 portions with 10 minutes of heating between additions. However, 
these revised conditions failed to lead to an improved yield. 
Another paper suggested the yields of NOAC reactions could be greatly increased by 
activation involving non-thermal microwave effects.235 The latter work utilised a 
domestic microwave and a solvent free system where the reactants were coated on 
alumina. We wished to explore this approach, however it was difficult to strictly follow 
the conditions of the paper since it was ambiguous about the type of alumina used. As 
the reported reaction lacked a base, which is generally required for in nitrile oxide 
formation from a chlorooxime, it was thought that basic alumina might best facilitate 
the reaction. 
To coat the alumina with 176 and 209 the compounds were dissolved in DCM, basic 
alumina was then added and the solvent removed under vacuum. The synthesis reported 
in the literature used eight equivalents of the nitrile oxide precursor with respect to the 
alkyne. However, we considered the risk of dimerization or polymerisation with the bis 
substrate 176 was high and an equimolar ratio of reactants (i.e. 2:1 chlorooxime to 
alkyne functional group ratio. 50 mg of alumina was employed with a 0.05 mmol loading 
of alkyne. The reactants were heated in a domestic microwave at 800 W for 3 minutes. 
Following work up and purification by flash chromatography, the cycloadduct 221 was 
isolated in 42% yield. This reaction was undertaken on an extremely small scale due to 
safety concerns around the use of a domestic microwave. 
In the interest of reproducibility, the reaction was repeated on doubled scale in a 
scientific microwave, with heating to 100 ˚C (80 W, 30 mins) with vigorous stirring. 
Analysis of the crude products by 1H-NMR spectroscopy allowed an estimate of the 
conversion to the cycloadduct at ~40%. 
A clumping of the reaction material due to the sticky nature of the carbohydrate substrate 
209 was identified as potentially limiting the success of the reaction. To try to limit 
aggregation the reaction was repeated with an increased quantity of alumina. Initially it 
was increased from 100 mg to 200 mg, however, the problems surrounding the 
aggregation of the material remained. Subsequent increase to 1000 mg of alumina 
afforded loaded material with a uniform appearance as a fine and free flowing power. 
The revised conditions led to a crude product with an improved conversion of 50%.  
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In an attempt to further optimise the reaction the solvent used during the initial 
adsorption of 209 (0.1 mmol) onto the alumina (1000 mg) was changed from DCM to 
EtOAc, this resulted in a conversion of 55%. 
In a further reaction the ratio of chlorooxime to alkyne was doubled to 2:1 (4:1 molar 
ratio). Analysis of the crude product by 1H-NMR spectroscopy suggested near complete 
conversion at 94%. With this much improved conversion the crude product was subject 
to flash chromatography and cycloadduct was isolated in a 55% yield. 
The series of experiments exploring MW activated, alumina supported cycloaddition 
reactions are summarised in table E3 in the experimental section. Their uncertain 
outcome lead to the conclusion that they did not provide a viable route for accessing 
further bioconjugates. 
To access the mannose analogue of 221, p,p-chlorooxime 176 and dipolarophile 211 
were dissolved in ethyl acetate before the addition of triethylamine over four hours, 




Scheme 63: Synthesis of the divalent carbohydrate-azobenzene conjugates 223 and 224. 
 
Deprotection of the symmetric products 221 and 223 was achieved by treatment with 
NaOMe in THF/MeOH/H2O. Each product precipitated upon acidification with Dowex 
resin. The 1H-NMR spectra of the mannose products 223 and 224 were more complex 
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than expected. Several unexpected resonances were observed, in particular, for each 
compound three signals were observed in the isoxazole region: at 6.71, 6.72 and 6.73 
for the protected 223 (CDCl3), and at 7.20, 7.23 and 7.25 for the deprotected 224 
(DMSO-d6), spectra Figure 49. There were also four extra sets of doublet signals in the 
aromatic region for both compounds. The relative integration of the Ar-H and the 
isoxazole-H signals suggested one major structure where the proton resonances of the 
isoxazole rings at each end of the molecule were the same (7.23 ppm for 223) and a 
second minor structure where there was a higher degree of asymmetry and in which the 
isoxazole-H at each end of the molecule has a unique signal (7.20 and 7.25 ppm for 223).  
To confirm that the two structures were not geometrical isomers about the N=N a sample 
of 224 was irradiated with light at 365 nm to induce photoisomerisation. This experiment 
confirmed that none of the extra peaks arose from the cis isomer. In fact, the spectrum 
of the irradiated sample showed resonances for the cis counterparts of both structures 
present in the dark adapted sample, figure 49.  
We hypothesise that the extra signals in the dark adapted sample arise from a second 
asymmetric conformation, brought about by restricted rotation – likely of the 
cisoid/transoid nature observed in the solid state structure of 218 (page 112). To 
investigate this possibility the 1H-NMR spectrum of 224 was also recorded at 50 ˚C in 
the hope that rotational freedom might be facilitated at this elevated temperature. 
However, aside from a very slight shift in the resonance position, no significant change 
was observed in the downfield region between the spectra recorded at room temperature 
and at elevated temperature spectrum, figure 50. 
It is possible the energy barrier for rotation about the single bonds was not reached when 
heating to 50 ˚C and further elevation of the temperature may have induce convergence 








Figure 50: 1H-NMR spectra of 224, top: spectrum recorded at 300 K; bottom: spectrum recorded at 323 K (DMSO-








To increase the structural diversity meta substituted azobenzene sugar conjugates were 
targeted. In order to access these, the novel m-chloroxime 225, was prepared. It was 
obtained in 91% yield from the precursor oxime 111 by treatment with NCS in DMF. 
The 1H-NMR spectrum of 225 presented as trans isomer in CDCl3 trace amounts of the 
cis form. Its NOH singlet appeared within the aromatic signals at 8.06 ppm. 
The m-chlorooxime 225 and the propargylated galactose 209 were dissolved in ethyl 
acetate followed by addition of triethylamine over four hours, the reaction mixture was 
then heating to reflux overnight. Following work up and purification, the galactose-
azobenzene conjugate 226 was isolated in a slightly disappointing 56% yield, scheme 
63 (i). An improvement in yield to 76% was achieved when the reaction repeated with 
heating to reflux from the beginning, scheme 63 (ii). With this success, the slow addition 
of the base (4 hrs.) to a refluxing solution of the chlorooxime and dipolarophile was 
established as the standard approach for all future NEt3 induced NOAC reactions. Under 
these conditions the mannose alkyne 211 and m-chlorooxime 225 were reacted to give 
the mannose-azobenzene conjugate 228 in 68% yield. 
 
 




Unlike their para regioisomers 214 and 217, the 1H-NMR spectra of 226 and 228 both 
showed considerable amounts, up to 20%, of the cis isomer. However, substitution 
pattern does not affect the resonance position of the isoxazole CH, which resonated at 
~6.7 ppm in all cases. 
Deprotection of 226 and 228 was attempted by treatment with NaOMe in a 
THF/MeOH/H2O solution. Whilst the mannose conjugate 228 could be deprotected in 
good yield under these conditions, the carbohydrate unit of 226 suffered from 
degradation. Two isoxazole peaks were observed in the 1H-NMR spectrum, the less 
intense one corresponded with the diastereotopic OCH2 signals, indicating some survival 
of the desired product (shown in red). However the major isoxazole peak corresponded 
to a singlet OCH2 peak likely indicating loss of the carbohydrate functionality (shown 
in blue). The isoxazole singlets and methylene protons are highlighted in figure 51. 
 
 
Figure 51: 1H-NMR spectrum of degraded material in the attempted deprotection of 226 (DMSO-D6, 500 MHz). 
 
To gain access to divalent meta substituted cycloadducts, the m,m-bischlorooxime 230 
was an important target. It was synthesised from the parent oxime 112, by treatment with 
NCS in DMF for 5 hours. The chlorooxime 230 was insoluble in chloroform and its 1H-
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NMR spectrum was recorded in DMSO-d6, the NOH signal appeared at 12.65 ppm. Like 
its mono substituted analogue 225, the 1H-NMR spectrum was dominated by signals of 
the trans isomer.  
The m,m-symmetric galactose and mannose adducts 231 and 233 were formed in a series 
of experiments, using the conditions discussed above for the synthesis of 226 and 228. 
The compounds were isolated after purification by flash chromatography in 72% and 
74% yield respectively scheme 65. Once again, these meta products showed a greater 
amount of the cis isomer than had been observed for their para counterparts. The cis 
isomer represented up to 25% of the material in solution in CDCl3 when analysed by 
1H-
NMR spectroscopy, as can be seen in figure 52. 
 
Figure 52: Portion of the 1H-NMR spectra of 231 (top) and 233 (bottom) showing the signals for the cis isomer 
boxed in red (CDCl3, 500 MHz) 
 
Following deprotection in the usual manner (NaOMe, THF/MeOH/H2O), the products 
232 and 234 were isolated in 83% and 81% yield respectively, scheme 65. In contrast to 
their parents, only low intensity signals were observed for the cis isomer and their 1H-




The protected propargylated saccharides 209 and 211 were also suitable substrates for 
reaction with the azidoazobenzene 171. Copper sulphate pentahydrate and sodium 
ascorbate were used to generate the copper (I) catalyst in aqueous DMSO and reaction 
between equimolar amounts of the dipole and dipolarophile was allowed to continue 
overnight at room temperature. After purification by flash chromatography, the 
protected galactose adduct 235 was isolated in 80% yield. The 1H-NMR spectrum 
revealed the compound presented in solution as an approximately 10:1 ratio of trans to 
cis isomers (CDCl3). 
 
 




Following an analogous reaction, the 1H-NMR spectrum of the crude product from the 
reaction with the mannose substrate 211 suggested a successful cycloaddition. However, 
the mannose adduct 237 could not be successfully isolated. After several attempts at 
purification, the partially purified material was taken on for deprotection. 
 
 
Scheme 66: Synthesis of triazole ligated azobenzene-carbohydrate conjugates 236 and 238. 
 
Both pure 235 and incompletely purified 237 were fully deprotected using sodium 
methoxide in THF/MeOH/H2O and 236 formed from 238 in 83% yield, i.e. in 66% over 
the 2 step cycloaddition and deprotection sequence. In contrast, 238 was isolated in 80% 
yield over the deprotection and cycloaddition steps. Both the deprotected conjugates 236 
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and 238 presented with very limited amounts of the cis isomer. The 1H-NMR spectrum 
of 238 presented as second order for its aromatic protons, figure 53, due to magnetic 
non-equivalence. Several peaks are present for the triazole proton, suggesting the 
possibility of several conformers.  
 
Figure 53: 1H-NMR spectrum of 238, showing triazole resonances at 8.77 and 8.92 ppm. 
 
3.1.2 Synthesis and cycloaddition of carbohydrates with dipolarophile functionality 
 
To illustrate the versatility of the cycloaddition approach to azobenzene carbohydrate 
conjugation, we turned our attention to developing carbohydrates with dipole 
functionality. A search of the literature revealed while several azide bearing saccharides 
are known, including the attractive 1-O-azido-tetraacetate pyranoses, there are relatively 
few oxime bearing substrates. For our purpose, 241 was attractive as it offered a 
saccharide bearing an aryl aldoxime, which may have been expected to have a similar 
reaction profile to the test case benzaldehyde oximes. It is based on the naturally 
occurring compound helicid 239 which has been converted to its oxime derivative for 
investigation as potential inhibitors of acetylcholinesterase and mushroom 
tyrosinase.236,237 Following the literature procedure 239 was protected with acetic 
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anhydride prior to oximation with hydroxylamine hydrochloride in the presence of 
pyridine to obtain 241 in 70% yield. 
 
 
Scheme 67: Synthesis of the sugar oxime 241. 
 
Attempts at the chlorination of oxime 241 with NCS in DMF proved unsuccessful and 
generation of the desired nitrile oxide was explored by treatment with Ch-T 
(ethanol/water). A total of eight equivalents of the nitrile oxide precursor were reacted 
with bis alkyne 113. The oxime and Ch-T (8 eq.) were added portion wise on four 
occasions at 90 minute intervals to the alkyne in aqueous EtOH. Eight molar equivalents 
of the nitrile oxide precursor equates to a four-fold functional group excess as 113 bears 
2 alkyne groups. The product 242 was obtained in 59%, scheme 68. Only very low 




Scheme 68: Synthesis of the helicid-azobenzene conjugate 243. 
 
The cycloadduct was deprotected with sodium methoxide in THF/MeOH/H2O to give 
243 in 95% yield. Like its parent the contribution of the cis isomer in the 1H-NMR 
spectrum was insignificant (DMSO-d6). 
Although the helicid was an attractive substrate for nitrile oxide formation, the allose 
sugar has limited biological appeal; the C-3 epimer of glucose is rarely observed in 
nature and applications involving this unit are infrequent compared to other aldohexoses. 
Therefore, we were keen to develop galactose or mannose derivatives of 241 and 
targeted the oximes 248 and 249. 
The pentaacetates of both galactose and mannose were prepared and treated with 
hydrobromic acid in acetic acid, to give the brominated mannose 244 in 76% and the 
brominated galactose 245 in 85% yield. They were allowed to react with 4-
hydroxybenzaldehyde in a biphasic system of chloroform and aqueous sodium 
hydroxide solution; with tetrabutylammonium bromide was present as a phase transfer 
catalyst.236 After a somewhat difficult purification by flash chromatography the desired 
ethers were isolated, the mannose adduct 247 in 78% yield and the galactose adduct 246 
in 73% yield. Unfortunately, treatment of either aldehyde with hydroxylamine failed to 
yield the desired oxime, instead in each case a complex mixture was obtained with no 
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evidence for the formation of the desired oxime was observed in the 1H-NMR spectra of 
the crude products. 
 
 
Scheme 69: Attempted synthesis of the galactose and mannose oximes 248 and 249. 
 
Due to the failure to form the helicid derivatives 248 and 249, structures with an aryl 
oxime unit linked at the 6-position of the pyranose were targeted. To facilitate this 
reaction galactose was protected as the 1,2- and 3,4-acetonides by treatment with acetone 
in the presence of catalytic amounts of iron chloride.238 The remaining 6-position 
hydroxyl of 250 was free for the introduction of a mesylate leaving group, achieved by 
reaction with mesyl chloride in neat pyridine.239 The reaction of the mesylated 251, with 
4-hydroxylbenzaldehyde, 252, was attempted under a range of conditions. K2CO3 was 
used as a base and acetonitrile as a solvent; no conversion was observed. It was thought 
that a stronger base would more readily facilitate hydroxyl deprotonation. Therefore, the 
reaction was repeated in the presence of DBU again, as shown by 1H-NMR 
spectroscopy, no indication of formation of the desired ether. Neither did any of the 
starting aldehyde structure. It is presumed that the deprotected hydroxylbenzaldehyde 
may have been removed in the aqueous wash during work-up. 
It was reported in the literature that montmorillonite K10 can facilitate ether formation 
between mesylates and phenolic compounds.240 However attempts to utilise this 
approach in promotion of the reaction between 251 and hydroxybenzaldehyde failed. 
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No carbohydrate products were observed in the 1H-NMR spectrum of the crude 
products. 
Another publication suggested KOH in a toluene/DMSO mixture241  could be effective 
but we found these conditions did not promote formation of 250. The reaction was also 
attempted in the ‘reverse’ manner with the benzaldehyde bearing the leaving group, 255, 
in reaction with galactose derivative 250; however, it was without success. A complex 
mixture was observed with at least four aldehyde products were observed in the 1H-
NMR spectrum. 
Finally an attempt to react hydroxylbenzaldehyde mesylate 255 and protected galactose 
250 in the DMF in the presence of either CsCO3 (DMF)
242 or potassium tert-butoxide 
(DMF or CH3CN)
240 failed. In each case, a complex mixture resulted. 
 
 




In view of the failure to introduce a ‘benzaldehyde’ functionality to the 6-postion of 
galactose we considered the ability to exploit the secondary alcohol of the acetonide 
protected galactose remained a possibility. In particular the controlled oxidation of the 
secondary alcohol 250, followed by conversion through to the chlorooxime 253 is 
known in the literature, and has been shown to take part in cycloaddition reactions.243 
The conversion of the alcohol 250 to the oxime 254 followed the synthesis reported by 
Streicher and Wünsch with some adaptations.244 Firstly, by oxidation with PCC in DCM 
in presence of molecular sieves. This was followed by with reaction with NH2OH.HCl 
in the presence of sodium acetate in ethanol to give the oxime. Finally the oxime was 
chlorinated with NCS in DMF to form the hydroximoyl chloride 253, scheme 71.243 
 
 
Scheme 71: preparation of the chlorooxime 254. 
 
The chlorooxime 253 was reacted with the bis-propargylated azobenzene 113 by mixing 
the two compounds in ethyl acetate followed by addition of triethylamine over the course 
of 4 hours and finally heating to refluxing overnight, scheme 72. Initial analysis by 1H-
NMR spectroscopy and TLC revealed a complex mixture of products. Within the 
mixture there was strong support for the formation of the desired cycloadduct. In 
particular, the appearance of a singlet resonating at ~6.5 ppm in the 1H-NMR spectrum 
was indicative of isoxazole formation; a singlet at ~5.2 ppm was suggestive of the OCH2 
protons. The presence on the TLC plate of an orange coloured compound which charred 
when heated after staining with sulphuric acid in ethanol, further supported the 




Scheme 72: Attempted synthesis of the divalent galactose-azobenzene conjugate 254. 
 
Several attempts were made at isolating the cycloadduct by flash chromatography 
utilising different solvent systems (DCM/MeOH; Ether/pet ether; 
EtOAc/cyclohexane/pet. ether). Unfortunately, the product proved impossible to isolate. 
Despite the range of solvents a carbohydrate reaction by-product consistently 
maintained almost exactly the same Rf as the product. Ultimately, only a single fraction 
from the last chromatography attempt was found to contain only 254. The small quantity 
of material was enough for analysis by NMR spectroscopy and further structural 
characterisation data could not be obtained. Both the 1H-NMR and 13C-NMR spectra 
strongly supported formation of the desired cycloadduct 254. The proton data showed 
five peaks for the saccharide unit, a singlet for the isoxazole at 6.45 ppm, and the OCH2 
protons at 5.15 ppm. A pair of doublets for the aryl protons of the azobenzene units were 
observed. The 13C-NMR spectrum accounts for all expected signals and does not contain 
any unexpected resonances, both spectra are shown in figure 54. 
Separation of the compound was complicated by the fact that acetal deprotection would 
have resulted in a mixture of isomers at the anomeric position. The potential for 
generating both α and β mixture as well as pyranose and furanose isomers made 
separation of a deprotected mixture an unattractive prospect and we discontinued 
experiments with 254.  
Focus turned to carbohydrates substrates with azido functionality. Bromination of the 
pentaacetates followed by reaction with sodium azide245 or direct azide transfer from 
trimethylsilyl azide (TMSN3) with activation by tin (IV) chloride are the two most 
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common routes to access the azides at the anomeric position.246 Both the mannose (256) 





























Figure 54: 1H and 13C-NMR spectra of symmetrical cycloadduct product 254 (CDCl3, 500 MHz) 
 
 
Scheme 73: Azide transfer from TMSN3 to galactose and mannose pentaacetates 
 
The azidosaccharides were dissolved in DMSO alongside the p-propargylated 
azobenzene 107 or the p,p-diproparglyated azobenzene 113. The copper catalyst, 
generated by adding copper sulphate and sodium ascorbate to distilled water was added 
the solution. A 10% catalyst loading per alkyne functional group was used scheme 74. 
The reaction mixture was stirred overnight, followed by work-up and purification by 
flash chromatography. The monovalent cycloadducts were isolated in 77% yield for the 
galactose derivative 257 and 84% yield for the mannose derivative 259. Both samples 






















spectroscopy, with a 1:0.25 ratio of trans to cis observed for both compounds. The 
proton NMR spectrum no longer distinguishes the diasterotopic OCH2 protons. 
 
Scheme 74: Synthesis of triazole ligated azobenzene-carbohydrate conjugates 258 and 259. 
 
The symmetric galactose adduct 261 formed in a slightly higher yield at 74% compared 
to the mannose adduct 263 at 71% yield, scheme 72. Both compounds show minor peaks 





Scheme 75: Synthesis of divalent, triazole ligated azobenzene-carbohydrate conjugates 262 and 264. 
 
The same catalyst loading in an aqueous DMSO solution was found to be suitable for 
the conjugation of the galactose azide 255 with the ortho substituted azobenzene 265 
with cycloadduct 265 being isolated in 85% followed by deprotection in 86% yield, 
scheme 76. 1H-NMR spectroscopy revealed the protected product to be present in 1:0.22 
trans to cis ratio (CDCl3) whilst the deprotected product was found to consist of 1:0.4 




Scheme 76: Synthesis of the carbohydrate-azobenzene cycloadduct. 
 
3.2 Synthesis and cycloaddition of nucleosides bearing dipolarophile 
functionality 
 
Following the synthesis of a range of azobenzene carbohydrate conjugates, the 
application of this chemistry to the ribose units of nucleosides was planned. While 
functionalisation of the ribose can affect the ability of the nucleobase to be built into a 
DNA sequence it generally has a lesser effect upon the nucleobase pairing. On the other 
hand, functionalisation of the nucleobase can avoid disruption of the sugar-phosphate 
backbone, but it often affects the nucleosides ability to bind to its nucleobase 
counterpart, disrupting DNA duplication.  
Functionalisation of either the 3’- or 5’- hydroxyl of nucleic acids blocks any potential 
for oligonucleotide growth in that direction, as the site becomes unavailable for 
phosphoramidite coupling. However, the hydroxyl groups at the 3- and 5-postions of the 
ribose can allow for the introduction of alkyne functionality. Selective protection of the 
5’- primary alcohol by using bulky protecting groups offers an important synthetic 
advantage to introduction of alkyne functionality to C-3 secondary alcohol. 
131 
 
Thymidine was 5’-protected with trityl chloride in the presence of pyridine in DMF. 
Alkylation of the 3’-hydroxyl followed by treatment with propargyl bromide, after 
deprotonation by sodium hydride in a one-pot reaction, scheme 77. 
 
 
Scheme 77: Synthesis of thymidine alkyne 269. 
 
Having synthesised the thymidine alkyne 269, cycloadditions with the various 
azobenzene nitrile oxide precursors and azidoazobenzenes were attempted. Initially 
controlled addition of NEt3 to a refluxing solution containing a threefold excess of p-
chlorooxime azobenzene 174 and the propargylated thymidine was attempted, synthesis 
details are summarised in scheme 78. After separation by flash chromatography the 
cycloadduct 270 was isolated in 57% yield. The 1H-NMR spectrum showed a roughly 
4:1 ratio of the trans to cis isomers (CDCl3, 500 MHz). Finally, the trityl protecting 
group was removed by stirring the cycloadduct in a solution of dichloroacetic acid and 
DCM at room temprature, to give the thymidine azobenzene adduct 271 as an orange 
solid in a 67% yield.  The relative amount of cis form in the 1H-NMR was half that of 
the protected parent molecule at 6:1 trans to cis 
 




Under the same reaction conditions, cycloaddition of m-chlorooxime 225 and the 
thymidine derivative 269 proceeded to give 272 in 73% yield, scheme 79. Treatment 
with dichloroacetic acid gave the deprotected product in 70% yield. Unlike the protected 
para analogue 270, the cis form of 272 could only be seen as very low intensity signals 
in the proton NMR spectrum. The deprotected showed a 5:1 ratio of trans to cis isomers, 
similar to its para analogue. 
 
Scheme 79: Synthesis of azobenzene-thymidine conjugate 273. 
 
With the success of these two conjugation reactions, the next targets were the divalent 
adducts 274 and 275. Again the slow addition of NEt3 to a refluxing solution of the 
alkyne and chlorooxime reagents was utilised, scheme 80. In the case of the divalent 
substrates a 6-fold molar excess of the thymidine alkyne 269 was used, (i.e. three 
equivalents of alkyne to each nitrile oxide functionality). The reactions gave the 
protected cycloadducts moderate yields of 65% for 274 and 46% for 275. However, after 
characterisation, there was insufficient material left to undertake deprotection. As all the 
other trityl deprotections proceeded without difficulty, there is little to suggest 
deprotection would not have been successful. The 1H-NMR of both compounds showed 
a dominance of the trans form with only weak intensity signals present for the cis isomer 





Scheme 80: Synthesis of the divalent azobenzene-thymidine cycloadducts 274 and 275. 
 
Conjugation of the propargylated thymidine 269 and the azidoazobenzene 171 was also 
explored. A 1:1 ratio of the azide and alkyne were dissolved in DMSO and followed by 
addition of sodium ascorbate and copper sulphate in distilled water. After stirring 
overnight the cycloadduct 276 was isolated in 84% yield, scheme 81.  The trityl group 
was removed by treatment with dichloroacetic acid in DCM to give the deprotected 277 
in 76% yield. NMR spectroscopy showed both samples were heavily dominated by the 




Scheme 81: Synthesis of azobenzene-thymidine conjugate 277. 
 
 
3.3 Summary  
 
 Glycosidic bond formation reactions allowed a family of carbohydrates bearing 
an alkyne dipolarphile to be synthesised. 
 These were successfully reacted in cycloadditions with nitrile oxide and azido 
bearing azobenzene substrates. 
 The introduction of an oxime functionality into a carbohydrate substrate was 
found to be more challenging.. 
 Several azido-carbohydrates, accessed through know chemistry, were 
subsequently reacted with azobenzene-alkynes to produce carbohydrate-
azobenzene cycloadducts. 
 A nucleoside bearing an alkyne dipolarphile was synthesised and successfully 








As discussed in the introduction, the integration of photoswitches, such as azobenzenes, 
into peptides and proteins has been the focus of much research. Due to their binding site 
specificity, the structure of proteins is key to their function. The introduction of 
azobenzene photoswitches to peptides can be very effective for controlling their 
bioactivity as changes in geometry often result in the turning ‘on’ and ‘off’ function in 
a peptide.  
The most common routes to introduce photoswitches into peptides include amide 
coupling reactions81,247 and succinamide-cysteine reactions.109,110 Other routes include 
CuAAC reactions, and on occasion either azide or alkyne functional groups have been 
introduced into peptides either along the backbone or within the sidechains 
positions.125,126 The application of NOAC chemistry to peptide modification is much 
more limited and only a few examples of alkyne bearing peptides in reaction with nitrile 
oxide moieties have been reported.150,155 
We aimed to create a range of peptides bearing either a dipolarophile or 1,3-dipole (or 
its precursor) for use in conjugation by cycloaddition to azobenzenes bearing the 
reciprocal functionality. It was intended to introduce the reactive functionalities at the 
N-terminal position or in the middle of peptide by building in residues with either azido 
or alkyne functionalities into the peptide sequence. We considered exploring the 
conjugating cycloaddition reactions by both solid phase peptide synthesis (SPPS) and 
solution phase synthesis. 
 The introduction of reactive functionalities into peptides presents a range of challenges. 
In particular, the cycloaddition precursors or their partners need to be stable during both 






4.2 Solid phase peptide synthesis 
 
While solution phase peptide synthesis is viable and is attractive under certain 
conditions, SPPS has become the standard for peptide synthesis.248 The original Boc 
protection SPPS methodology has largely been replaced by Fmoc protocols. Currently 
Boc protocols are attractive for synthesis of peptides prone to aggregation or those 
containing base sensitive moieties.249 The Fmoc group is deprotected with a piperidine 
solution, while the Boc group is removed with a TFA solution.The attractiveness of 
Fmoc chemistry is that it allows the use of milder reaction conditions. In particular, 
cleavage in Fmoc protocols involves a TFA based mixture whilst Boc protocols require 
HF for resin cleavage. The latter requires specialist handling. 248 
Both Fmoc and Boc SPPS follow cycles of coupling and deprotection steps. Rapid, 
controlled formation of peptides can be achieved. The reactions summarising the 
processes are shown in figure 55. Initially the resin must be deprotected if necessary. 
This is followed by coupling of the first C-activated, and ,if necessary, sidechain 
protected, N-protected amino acid. N-terminal deprotection then follows. The next 
coupling can proceed with an N-protected C-activated residue. When all the required 
amino acids in the sequence have been added, the final deprotection can be undertaken, 
leaving the N-terminus as the free amine. Alternatively a capping reaction, such as 
acetylation can be applied. When under-taking SPPS the greatest care must be applied 
to washing the resin bound material between steps, particularly after deprotection. This 
is important as any residual base present during the coupling steps will cause insertions 
and the prematurely deprotected material can polymerise. To optimise the final yield of 
the peptide, it is usually required that each coupling and deprotection step maintains at 
least 95% yield. Finally, the peptide is cleaved from the resin and all sidechain protecting 




Figure 55: Flow diagram of a typical solid phase peptide synthesis. 
 
The mechanism for the coupling step varies depending upon the choice activating agent. 
Usually the carboxylic acid of the residue to be coupled is first activated to induce 
nucleophilic attack by the free amine of the growing peptide. Most modern coupling 
agents operate by a two-part mechanism. Initially the carboxylic acid is activated in a 
reaction with a phosphonium or uronium species. This is followed by reaction with an 
oxybenzotriazole (OBt-) ion. The resulting OBt ester is then readily attacked by the 
terminal amine of the resin bound peptide. The desired amide bond is formed without 
racemisation of the coupled residue. The mechanism of benzotriazol-1-yl-
oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) activated coupling as a 





Scheme 82: Mechanism of peptide coupling with PyBOP as activating agent. 
 
A great many coupling agents for SPPS have been developed, however, most modern 
syntheses are based around HBTU and BOP couplings. Even within each of these groups 
there are a range agents including BOP, PyBOP, PyAOP, PyBrOP, BOP-Cl, HATU, 
HBTU, HCTU, TATU, TBTU (all acronyms are listed in the table of abbreviations). 
Each agent has its own advantages and disadvantages typically offering trades in terms 
of cost, toxicity and coupling efficiency. For manual peptide coupling experiments 
PyBOP is often selected as the activating agent as it offers rapid couplings whilst 
suppressing racemisation and avoiding toxic by-products. HATU is a popular selection 
for automated synthesises. 
The choice of reagents to effect terminal deprotection depends on the protecting group 
used. Typically a TFA solution is used for Boc chemistry and a piperidine solution for 
Fmoc chemistry. Weak bases like piperidine mediate Fmoc deprotection following 
attack of the acidic hydrogen in the 9-postion of the fluorene aromatic system. This 
results in formation of dibenzofulvene and a carbamate ion which eliminates carbon 
dioxide and is protonated to give the free amine. Dibenzofulvene adduct has distinctive 
absorption properties which can be used to determine the efficiency of the deprotection 
139 
 
step and therefore indirectly inform on the success of the previous coupling or resin 
loading steps. The mechanism of Fmoc deprotection is shown in figure 56.  
 
 
Figure 56: Mechanism of piperidine mediated Fmoc deprotection. 
 
Manual and automated solid phase peptide synthesis (SPPS) are both commonly used 
and both methods are applicable for the synthesis of the majority of peptides. Automated 
synthesis drastically reduces the amount of time need to make a given peptide, offering 
advantages both in terms of overall synthesis time and in active participation time. 
However, the automated synthesis generally consumes much more materials. Often up 
to 10 equivalents of each amino acid and of the coupling agents are used for each 
coupling.  Automated SPPS also often utilises N-methyl-2-pyrrolidone (NMP) as a 
solvent which is expensive, whereas manual syntheses typically uses DMF. Another 





4.3 Resins and capping 
 
The most popular resin choices for SPPS are polystyrene (PS) or polyethylene glycol 
(PEG) based. PEGs are favoured for Boc syntheses for their greater TFA stability. 
Polystyrenes are favoured in Fmoc syntheses because of their higher loading 
capabilities.250 The loading of resins generally lie with in the 0.1-1.0 mmol per gram 
range, with lower loadings being favoured for the synthesis of hydrophobic peptides. 
There is a wide range of resins within each category and they each offer a different 
terminal functionality upon cleavage. For example, an 
oxymethylphenylacetamidomethyl (PAM) resin would be selected for a Boc protocol if 
a free acid was required. A Wang resin would be selected if the terminal acid was 
required from an Fmoc synthesis. A Rink amide (Fmoc), or a 
paramethylbenzhydrylamine (pMBHA) (Boc) resin, would be suitable if an amide was 
required at the C-terminus.250 The structures of each of these resins are shown in figure 
57. Irrespective of the resin, the N-terminus of the peptide can be left as the free amine 
or capped, for example by acetylation. 
 
 
Figure 57: Common resins for SPPS 
The ability to control the functionality at the terminal positions is important since 
derivatisation at these points can have a significant effect on the overall properties of a 
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peptide, especially in short sequences. For example, peptides with capped termini 
generally adopt the characteristics of longer peptides. In biological settings, capped 
peptides are more likely to be recognised as if they were part of a protein and are less 
likely than their uncapped counterparts to be digested by exopeptidases.251 However, it 
should be noted that capping can have a negative effect the solubility of a peptide.252 
 
4.4 Peptide sequence 
 
We wished to demonstrate the potential to conjugate an azobenzene unit to a peptide 
through click chemistry and chose a short, biologically relevant peptide to demonstrate 
the chemistry. RGD peptides were identified as a simple template from which to work, 
as well as providing relevance to the work of biomolecule-azobenzene conjugation 
RGD peptides contain the tripeptide sequence of arginine (Arg, R), glycine (Gly, G) and 
aspartic acid (Asp, D). The structure of the tripeptide is represented in figure 58. The 
RGD motif is a recurring feature in cell recognition processes.253 RGD peptides are 
known to interact with integrin receptors of cell membranes to control adhesion of 
peptides to cells. Although the RGD sequence has since been shown to feature in many 
proteins, it was initially discovered as the cell recognition motif of fibronectin, a 
molecule involved in cell growth, cell migration and many other cellular roles.254 Since 
their initial discovery RGD peptides have been used in a plethora of applications, 
ranging from tissue engineering255 to targeting apoptosis.256  
 
 





4.5 Amino acid residues bearing 1,3-dipoles and dipolarophiles 
 
There are two main routes to introducing functionality into a peptide. Side chain 
modification is possible through incorporation at any point along the peptide sequence 
of a suitable substituted unnatural amino acid. Alternatively, the functionality can be 
introduced at one terminus after peptide growth. The introduction of alkynes and azides 
to the terminal and internal positions of peptides has been reported in papers describing 
the synthesis of a range of peptide cycloadducts.125 While some examples of NOAC 
have been reported for peptide substrates,150,155 the reactive nature of this dipole may 
make it less attractive than the azide dipole for peptide modification. NOAC is 
potentially more problematic since the broad range of functional groups present in 
peptide side chains could allow side reactions with nitrile oxides to compete with desired 
cycloadditions.  
Several side chains are suitable for the introduction of azide and alkyne functional 
groups into a growing peptide. Serine, threonine, cysteine and tyrosine are the amino 
acids most commonly targeted to introduce alkynes following reaction with propargyl 
bromide.257-259 Azide transfer has typically been applied to a range of residues including 
arginine, glutamic acid, serine and threonine.259 The side chain of Fmoc protected lysine 
can be converted to an azide in one step.250,251 The prominence of CuAAC chemistry has 
rendered many of the azide and alkyne modified amino acid residues commercially 
available, however, they are often prohibitively expensive.  
The azidolysine 281 was the first building block targeted in this research. It was 
synthesised in 83% yield by the reaction of Fmoc-Lys-OH with the hydrogen sulphate 
salt of imidazole-1-sulfonyl azide, 280,*260 in the presence of pyridine in DMF.261 This 
residue was suitable substrate for SPPS synthesis. 
The propargylated serine 285 was the second building block targeted. Starting from Boc 
protected serine, treatment with sodium hydride was followed by reaction with 
propargyl bromide to give the Boc protected 283. The Fmoc analogue was required as a 
SPPS substrate so the Boc group was removed by treatment with TFA in DCM, followed 
by protection with 9-fluorenylmethyl N-succinimidyl carbonate (Fmoc-OSu) in DMF.262 
                                                 
* imidazole-1-sulfonyl azide should be handled with care. It is known that some salts have explosive 
properties. It should only be isolated as its hydrogen sulphate salt 280. The synthesis of 280 is detailed in 
reference 260, along with a number of precautionary measures. 
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The overall yield of the three step synthesis (282 → 285) was 56%. The synthesis of 
both of the derivatised Fmoc amino acid cycloaddition partners are shown in scheme 83. 
 
 
Scheme 83: Syntheses of azidolysine (above) and propargylated serine (below) residues suitable for Fmoc SPPS. 
 
Alkyne and azide functionalities have commonly been introduced at the N-terminus of 
peptides through alkylation and azide transfer reactions respectivly.252,253 We considered 
access to N-terminal azides by direct azide transfer from imidazole-1-sulfonyl 
azide.H2SO4 280.
251,254 In an alternative strategy we also explored the reaction of 2-
bromoacetic acid, 289, with sodium azide in search of 2-azido acetic acid, 290, scheme 
84263,264 which we believed would be a suitable substrate for peptide coupling chemistry, 





Scheme 84: Routes to be explored for the introduction of azido functionality at the N-terminal position of a peptide. 
 
 
4.6 Synthesis of an azobenzene-peptide conjugate through peptide 
coupling 
 
Initially, the short RGD peptide-azobenzene conjugate 295 was targeted by two routes 
involving reactions with the supported peptide H-GRGDG-resin. The routes considered 
for constructing the conjugate are summarised in scheme 85. Although all routes are 
potentially suitable for solution phase chemistry, solid phase conditions were more 
attractive for the initial syntheses. 
 
Route 1 –Direct coupling chemistry between a growing peptide (291) and a preformed 
azobenzene carboxylic acid (292). 







Scheme 85: Synthetic routes explored for access to the N-terminal peptide-azobenzene conjugate 295. 
 
Initially route 1 was explored. The synthesis of peptides is the costly and time-
consuming component and this route involves a ‘traditional’ amide bond forming 




Azidoacetic acid 290 was reacted with the propargylated azobenzene 107 in the presence 
of copper sulphate and sodium ascorbate. The cycloadduct 292 was obtained as one 
major isomer in 61% yield.  
The supported tetrapeptide 291 (H-RGDG-Resin) was synthesised manually using Fmoc 
amino acid building blocks with the standard SPPS protocol on a Rink amide resin at a 
0.311 mmol scale and using PyBOP as the activating agent. A small portion of the 
material was deprotected and cleaved from the resin and analysed by mass spectrometry, 
which supported formation of the desired sequence. The coupling of the triazole linked 
carboxylic acid terminated azobenzene 292, to the resin bound peptide was achieved 
through treatment of PyBOP under standard SPPS conditions. The success of the 
reaction was inferred by the strong orange colour imparted to the washed resin which is 
attributable to the incorporation of an azobenzene unit. 
The supported peptide-azobenzene conjugate 294 was cleaved from the resin and the 
side chain protecting groups simultaneously removed by treatment with a TFA/H2O/TIS 
mixture (30 minutes, r.t,). The product was isolated following precipitation by the 
addition of diethyl ether. The solid was collected by centrifugation and the supernatant 
discarded. After several washing steps (diethyl ether) the solids were dissolved in water 
and the minimum amount of acetonitrile before lyophilisation. The crude product 295 





Scheme 86: Sold phase synthesis of azobenzene-peptide conjugate 295. 
 
The crude product was analysed by HRMS and HPLC, and was purified by semi-
preparative HPLC (H2O/CH3CN). Following lyophilisation of the isolated fractions, the 
product 295 was obtained as an orange solid in 64% yield†.  HRMS and analytical HPLC 
were used to support formation of the desired structure and its purity, figure 59. 
                                                 
† The yields of the peptides are based on the initial loading of the resin, and so are representative of all 












Found: 722.3130 (1.80 ppm) 
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4.7 Cycloaddition to N-terminal azidopeptides:  
 
To better explore the potential of cycloaddition chemistry as a general approach to 
peptide and protein conjugation, solution phase cycloaddition to azidopeptides was 
studied. This time the supported pentapeptide, H-GRGDG-resin 291, was synthesised 
by automated SPPS on a 0.1 mmol scale. While still on the resin the terminal amino 
group was converted to an azide by treatment with the azide transfer reagent 280 in DMF 
in the presence of DIEA. The resulting azidopeptide was cleaved from the resin by 
treatment with TFA/H2O/TIS, in a reaction that also caused deprotection of the 
sidechains. The peptide 296 was precipitated by addition of diethyl ether. HRMS 
analysis of the crude material, supported survival of the azido functionality after the 
cleavage process (M+H+ calculated: 486.2168; found: 486.2183; difference: 3.16 ppm). 
Cycloaddition to 296 was attempted using the crude material which was dissolved in 
DMF. The propargylated azobenzene 107 was added followed by copper sulphate and 
sodium ascorbate in H2O, scheme 87. After stirring overnight at room temperature, the 
solvent was removed under vacuum without heating. The resulting oily material was 
purified by HPLC (CH3CN/H2O). The collected fractions were dried by lyophilisation 
and the cycloadduct 295 was isolated as an orange solid in 51% yield. The synthesis of 
295 is shown in scheme 87. HPLC and HRMS data was in agreement with that obtained 





Scheme 87: Solution phase synthesis of azobenzene-peptide conjugate 295. 
 
4.9 Cycloaddition to propargylated peptides (CuAAC) 
 
The sequence H-RGDSTF-OH was selected for the introduction of a dipolarophile into 
the side chain of a peptide; this sequence was taken directly from the α-chain of 
fibrinogen.265 The peptide was manually synthesised using the Fmoc SPPS protocol on 
a 0.3 mmol scale. The propargylated serine derivative 285 was used as direct 
replacement for natural serine. The N-terminus was capped by treatment with acetic 
anhydride in the presence of pyridine and the final supported peptide has the structure 
Ac-RGDS*TF-resin‡, 297, scheme 88.  
                                                 
‡ A residue marked with an asterisk indicates one modified with a cycloaddition partner 
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While still on the resin, the peptide (297) was reacted with 4-azidoazobenzene, 171, in 
the presence of copper sulphate and sodium ascorbate. The success of the cycloaddition 
was strongly inferred by the vivid orange colour afforded to the washed resin. When the 
resin bound peptide was treated with the cleavage cocktail (TFA/H2O/TIS 95:2.5:2.5), 
conditions 1, scheme 88, it unexpectedly turned black. Following the addition of diethyl 
ether to the TFA solution a light brown precipitate was observed. It was washed several 
times with diethyl ether and lyophilised from water/acetonitrile to give an off white 
powdery solid (89%). 
The off-white sample was analysed by HRMS and by HPLC which supported the 
presence of two products. The mass spectrum showed a pair of peaks at 895.4171 (H+) 
and 448.2152 (2H+), and a second pair at 984.4501 and 492.7292, figure 60. The HPLC 
trace showed 2 peaks; one at ~10 minutes and the other at ~15 minutes. Following 
irradiation of the sample with light at 365 nm, the peak at ~10 minutes did not change, 
whilst the peak at ~15 minutes decrease in size and was largely ‘replaced’ by a new peak 
with a retention time of ~14 minutes. Since the product which eluted at ~15 minutes 
photoisomerised it is likely that it gives rise to the mass 984.4445 and 492.7292, since 
these masses are in keeping with that expected for the azobenzene conjugate 300. The 
HPLC data shown in figure 61. 
The failure of the peak eluting at ~10 minutes to photoisomerise, suggests the molecule 
giving rise to it has lost its azo functionality. A search of the literature revealed that 
under certain conditions, TIS can reductively cleave the azo linkages.90,266 If this had 
occurred in our experiment, the anilino product 299 would be the likely product. The 
HRMS peaks at 448.2154 and 895.4234 are consistent with the formation of 299. It was 
decided in future experiments that TIS would not be used in the cleavage protocols of 





Figure 60: HRMS data for the crude products of cycloaddition between 297 and 171 involving cleavage conditions 
1: supporting formation compounds 299 and 300. 
 
 
Figure 61: HPLC traces in support of 299 as an aminopeptide conjugate and 300 as an azobenzenepeptide 
conjugate; the reaction products of cleavage and deprotection of 298. A: sample kept in the dark; B: sample 
















Scheme 88: Synthesis of peptide conjugates 299 and 300. 
 
The supported peptide 297 (Ac-RGDS*TF-resin) was synthesized through automated 
SPPS (0.1 mmol) and deprotected and cleaved from the resin with a TFA/H2O/TIS 
mixture. HRMS confirmed the desired peptide 301 had formed. Together with 4-
azidoazobenzene 171, it was dissolved in DMF and an aqueous solution of copper 
sulphate and sodium ascorbate was added and the mixture left to stir overnight at room 
temperature. The synthesis is shown in scheme 89. Attempts to precipitate the product 
by addition of diethyl ether failed. Therefore, the reaction mixture was concentrated 
under vacuum. The resulting material was subjected to purification by semi-preparative 
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HPLC. Several sets of fractions were collected. However, the HRMS data of no fraction 
group was consistent with that expected for the desired product 300.   
 
 
Scheme 89: Attempted solution phase formation of peptide-azobenzene conjugate 300. 
 
The difficulties encountered with TIS in the deprotection protocol for on-resin (scheme 
88) and the complexity of the product mixture for the off resin approach to 300 (scheme 
89) resulted in a return to an on-resin approach. The supported peptide 297 was once 
again synthesised (manual, 0.305 mmol scale) and was reacted with the 
azidoazobenzene 171 under the same conditions as before (CuSO4, sodium ascorbate, 
DMF, r.t.), scheme 88. Once again the resin was a vivid orange colour. In this case, 
crucially, the final deprotection and cleavage was conducted with TFA and H2O (95:5) 
in the absence of TIS, scheme 88 conditions 2. With this modification the solution 
remained orange and following addition of diethyl ether an orange precipitate was 
returned. Following purification by HPLC and lyophilisation, the desired product 300 
was returned as an orange solid in 69% yield, ([M+H]+ calculated: 984.4435, found: 




4.10 Cycloaddition to azidopeptides (CuAAC) 
 
The sequence SRK*RGDS was selected for integration of an azidolysine residue. It was 
manually synthesised on rink amide resin and 302 was prepared on a 0.16 mmol scale. 
Propargylated azobenzene 107, copper sulphate and sodium ascorbate in DMF/H2O 
were added to the resin bound azidopeptide 302. Following reaction at room temperature 
for one hour the liquid phase was removed and the resin washed, The resin was now a 
yellow/orange colour. Cleavage of the peptide from the resin and sidechain deprotection 
was carried out using a TFA/H2O mixture. The resulting orange solution was diluted 
with ether until precipitate formation. The precipitate was washed three times with 
diethyl ether and lyophilised to give the crude product as a yellow/orange solid. The 
synthesis of 303 is shown in scheme 90.  
The material was subjected to purification by HPLC and the desired product 303 was 
isolated as a yellow/orange solid in 56% yield. HRMS data of the compound is shown 
in figure 62. 
In a parallel experiment preparation of 303 was attempted by solution phase conjugation 
chemistry. The supported azidopeptide Ac-SRK*RGDS-resin 302 was again manually 
synthesised on a 0.16 mmol scale. It was then deprotected and cleaved from the resin 
upon treatment with a TFA/H2O solution and precipitated by addition of ether. After 
isolating the peptide by centrifugation it was dissolved in DMF. The propargylated 
azobenzene 107 and an aqueous solution of copper sulphate and sodium ascorbate were 
added. After stirring overnight, the solution was concentrated under vacuum without 
heating to give the crude material as a brown oil. This was subjected to purification by 
HPLC whereupon the desired cycloadduct 303 was isolated as an orange solid in a much 
reduced 14% yield. The HRMS data agreed with that of the conjugate formed by the on 





Scheme 90: Synthesis of internally modified peptide-azobenzene conjugate 303. 
 
 
Figure 62: HRMS data of the peptide-azobenzene conjugate 305. 
303; C47H70,N19O13+; 
Calculated: 1108.5395 
Found: 1108.5432 (3.34 ppm) 
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4.11 Cycloaddition to propargylated peptides (NOAC) 
 
Following from the successful synthesis of a range triazole linked azobenzene-peptide 
conjugates, NOAC reactions were explored in search of isoxazole analogues. The base 
sensitive nature of chlorooximes makes them incompatible with Fmoc SPPS conditions. 
Oxime functional groups could potentially be integrated into a peptide sequence but the 
resin swelling is poor in aqueous alcohol solutions and would most likely hinder the 
cycloaddition efficiency. These limitations restricted us to the use of an azobenzene 
oxime or chlorooxime in partnership with a dipolarophilic peptide. As it would lead to 
304 the ‘isoxazole analogue’ of the triazole ligated 300, reaction between the 
chlorooxime 174 and the supported propargylated peptide 297 was selected for study. 
The resin bound peptide was selected as SPPS had proven more successful than the 
solution phase chemistry for the generation of 300. 
The nature of the SPPS vessels makes the slow addition of base difficult, as they are not 
easy adapted to allow deliveries to be made with a syringe pump. To compensate for the 
established advantages of slow dipole generation, a large excess of chlororoxime was 
utilised. We were not concerned about work-up difficulties, since in common with all 
solid phase reactions, any solution phase by-products and unreacted material could be 
easily washed away from the supported product at the end of the reaction. The resin 
bound Ac-RGDS*TF peptide 297 was treated with a threefold excess of both 
chlorooxime and base. The reaction mixture was agitated for 30 minutes, the solution 
was drained from the resin followed by washing and exposure to a further three 
equivalents of both the dipole precursor and base, followed by agitation for an additional 
30 minutes. After the post reaction washes, the resin only retained a faint orange colour. 





Scheme 91: Synthesis of the isoxazole ligated azobenzene peptide conjugate 304 by on resin NOAC. 
 
Deprotection and cleavage from the resin by treatment with TFA and water gave the 
crude reaction products. Following precipitation induced by diethyl ether, the crude 
material was isolated as a faint orange solid. After separation by HPLC, the 
propargylated peptide 301 was isolated in 41% and the azobenzene-peptide conjugate 
304 in 13%. The HRMS data of 304 is shown in figure 63. The poor yield of 304 (13%) 
with respect to the 56% obtained for analogous triazole adduct 300 may be a 
consequence of side-reactions of the more reactive transient nitrile oxide dipole. Future 
experiments aiming to optimise the yields of isoxazole ligated peptide conjugates may 





Figure 63: HRMS data of isoxazole ligated peptide-azobenzene conjugate 304 
 
4.12 Ligation of a peptide with a saccharide 
 
Finally, we wished to demonstrate the use of this chemistry to make highly 
functionalised molecules and chose to conjugate a saccharide to a peptide, with a 
photoresponsive azobenzene spacer between the biomolecule units. For the purposes of 
demonstrating this possibility we aimed to ligate a galactose unit with a pentapeptide, as 
shown in scheme 92. The azobenzene 152, with both alkyne and carboxylic acid 
functionalities, was coupled to a resin bound GRGDG peptide 291 using the standard 
SPPS protocol. The success of the coupling was verified following cleavage and 
deprotection of a small sample by HRMS (calculated: 722.3117, found: 722.3130, 
difference 1.79 ppm).  The resulting orange coloured supported peptide 305 was reacted 
with the azidogalactose 255 in the presence of a copper I catalyst generated in situ from 
copper sulphate and sodium ascorbate. The peptide was deprotected and cleaved from 
the resin using a TFA/H2O mixture. The adduct was precipitated by addition of diethyl 
ether, giving the crude product as an orange solid. The reactions are summarised in 
scheme 92. 
Following purification by HPLC and lyophilisation 306 was isolated as an orange solid 
in 24% yield. Unreacted N-terminal azobenzene-alkyne 307 was recovered in 39% yield. 
304; C46H58N13O12+; 
Calculated: 984.4322 
Found: 984.4353 (3.15 ppm) 
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Deprotection of the sugar unit in 306 was not attempted as it is likely that the aqueous 
basic solution required would degrade the peptide. Future work in the area might include 
a ‘repeat’ of this experiment with protecting groups which could be removed without 
the need for strong acid, base, or heating. 
 
 




4.13 Summary  
 
 Simple peptides integrating 1,3-dipoles, their precursors, or an alkyne 
functionality were synthesised by both manual and automated solid phase 
peptide synthesis. 
 Azide-alkyne cycloadditions between peptides and partnering azobenzene units 
were successful where the azide was located at the terminal or at a sidechain 
position of the peptide. 
 Conjugation by CuAAC was demonstrated for a peptide with a sidechain alkyne 
functionality. 
 Conjugation by NOAC was demonstrated for a peptide with a sidechain alkyne 
functionality . 






5. Photophysical properties of the conjugates 
 
We wished to investigate the photophysical properties of a selection from amongst the 
wide range of azobenzene biomolecule conjugates synthesised in this project. We 
wished to establish, firstly, the photostationary states of the selected compounds and 
secondly, their thermal relaxation rates from the cis isomer to the trans isomers. 
We considered that the compounds selected for investigation should include those which 
would allow direct comparisons of the influence of the following: (1) the biomolecule 
structure: mannose vs galactose, mono vs disaccharide and sugar vs nucleoside (2) the 
nature of the linkage: isoxazole vs triazole, heterocycle vs ether (3) the relative 
orientation of the biomolecule about the azobenzene skeleton: para substitution vs meta 
or ortho substitution  and (4) valency: mono substituted vs divalent conjugates. 
The influence of the biomolecule on the properties of the conjugates is of interest as the 
size of the ‘substituents’ is known to affect the rates of isomerisation,267 for example 
slowing the trans to cis and facilitating the cis to trans conversion for bulky substrates.268 
The nature of the linkage between the azobenzene and biomolecule motifs is also 
potentially an important influencer of the photophysical properties of the conjugates. 
Electron donating or withdrawing properties of substituents are known to have a 
significant effect upon the properties of an azobenzene. As well as influencing the 
efficiency of the isomerisation, it has been proposed that the mechanism of isomerisation 
may change with the electronic nature of the substituents, with electron donating groups 
favouring rotation mechanism and electron withdrawing groups favouring inversion 
pathways.269,270 
Typically, as might be expected from their weak to moderate electron donating or 
withdrawing properties groups like aryl, alkyl, halide, carbonyl and amide are viewed 
as having very little effect upon the photophysical properties of an azobenzene. In 
contrast, amino or hydroxyl functionalities show significant effect upon the position of 
absorption bands of azobenzene so substituted.51 This parameter is important since when 
irradiating substituted azobenzene at a fixed wavelength, the rate of isomerisation is 
impacted by the absorption intensity at that particular wavelength.  
The effect of electron donating groups on an azobenzene photophysical properties is also 
dependent upon the position at which the substitution is present with respect to the azo 
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group. Ortho and para electron donating substituents have a greater influence than meta 
positioned groups. 
However in general comparisons of the physical properties of families of azobenzenes 
is somewhat understudied; from what is known, meta- and ortho- substitution can have 
effects beyond their electronic donating/withdrawing properties.271,272 In particular, 
substitution ortho to the azo linker can cause destruction of planarity and a reduction in 
the efficiency of isomerisation processes.273 
In light of the structural diversity within the biomolecule conjugates prepared in this 
research and their potential value as probes in biological settings we wished to 
characterise the photostationary states and thermal relaxation parameters for a range of 
conjugates. 
 
5.1 Photostationary states 
 
The photostationary state for any given azobenzene is the point at which the rates of 
formation of trans to cis isomerisation and cis to trans isomerisation become equal.  The 
point at which is this equilibrium is reached is dependent upon a number of factors54: 
 The nature and pattern of substituents on the azobenzene core. 
 The wavelength of irradiation. 
 Environmental factors including solvent and temperature.   
 The wavelength of irradiation  
Whilst the exact processes of isomerisation are somewhat complicated by the various 
modes by which it can take place. The absorption associated with the π→π* transition, 
typically between 300-400 nm, is more intense than that associated with the n→π* 
transition, 400-500 nm, for the trans isomer. The inverse is the case for the cis isomer.271 
This means that to optimise the trans to cis isomerisation that the wavelength of the light 
selected should be as close to the λmax of the π→π* band as possible whilst being as far 
from the n→π* (nm) absorption as possible. Conversely light of a wavelength as near 
the λmax of n→π* band and as far away from the π→π* band would be favourable to 
promote cis to trans isomerisation. 
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In order to support the choice of wavelength of light to be used for determining the 
photophysical states of the compounds in this series the UV/Vis spectra of a number of 
compounds were recorded. The UV/Vis spectra of 215 recorded in DMSO (25 μM), is 
shown in figure 64. The blue trace is the spectrum of a sample left in the dark for a 
period of several days, the sample, dominated by the trans isomer is referred to as the 
‘dark adapted’ spectra. The intense π→π* band appears with a λmax at ~ 335 nm, with 
the weak n→π* band having a λmax at ~ 435 nm. The cis dominated PSS365 is shown 
as an orange trace. The n→π* band has an approximately similar λmax but is more 
intense than that of the dark adapted sample. 
 
 
Figure 64: UV/Vis spectra of 215 (25 μM, DMSO); Dark-adapted sample in blue and cis photostationary state in 
orange 
 
Electron donating substituents are known to cause a shift to longer wavelengths for the 
π→π* band,274,275 as is observable for the ether ligated 258, with respect to isoxazole 
linked adduct 218, figure 65. The λmax (π →π*) ~ 350 nm, while the n→π* band is 






















335 nm  




Figure 65: UV/Vis spectra of 258 and 218 (25 μM, DMSO); 258 in blue, 218 in orange 
 
In idealised situations photostationary state studies utilise a range of light sources to 
irradiate each molecule at a wavelength as close as possible to the λmax of each band.276 
However, in other cases, like ours commercial diode lamps are used. We purchased two 
diodes which irradiate at 365 nm and 420 nm as these wavelengths are a very good 
compromise for the λmax of the compounds selected for study. Therefore the 
photostationary state study will identify characteristics of the isomerisation processes at 
these particular wavelengths rather than at the wavelengths at which maximum 
efficiency may be obtained. 
The photostationary states of azobenzenes have been determined using a number of 1H-
NMR spectroscopy techniques.276-280 Typically the integral values of signals 
respresentive of a single geometric isomer are determined and these values used to 
calculate the ratio of the cis and trans isomers under the experiment conditions.  
The choice of solvent has a significant effect upon the quantum yields of the 
isomerisation processes. Polar solvents facilitate higher quantum yields for trans to cis 
isomerisation. Non-polar solvents are more conducive to the cis to trans process.51 It is 
therefore important to ensure that all experiments to characterise a series of compounds 
are conducted in the same solvent. DMSO and DMF were found to be the solvents in 




















335 nm  
350 nm  
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Whilst temperature does not effect the trans to cis process, the quantum efficiency of 
the cis to trans isomerisation increases with increased temperatures.55 Therefore, all 
experiments to determine photostationary states were conducted at 25 ˚C. 
Each adduct was made up to a known concentration in deuterated solvent (5 mM). These 
samples were left in the dark for a period of no less than 3 days. The 1H-NMR spectra 
of the so called dark adapted samples were recorded and all the resonances of the trans 
form identified and assigned. 
The samples were irradiated at 365 nm to effect the trans to cis photoisomerisation as 
described in the general experimental (7.4 protocols for determination of photostationary 
states (PSS) and thermal relaxation measurements). Spectra were recorded periodically 
until the photostationary state, PSS365, was reached and the relative integrations of the 
resonances of the trans and cis isomers remained constant. At the PSS365 the relative 
amounts of the two isomers was determined by examining and relating the relative 
integrations of signals attributed to each isomer in the aromatic region of the spectrum. 
The process was then repeated with irradiation at 420 nm to follow the cis to trans 
isomerisation and establish the PSS420.  
The process for determining the percentage of the cis isomer in each sample from the 
proton NMR spectra at the photostationary state is detailed using the conjugate 218 as 
an example. 
1. The spectrum was recorded for the dark adapted sample, spectrum 1, figure 66. 
2. Spectra were recorded, following irradiation at 365 nm, at one minute intervals 
until no further change was observed, Spectrum 2, figure 66. 
3. The spectrum of the PPS365 was recorded, spectrum 3, figure 66. 
4. Spectra were recorded, following irradiation at 420 nm, at 1 minute intervals 
until no further change was observed, spectra 4, figure 66. 
5. The spectrum of the PPS420 was recorded, spectrum 5, figure 66. 
 From the dark adapted sample the peaks A (2H), B (2H), C (2H), D (3H) and E 
(1H) were assigned as the trans isomer resonances (9 Ar-H and the isoxazole-C-
H), spectrum 1. 
 As the photoisomerisation was induced, the resonances F (2H), G (2H), H (1H), 
I (1H), J (2H) and K (2H) continued to grow in intensity as the resonances for 




Figure 66: Selected spectra (aromatic region, 500 MHz, DMSO-d6) from the photoisomerisation of 218: From top 
to bottom: (1) dark adapted sample, (2) irradiation at 365 nm for 1 minute, (3) irradiation at 365 nm for 4 minutes, 
(4) irradiation at 420 nm for 1 minute and (5) irradiation at 420 nm for 3 minutes. 
 
 Upon reaching the photostationary state, PPS365, (spectrum 3) i.e. when no 
change was observed in the spectrum upon further irradiation, the relative 
amounts each isomer were calculated. All the resonances were integrated, except 
where signals of the cis and trans isomers overlapped. In the case of 218 the 
signals E and H were not included in the analysis because the isoxazole C-H 
trans resonance (E) overlapped with an Ar-H cis resonance (H). The integration 
of the resonances associated with the trans and cis isomers of 218 at the PSS365 


















Figure 67: Expansion in the PSS365 of the 1H-NMR spectrum (DMSO-d6, 500MHz) of 218 showing the integration 
of both the trans and cis isomers 
 
 The integration values were divided by the number of hydrogens that each signal 
represented. For example, resonance A with a relative integration of 0.25 was 
divided by the 2 as it represents 2H, to give a value of 0.125 per proton. These 
values were determined for all the signals associated with trans and with cis 
isomers. The average intensity of a 1H signal for each isomer in the PSS365 
samples was determined in this way, This allowed all the available integration 
values to be used for the average without concern for having an equal amount of 
proton signals from the trans and cis isomers. From the two averages the ratio 
between the geometric forms or the percentage of either cis or trans isomer can 
easy be calculated.  
 Manipulation of the data, shown in table 2 reveals a 20:80 ratio of cis to trans 


























A 0.25 (2H) 0.125 F 1.00 (2H) 0.50 
B 0.25 (2H) 0.125 G 1.04 (2H) 0.52 
C 0.25 (2H) 0.125 I 0.52 (1H) 0.52 
D 0.41 (3H) 0.137 J 1.02 (2H) 0.51 
   K 1.00 (2H) 0.50 
Average integration 




per H atom 
 
0.51 
Percentage trans       0.128    x     100 
                              0.128 + 0.51         1 
                                  20.1% 
Percentage trans       0.51    x     100 
                              0.51 + 0.128     1 
                                  79.9% 
 
The same process was applied to establish the PSS420 and it was found to comprise of 
21% cis isomer. Each compound in the series was then investigated in the same way and 
the photostationary state data is shown in the tables below. 
The compounds 215, 218, 220 and 271 were investigated to explore the effect the 
biomolecule structure has on the PPS, table 3. In each compound within this family the 
azobenzene unit is linked directly to an isoxazole and a CH2O spaces the isoxazole and 
sugar (215, 218 and 220) or the nucleic acid (271). 
As shown in figure 68, all of these molecules show approximately the same λmax for 
the π →π* and n →π* bands, meaning that each compound absorb equally as well at 





Table 3: Photostationary states of 215, 218, 220 and 271. 
Compound 
number 




























The data shows that the biomolecule has little bearing on either PPS365 or PSS420. The 
lactose derivative 220 shows a slightly reduced cis content in the PSS365 sample, this 





Figure 68: UV/Vis spectra of the dark adapt samples of 215, 218, 220 and 271; 25 μM DMSO 
(Y-axis: Absorbance (A.U.), X-axis: Wavelength (nm) 
 
We next aimed to explore the effects of the relative orientation of the biomolecules with 
respect to the azo linkage. The para ligated azobenzene-mannose conjugate 218 and its 
meta derivative 229, as well as the para and meta ligated azobenzene-thymidine 
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Table 4: Photostationary states of 218, 229, 271 and 273. 
Compound 
number 



























At the PSS365 the percentage of the cis isomer is significantly less than that of their trans 
counterparts. This may be explained by examining the UV/Vis spectra of the 
compounds. The spectra of the mannose conjugates 218 and 229, and the thymidine 
conjugates 271 and 273 are shown in figure 69. It is noticeable that the π →π* bands 
are less intense and shifted to a lower wavelength for the meta adducts 229 and 273, 
with respect to their para substituted analogues 218 and 273. This means that the meta 
compounds absorb less strongly at 365 nm than their para analogues. This would be 
expected to decrease the efficiency of trans to cis isomerisation, resulting in a lower 





Figure 69: UV/Vis spectra of the dark adapt samples of 218, 229, 271 and 273; 25 μM DMSO;  
(Y-axis: Absorbance (A.U.), X-axis: Wavelength (nm) 
 
We then set out to investigate the effects of valency on  the PSS of the conjugates. The 
photostationary states of monovalent galactose conjugate 215, its divalent analogue 222 
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The isomeric divalent conjugates (p,p-) 222 and (m,m-) 234 both showed a moderate 
percentage of the cis isomer in the PSS365 sample. The UV/Vis spectra of the divalent 
compound 234, shown in figure 70, shows a blue shifted π →π* band with respect the 
monovalent analogue 215. The m,m-disubstituted compound 234, like the m-
monosubstituted 229 and 273 has relatively low intensity absorbance bands with respect 
to their p,p-substituted analogues. The lower percentage of the cis isomer present in the 







Figure 70: UV/Vis spectra of the dark adapted samples of compounds 215 and 234; 25 μM DMSO (Y-axis: 
Absorbance (A.U.), X-axis: Wavelength (nm) 
 
Next attention turned to a study of the effect on the photostationary state of the choice 
of ligation unit, and a series of compounds bearing a triazole or either linkage next to 
the azobenzene were studied. 
The data, shown in table 6, indicates all of the compounds 238, 258 and 266 have highly 
efficient trans to cis isomerisation. In particular the ether linked 258 has a PSS365 with 
nearly 90% conversion to the cis isomer. This is perhaps an expected outcome 
considering that electron donating groups are known to cause shifts in the π →π* band 
to higher wavelengths, meaning that the ether group of 258 should cause a shift bringing 
the irradiation wavelength (365 nm) close to the λmax of the π →π* band for this 
compound. The closeness of the λmax and the irradiation wavelength should result in 
more efficient trans to cis isomerisation. The shift to longer wavelength for the π →π* 
transition cause a greater overlap with the n →π* absorbance, The same shift also moves 
the π →π* closer to the 420 irradiation wavelength, explaining reduction in efficiently 
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Table 6: Photostationary states of 238, 258 and 266 
Compound 
number 
































The absorption profile of 266, with the biomolecule conjugation through ortho ligation, 
is distinctly different from the other compounds in this series. The difference is 
suggestive of partial destruction of planarity in the azobenzene unit, a known effect in 
ortho substituted azobenzene derivatives.273 The effects of steric hindrance must also be 
considered for the isomerisation processes of compounds like 266.271 The electron 
donation for the ortho oxygen atom appears to influence the PSS365 of 266 (85.2) in the 
same way as the similar p-ether linked 258 (89.2) and PSS420 (45.4) are likely attributed 
to the same structural features.  
 
 
                                                 
§ This compound presented as having multiple conformations. 
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Figure 71: UV/Vis spectra of the dark adapted samples of compounds 238, 258 and 266; 25 μM DMSO; (Y-axis: 
Absorbance (A.U.), X-axis: Wavelength (nm) 
 
5.2 Determination of kinetic parameters for the thermal cis to trans 
isomerisation 
 
The stability of the cis isomer of a given azobenzene is often viewed as one of the key 
parameters in determination of its usefulness as a photoswitch. For many applications  it 
is desirable to have long term stability,281 in effect giving precedence to 
photoisomerisation over thermal isomerisation. A search for more stable cis isomeric 
azobenzenes has led to several approaches to extending the cis life time including: 
ligation with peptides179 binding to surfaces282 and appropriate substitution.283 In 
particular, it has been shown that there is a 100 fold decrease in the speed of thermal 
isomerisation for an azobenzene substituted with a range of tertiary amino functionalities 
in the ortho-substitution compared to their regioisomeric para-analogues.284  
Whilst the thermal stability of azobenzene derivatives can be followed by 1H-NMR 
studies UV/Vis spectroscopy is more commonly employed as it allows much more rapid 
data acquisition.285-287 There are several possible methods of data acquisition when 
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like that shown for 215 in figure 72 at the extremes of the time course of the experiment. 
Alternatively, a fixed wavelength time course measurement can be adopted, often it 
offers the data in the most suitable form for analysis. The thermal relaxation profile plots 
measured at 335 nm, for 215 at a range of temperatures (60-90 ˚C) and over a time 
window of 0-3000 seconds are shown in figure 73.  
 
Figure 72:  UV/Vis spectra of 215 at the extremes of the time course of the experiment: dark-adapted 
sample in blue, PSS365 in orange. The red line indicates the absorption at 335 nm; 25 μM DMSO. 
 




















































In this thesis, and taking compound 215 as an example, the thermal relaxation 
parameters for each compound were determined as follows: 
 A UV/Vis of a sample kept in dark was recorded. This represents the spectrum 
for a sample of exclusively trans isomer – the “dark adapted sample” 
 The sample was irradiated to its cis dominated photostationary state PSS365 , and 
a UV/Vis vis spectrum recorded. 
 By comparing the two spectra, a suitable wavelength was selected to monitor the 
thermal relaxation rate. We selected the λmax of the π →π*, in this case 335 nm. 
 The PSS356 (cis dominated) sample was placed in a spectrometer fitted with a 
Peltier unit to maintain a fixed temperature  
 The absorption of the sample was continuously monitored at the selected 
wavelength 
 The process was repeated over a range of temperatures (60 to 90/100 oC) 
For each compound the data was manipulated in determination of a selected range 
of photophysical properties. 
 
The data from the time course measurement was normalised using the equation [(At-
A0)/(A∞-A0)] where  
At is the absorbance at 365 nm  measured at a given time, t,  
A0 is the absorbance at t = 0 s (the PSS365) 
A∞ is the absorbance at the all trans form – the dark adapted sample.  






Figure 74: Normalised plots of absorbance intensity, measured at 335 nm for 215 at various temperatures over a 
time period of 3200 s; 25 μM DMSO. 
 
The plot for 215 supports first order kinetics for the cis to trans thermal relaxation 
process.  
Curve fitting was used to determine the isomerisation rate constant (k) at each 
temperature using GraphPad Prism 7.  
The rate constants (k) determined for 215 at each temperature studied are listed in table 
7. 
Table 7: Rate constant for the thermal relaxation of 215 at different temperatures. 
Temperature (K) Rate constant (s-1) 
333 1.031X10-4 
343 2.248 X10-4 
353 5.338 X10-4 
363 13.35 X10-4 
 
The Arrhenius equation  relates the rate constant with the activation energy required for 
the isomerisation process : 



























which can also be expressed in the linear form: 
Arrhenius equation – linear form: In(k) = In (A) – EA/R(1/T) 
In the equation: 
A is the Arrhenius pre-exponential factor, typically defined as the frequency of 
collisions in the correct orientation, it is a unique constant for each reaction.  
EA is the activation energy.  
R is the gas constant (8.314 J K-1 mol-1).  
T is  temperature (K).  
 
An Arrhenius plot, -[ln(k) against 1/T], was constructed to determine A and Ea   
The data for 215 is shown in Figure 75. From this linear plot   
 The y-axis intercept is equal to in A. 
 The slope is equal to (-EA/R).  
For 215 the y-axis intercept is at 21.75, giving a value for the Arrhenius pre-exponential 
factor, A = 2.88 X 109 s-1. The slope of the graph is -10318 giving an EA = 85.9 kJ mol-
1 for the isoxazole linked galactose-azobenzene conjugate 215. 
 
 
Figure 75: Arrhenius plot following the thermal relaxation of 215: plot of ln(k) against 1/T/ 



















The Eyring equation relates the rate constant for a given reaction with G  






It can be presented  as a linear expression: 
Eyring equation - linear form     In(k/T) = (-ΔHǂ/R)(1/T)+In(kB/h)+ΔSǂ/R 
In the equation  
ΔHǂ is the enthalpy of activation. 
R is the gas constant (8.314 J K-1 mol-1). 
kB is the Boltzmann constant (1.380×10
−23 J⋅K−1) 
h is Plank’s constant (6.626×10−34 J⋅s) 
ΔSǂ is the entropy of activation 
R is the gas constant.  
An Eyring plot, In(k/T) against 1/T, was constructed to determine ΔHǂ  and ΔSǂ  
The straight line plot for 215 is given in Figure 76. From this plot 
 the slope represents -ΔHǂ/R  
 the intercept of the y-axis gives In(kB/h)+ΔSǂ/R.  
 
For 215, the y-axis intercept is at 14.90 and the slope -9970.Analysis of this data gives 





Figure 76: Eyring plot following the thermal relaxation of  215:plot of In(k/T) against 1/T 
 
The analysis conducted for the isoxazole-linked galactose conjugate 215 was repeated 
and the data extracted for the range of conjugates shown in Tables 8-10. 
  


















The data in table 8 shows that the nature of the biomolecule has some effect on the 
characteristics of the molecule. The galactose 215 and its lactose analogue 220 show 
similar characteristics. The mannose 218 (t1/2 ~ 40 hrs) and the thymidine conjugate 271 
(t1/2 ~30 hrs) are also similar with both showing larger activation energies and 
significantly longer half lives than 215 and 220 (~20 hrs). 
 
Table 8; Kinetic parameters for the thermal cis to trans isomerisation of compounds 215, 218, 220 and 271 
determined via UV/Vis absorption spectroscopy in DMSO 



















102.1 77.0 99.2 -29.5 42.5 
 
220 
86.0 0.28 83.1 -76.2 21.6 
 
271 
93.9 4.68 90.6 -54.0 28.3 
*Measured at 37 ˚C  
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Conjugates 271 and 273 differ only the relative orientation of the thymidine unit with 
respect to the azolinkage. The meta adduct 273 has a much lower activation energy for 
the isomeriation process than its para counterpart 271. Considering this difference it is 
somewhat surprising this pair have extremely similar half-lives (~30 hrs), table 9. 
 
Table 9: Kinetic parameters for the thermal cis to trans isomerisation of compounds 271 and 273 determined via 
UV/Vis absorption spectroscopy in DMSO. 



















77.4 0.0059 74.4 -108.6 28.3 




The compounds in table 10 differ in their linkage between the carbohydrate and 
azobenzene units. Compound 238 can be directly compared with its isoxazole-ligated 
analogue 215. It can be seen that the activation energy for isomerisation of the triazole 
ligated 238 is slightly higher and the half-life of the cis isomer slightly shorter than the 
isoxazole analogue 215. Whilst the ether linked 258 does show a relatively long half-
life, the activation energy for its isomerisation is similar, if not slightly lower, than many 
of the other compounds in this series.  
The data shows the ortho substituted 266 has a higher activation barrier for the 
isomerisation that the two para-substituted sugar conjugates 238 and 258. Significantly, 
the half-life of 266 is nearly double that of any of the other compounds investigated in 
this series. This observation fits with literature precedence suggesting steric bulk at the 
ortho position causes the resulting azobenzenes to experiencing slower thermal 
relaxation times.288 
Table 10: Kinetic parameters for the thermal cis to trans isomerisation of compounds 238, 258 and 266 determined 
via UV/Vis absorption spectroscopy in DMSO 





ΔHǂ   
kJ mol-1 
ΔSǂ 










83.9 0.083 80.9 -86.47 33.5 
 
266 
98.5 10.3 95.6 -46.5 
 
78.1 
                                                 
** This compound presented as having multiple conformations. 
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*Measured at 37 ˚C 
Whilst the results of these experiments are interesting and whilst we can reliably report 
the orthosubstituted, ether linked 266  is the stand out compound in this series, further 
work is need to fully understand the relationship between the structural features of the 
conjugated azobenzenes and the kinetic parameters of their thermal relaxation. In 
particular, it is acknowledged that before a more robust relationship is established the 
experiments would need to be repeated in triplicate. 
 
 
5.3 Summary  
 
 The photophysical properties of several of the carbohydrate-azobenzene 
conjugates were studied. 
 The photostationary states of the compounds at 365 nm and 420 nm, PS365 and 
PS420 were determined by 
1H-NMR spectroscopy. 
 The position of the conjugated group relative to the azo linkage and the 
opportunity, or not, for electron donation into the azobenzene unit were 
important influences on the PSS.The structure of the adduct had little bearing on 
the PSS.  
 The thermal relaxation process of the adducts was studied by UV/Vis 
spectroscopy and the thermodynamic and kinetic properties of the process 
determined. 
 The electron donating potential of the substituents and the substitution position 






6. Conclusions  
 
This project has achieved the following: 
 
A broad range of azobenzenes bearing oxime and chlorooxime functionalities were 
successfully synthesised. The reactive species were designed to offer, following 
cycloaddition, access to regioisomeric heterocycle linked azobenzene conjugates. 
Azobenzenes with the cycloaddition partner in the para and meta positions were 
prepared. Substrates  were designed to allow formation of  both the mono and divalent 
compounds. Unfortunately ortho functionalised dipole precursors could not be accessed 
due to complications, not least the formation of indazoles. 
Azidoazobenzenes and azobenzenes bearing nitrile oxide precursor functionalities were 
prepared. Reaction conditions were explored to find those best suited for nitrile oxide 
generation from an oxime – the Ch-T and NCS methods.  
The synthesis of both mono- and disubstituted propargylated azobenzene derivatives 
were also successful and initial test reactions showed they were suitable for 
cycloaddition with azido-substrates as well as nitrile oxides generated through both NCS 
and Ch-T NOAC methodologies. Meta and ortho dipolarphilic azobenzenes were 
synthesised.  
The integration of a dipolarphilic functionality into a carbohydrate substrates was readily 
achieved through glycosylation chemistry.  
The cycloaddition alkyne-bearing sugars reaction with the nitrile oxide dipoles was 
found to be challenging especially for the divalent cycloaddition reactions. A range of 
conditions were explored and ultimately good yields were achieved utilising controlled 
formation of the dipole via the slow addition of base to the chlorooxime bearing 
azobenzenes.  
Azidoazobenzene was found to readily undergo cycloaddition with propargylated 
carbohydrates. Ultimately a wide range of adducts were synthesised through these 
reactions, producing conjugates with varying regiochemistry and valency. 
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The introduction of an oxime functionally into carbohydrates was found to be difficult 
and the only conjugates that could be formed were  mono and divalent allose-azobenzene 
compounds. In contrast azides were easily introduced into carbohydrate substrates and 
their cycloaddition with propargylated azobenzenes was found to be highly effective.  
In terms of future work in this area, the development of asymmetric glycoconjugates is 
of interest, in particular for the functionalisation of surfaces, peptides or other 
biomolecules.  
The chemistry developed during the conjugation of saccharides was found to be effective 
for creating nucleoside adducts and a range of isoxazole and triazole linked compounds 
were synthesised. There is much scope to further investigate these compounds. In 
particular, the integration of the conjugates into oligonucleotide may offer an insight 
into the effects of the photoiswitch upon DNA and RNA structures. 
For the creation of peptide-azobenzene conjugates, the azide functionality was 
introduced into peptides at both internal and terminal positins. These peptides were 
found to be good substrates for cycloaddition with alkyne bearing azobenzenes. Higher 
yields were obtained when working with the resin supported peptides, however the 
chemistry was also shown to be viable in solution. A peptide with an internal propargyl 
functionality was shown to undergo cycloaddition with both azide and nitrile oxide 
dipolarohiles. The is still much scope for optimising the reaction conditions, in particular 
with nitrile oxides-peptide conjugation. 
The CuAAC chemistry was also used during the ligation of a saccharide onto a peptide 
structure through an azobenzene linker. This reaction shows the potential to explore the 
use of asymmetric azobenzene units as linker for creating cyclic peptides or for chemical 
ligation in peptide synthesis. 
Finally the effects of variation in biomolecules type, regiochemistry, valency and linker 
type upon the photophysical properties of a range of azobenzenes was explored. The 
photostationary states (PSS), determined by NMR study, showed the importance of 
electron donating and withdrawing effects upon the azobenzenes PSS.  
Upon determining the kinetic parameters of the thermal relation process by UV/Vis 
studies, we found that bulky ortho –substituents had a dramatic effect on thermal 






7.1 Materials and instrumentation 
 
Standard reagents were supplied by: TCI Europe, Sigma Aldrich, Acros Organics or 
Alfa Aesar and were used as received without the need for further purification. Solvents 
were supplied in HPLC grade or higher. Solvents were used as supplied unless the 
reaction was moisture sensitive, in which case they were distilled and dried according to 
reported protocols.289,290 
Analytical TLC was performed on pre-coated silica gel 60 F254 plates from Merck. 
Visualisation was achieved by UV irradiation or with the use of a carbohydrate stain 
(5% H2SO4 in EtOH) followed by charring. 
 Flash chromatography was performed on silica gel (40-62 μM, 60 Å). 
NMR spectra were recorded on a Bruker Advance spectrometer at 300 K. NMR were 
recorded in CDCl3 or DMSO-d6, 
1H spectra were recorded at 300 or 500 MHz; 13C 
spectra were recorded at 75 or 125 MHz, as indicated. Chemical shifts are reported in 
ppm downfield from TMS as a standard. 
UV-Vis spectra were recorded on a Jasco V-630 Bio spectrometer at 25 ˚C unless 
otherwise stated. Temperature control was maintained by a Jasco ETC717 Peltier. 
Infrared spectra were recorded as a sample prepared as a KBr disc or by ATR using a 
Perkin Elmer system 2000 FT-IR spectrophotometer.  
Melting points were obtained with a Stewart scientific SMP 11 melting point apparatus 
Electrospray (ESI) mass spectra were obtained on an Agilent Technologies 6410 time 
of flight LC/MS. They were interpreted with ‘Agilent MassHunter workstation 
software’. 
HPLC was undertaken on system built with a Gilson 322 pump, a 172 diode array 
detector and a GX-272 liquid handler; using either a Macherey-Nagel C18, 21.0 mm x 
25 cm column for semi-preparative work or a Phenomenex C18, 4.6 mm x 15 cm column 
for analytical work. 
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Automated peptide synthesis was undertaken at Royal college of Surgeons Ireland on an 




7.2 Structural numbering and nomenclature. 
 
Azobenzene core:  
To facilitate assignment of NMR data the following structural numbering systems were 
used:  
For the purposes of discussion in this thesis, the numbering of the azobenzene core will 
supersede other standard numbering systems. 
(1)The numbers of asymmetric azobenzene molecules begins at the unsustituted phenyl 
C atom para to the azo group.   
 
(2) With symmetrical azobenzenes, the numbering will originate from the aryl C atom 
adjacent to the azo linkage 
 
Carbohydrate nuclei: 
Carbohydrate nuclei are numbered according to the standard numbering system; starting 
with the anomeric position as C-1. Disaccharide units carry the prime (‘) designation on 
the second sugar unit. 
 
Nucleic acids: 
The ribose unit is labelled 1’ to 5’ going from the anomeric position. The base is referred 
to by its functionality as necessary.  
Peptides: 
Peptides are ‘constructed’ using the standard one letter and three letter codes for their 
constituent amino acids, as is appropriate. Terminal positions are labelled post C=O or 




would be represented as Ac-RGDG-NH2 or Ac-arg-gly-asp-gly-NH2.  
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7.3 Protocols for SPPS 
 
General method for manual preparation of a peptide on the solid phase: 
Rink amide resin (0.50 g, 0.5-1.0 g/mmol) was swelled in DMF (5 mL) in a SPPS vessel 
with mild agitation for 30 minutes. The DMF was drained and fresh DMF (5 mL) was 
added, followed by 30 minutes of mild agitation. This process was repeated once more. 
Then a solution of 20% v/v piperidine in DMF (5 mL) was added and the vessel was 
agitated for 10 minutes, before being drained and a further portion of the piperdine 
solution (5 mL) added, followed by agitation for a further 10 minutes. The piperdine 
solution was drained and the resin was washed consecutively with DMF (3 x 5 mL), 
DCM (3 x 5 mL) and DMF (3x 5 mL). A solution of N-α Fmoc protected amino acid (4 
eq.) PyBOP (4 eq., 1.04 g) and NMM (8 eq., 0.414 g, 0.44 mL) in DMF (5 mL) were 
added to the resin in the SPPS reaction vessel, followed by agitation for 40 minutes. The 
reaction solution was drained and the resin was washed with DMF (3 x 5 mL), DCM (3 
x 5 mL) and DMF (3x 5 mL).  
Resin loading was determined as follows: 
Three samples of the resin then removed and accurately weighed (each 5-10 mg), and 
transferred to a flask followed by addition of  1.0 mL of 20% v/v piperidine in DMF to 
each portion of resin, followed by agitation for 20 minutes. 100 μl of each solution was 
added to DMF (10 mL), of this 2 mL was taken forward for UV/Vis spectroscopic 
analysis. The intensity of the absorbance at 301 nm (𝜆 (301) was recorded for each of 
the three samples and used in the following equation:  
𝑟𝑒𝑠𝑖𝑛 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 =
101 × (𝜆 (301)
7.8 ×  𝑊𝑒𝑖𝑔ℎ𝑡
 
The average of the three readings were used to determine the resin loading. 
 
The remaining sample was N-terminal deprotected through the addition of 20% v/v 
piperdine in DMF (5 mL) with 10 minutes of agitation, before draining and a further 10 
minutes of agitation with fresh piperidine solution (5 mL). The piperidine solution was 
again drained and the resin washed with DMF (3 x 5 mL), DCM (3 x 5 mL) and DMF 
(3x 5 mL).  
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Each new residue was added as a solution of N-α Fmoc protected amino acid (3 eq. of 
determined resin loading) PyBOP (3 eq. of determined resin loading) and NMM (6 eq. 
of determined resin loading) in DMF (5 mL) to resin, where it was agitated for 40 
minutes, followed by draining of the solution and consecutive washings with DMF (3 x 
5 mL), DCM (3 x 5 mL) and DMF (3 x 5 mL). With each being followed by deprotection 
involving two 10 minute reactions with 20% v/v piperidine solution, followed by 
draining and finally washing with DMF (3 x 5 mL), DCM (3 x 5 mL) and DMF (3x 5 
mL). 
If the SPPS needed to be interrupted (e.g. the end of a working day) and storage of the 
peptide was required, the resin was shrunk by washing with DMF (3 x 5 mL), DCM (3 
x 5 mL), DMF (3x 5 mL), DCM (3 x 5 mL) and dried under vacuum before being stored 
at 5 ˚C. To reswell the resin it was twice agitated in DMF (5 mL) for 20 miniutes. 
General procedure for capping peptides:  To the swelled, N-deprotected peptide 
bearing resin was added a fresh solution of acetic anhydride in pyridine (20% v/v, 5 
mL). The reaction vessel was agitated for 5 minutes before being drained of the solution. 
Fresh acetic anhydride solution (5 mL) was added and the mixture was agitated for 5 
minutes before being drained again. This process was repeated once more before the 
resin was washed with consecutively with DMF (3 x 5 mL), DCM (3 x 5 mL), DMF (3x 
5 mL) and DCM (3 x 5 mL). When using the automated synthesiser acetylation was 
achieved by the standard coupling protocol with acetic acid (10 eq.) on to the final 
residue. 
General procedure for cleavage of peptides from Rink amide resin: To the swelled 
peptide bearing resin in a SPPS vessel, a solution of TFA, triisopropylsilane and water 
(95:2.5:2.5; 5 mL) was added. The vessel was agitated for 1 hour, if two arginine 
residues were present this was increased by 30 minutes. Solution was then drained from 
the reaction vessel and three quarters of the TFA was removed by passing dry air over 
the solution. Diethyl ether was then added to the solution until no more precipitate 
formed. The resulting suspension was then pelleted by centrifuging (2800 rpm, 5 mins). 
The pellet was twice dispersed in fresh diethyl ether (10 mL), followed by pelleting by 
centrifugation (2800 rpm, 5 mins). Finally the pellet was dissolved in distilled water (1-
2 mL) and minimum of acetonitrile before being lyophilised to give the crude material 
as a powdery solid. 
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For automated synthesis: an Applied Biosystems 433A Peptide Synthesiser was used 
at Royal collage of Surgeons Ireland. The syntheses were performed on 0.1 mmol scale, 
therefore a rink amide resin (128 mg of 0.78 mmol per gram of known loading was 
used). N-Methyl-2-pyrrolidone (NMP) was used as the general solvent, with DCM for 
washing, Fresh HATU solution (1 M) was used for coupling and piperidine for 
deprotections Each of these solutions was fitted to the synthesiser in the correct 
positions. Each coupling used 10 equivalents of Fmoc protected amino acid (1.0 mmol), 
which were weighed into individual cartridges. The cartridges were placed into the 
machine in order of sequence. Once ready, the sequence was loaded in the synthesiser 
through the Synthesis Assistant 3.1 software. The peptide was then automatically 
synthesised with monitoring of the process through observation of the UV/Vis signature 
of the dibenzofulvene generated in the Fmoc deprotections.  
Purification: All peptides were purified by semi-preparative HPLC (Gilson 322 pump, 
172 diode array detector and GX-272 liquid handler, Macherey-Nagel C18, 21.0 mm x 
25 cm column) using ‘Trilution LC’ software. The mobile phase was a 0-100% gradient 
of H2O/CH3CN, with 1% TFA, run over the course of a 20 or 30 minute period. 




7.4 Protocols for determination of photostationary states (PSS) and 
thermal relaxation measurements 
  
Photostationary state determination: 
 
A 5 mM solution of the compound was made up in DMSO-d6. The solution was kept in 
the dark for period of no less than 3 days. 400 μL of the solution was transferred to a 
quartz NMR tube (Norell inc.) and a 1H-NMR spectrum was recorded. The resonance 
position and the relative integrations of the Ar-H and heterocycle-H were identified and 
recoreded as those representing the trans isomer.  
 The sample was irradiated directly in the quartz NMR tube.†† The tube was aligned with 
the light source (Thorlabs, M365L2, 365 nm‡‡) at distance of 5 cm; the NMR tube was 
propped up in an open box in room with no lights on. The sample was irradiated for a 
period of 1 minute and immediately placed into the NMR magnet (automatic shim, 16 
scans) and the 1H-NMR spectrum recorded. This process was repeated until no change 
was observed and the photostationary state was reached.  
For the final spectrum, the signals clearly identified as respresentive of the trans isomer 
were integrated and normalised by dividing each intergral by the number of protons the 
signal represented. The average of these numbers was calculated as the relative size of 
a 1H signal of the trans isomer. The same process was then applied to those signals 
representing the cis isomer§§. The two averages were used to calculate the percentage of 




                                                 
†† Whenever the diode lamps were on, protective lab glasses were worn. 
‡‡ The LEDD1B LED driver console unit was set to continuous wave (CW) and the current limit to 0.7 A, 
the limit dial on the front was set to its maximum.  
§§ Thorlabs M420L3 diode lamp, 420 nm. 
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Thermal relaxation measurements:  
 
A 25 μM solution of the compound was made up from the stock 5 mM solution prepared 
for the NMR PSS study. The solution was kept in the dark for period of no less than 3 
days. The UV-VIS spectrum was recorded (250-600 nm, 25 ˚C) for this dark adapted 
sample. The sample 3000 μL was irradiated with light at 365 nm following the same 
methodology as Photostationary study. After an irradiation period of 1 minute the UV-
VIS spectra was recorded. This process was repeated until no change was observed in 
the UV/Vis and the sample was deemed to be at the PSS365. 
The Peltier unit was set 60 ˚C and the system left to equilibrate for 30 minutes. The 
PSS365, freshly irradiated, was placed in the heated sample holder and allowed to 
equilibrate for 1 minute. The absorbance of the sample was continuously recorded at 
335 nm for a period of no less than 3000 seconds.  
This process was repeated with a freshly irradiated sample at 10 ˚C intervals over the 
60-100 ˚C  range, until the absorbance reached a plateau (measuring data at no less than 
4 different temperatures for each sample). 
The data, manipulated as discussed in the research and discussion section (5.2 thermal 












3-Hydroxyazobenzene, 141, (70 mg, 0.35 mmol), propargyl bromide (131 mg, 0.88 
mmol) and K2CO3 (235 mg, 1.7 mmol) were added to anhydrous CH3CN (10 mL). The 
reaction mixture was allowed to stir at room temperature for 16 hrs. It was then 
concentrated under vacuum, the resulting slurry was dissolved in diethyl ether (20 mL). 
The solution was washed with water (30 mL), then brine (30 mL), dried over anhydrous 
magnesium sulphate and concentrated under vacuum to give the crude product as an 
orange oil (101 mg). Following flash chromatography (ether: pet ether 1:4) desired 
product was isolated as an orange sticky solid 72 mg, 87%.  
1H-NMR: δH (500 MHz) (CDCl3): 2.55 (t, 1H, CH, J = 2.5 Hz), 4.78 (d, 2H, CH2, J = 
2.5 Hz), 7.11 (ddd, 1H, Ar-H, J = 8.0, 3.0, 1.0 Hz) 7.42-7.54 (m, 5H, Ar-H), 7.60 (ddd, 
1H, Ar-H, 8.0, 2.0, 1.0 Hz) 7.91-7.93 (m, 2H, Ar-H) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer; 10:1 trans to cis ratio 
13C-NMR: δC (125 MHz) (CDCl3): 56.1 (CH2), 75.8 (CH), 78.3 (C≡CH), 107.3, 117.7, 
118.4, 122.9, 129.1, 129.9, 131.1 (Ar-H), 152.6, 153.9 (Ar q-C) 158.3 (Ar qC-O) 
The 13C-NMR spectra shows a series of low intensity peaks consistent with the presence 
of the cis isomer 
Rf: (diethyl ether: pet. ether 1:2) 0.76 
IR (KBr disc): 3293.6 (C-H), 1598.0 (C=C), 1478.2 (N=N) 1238.6 (C-N) cm-1. 
HRMS (direct injection) [M+H]+, [C15H13N2O]
+ calculated: 237.1022, found: 237.1030; 
difference 3.23 ppm 
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2-Hydroxy-3-methylazobenzene, 143, (1.01 g, 4.6 mmol), propargyl bromide (1.80 g, 
15.1 mmol) and K2CO3 (3.29 g, 23.8 mmol) were added to anhydrous CH3CN (40 mL). 
The reaction mixture was allowed to stir at room temperature for 18 hrs. It was then 
concentrated under vacuum, the resulting mixture was partitioned in diethyl ether (50 
mL) and water (100 mL). The organics were washed with brine (100 mL), dried over 
anhydrous magnesium sulphate and concentrated under vacuum to give the crude 
product (1.40 g). Following flash chromatography (pet. ether) the desired product was 
isolated as an orange oil 0.94 g, 82%.  
1H-NMR: δH (500 MHz) (CDCl3): 2.34 (s, 3H, CH3) 2.52 (t, 1H, CH, J = 2.5 Hz), 4.90 
(d, 2H, CH2, J = 2.5 Hz), 7.13 (d, 1H, Ar-H, J = 8.5 Hz), 7.24 (dd, 1H, Ar-H, 8.5, 2.5 
Hz) 7.42-7.52 (m, 4H, Ar-H), 7.89-7.93 (m, 2H, Ar-H) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
13C-NMR: δC (125 MHz) (CDCl3): 20.6 (CH3), 58.3 (CH2), 75.9 (CH), 78.8 (C≡CH),  
116.5, 117.3, 123.0, 129.1, 130.9, 132.8 (Ar-H), 132.0 (q-C-CH3) 142.9, 153.1 (Ar q-C) 
153.3 (Ar qC-O) 
The 13C-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
Rf  (diethyl ether: pet. ether 1:19) 0.64 
IR (KBr disc): 3291.6 (C-H), 1500.8.0 (C=C), 1467.6 (N=N) 1219.3 (C-N) cm-1. 
HRMS (direct injection) [M+H]+, [C16H15N2O]
+ calculated: 252.1210, found: 252.1223; 







Route A:183 Benzaldehyde oxime 103 (154 mg, 1.68 mmol) was dissolved in ethanol (5 
mL), chloramine-T (574 mg, 2.56 mmol) was added, followed by distilled water (1 mL). 
the reaction mixture was left to stir for 10 minutes. The propargylated azobenzene 107 
(100 mg, 0.42 mmol) was added and the reaction was left to stir over night at room 
temperature. Ethyl acetate (30 mL) was added followed by consecutive washing with 
water and brine (50 mL each). The organics were dried over anhydrous magnesium 
sulphate and concentrated under vacuum to give the crude product as an orange solid 
(834 mg). Purification by flash chromatography (diethyl ether: pet. ether, 1:1) and 
crystallisation from diethyl ether and pet. ether gave the product as a crystalline orange 
solid 132 mg, 88%. 
Route B: Benzohydroximoyl chloride 97 (200 mg, 1.29 mmol) and the Propargylated 
azobenzene 107 (101 mg 0.43 mmol) were dissolved in EtOAc (10 mL), followed by 
addition of NEt3 (130 mg, 0.18 mL  1.29 mmol). The reaction mixture was stirred for 16 
hrs at room temperature. Ethyl acetate (20 mL) was added, followed by sequential 
washing with distilled water and brine (30 mL each). The organics were dried over 
anhydrous sodium sulphate and concentrated under vacuum to give the crude product as 
an orange solid (278 mg). Purification by flash chromatography (diethyl ether: pet. ether, 
1:1) gave the desired product as a crystalline orange solid 116 mg, 76%. 
1H-NMR: δH (500 MHz) (CDCl3): 5.30 (s, 2H, OCH2), 6.69 (s, 1H, CH-isoxazole) 7.09-
7.13 (m, 2H, H-7), 7.44-7.47 (m, 4H, Ar-H), 7.51 (t, 2H, Ar-H, J = 7.5 Hz), 7.80-7.83 
(m, 2H, Ar-H), 7.87-7.90 (m, 2H, Ar-H), 7.93-7.97 (m, 2H, H-6). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
13C-NMR: δC (125 MHz) (CDCl3):  62.6 (OCH2), 101.6 (CH-isoxazole) 115.1 (C-6/7), 
122.7 (Ar-H), 124.8 (C-6/7), 126.9 (Ar-H), 128. 7 (q-Ph), 129.0, 129.1, 130.2, 130.6 
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(Ar-H), 147.8 (C-5) 152.7 (C-4), 160.0 (C-8), 162.6 (CN-isoxazole), 167.9 (CO-
isoxazole). 
The 13C-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
m.p.: 122-124 ˚̊C 
IR (KBr disc): 3260.9, 3136.4 3058.5 (C-H), 1601.4, 1585.9, 1581.4 (C=C), 1502.3 
(C=N) 1441.1 (N=N), 1257.9 (C-O) cm-1 
HRMS (direct injection) [M+H]+, [C22H18N3O2]
+ calculated: 356.1394, found: 






A solution of triethylamine (293 mg, 0.404 mL, 2.9 mmol) in ethyl acetate (0.6 mL) was 
added over 4 hours with a syringe pump to a solution of the p,p-bis propargyloxy-
azobenzene 113 (140 mg, 0.48 mmol) and benzohydroximoyl chloride, 97 (450 mg, 2.9 
mmol) in ethyl acetate (30 mL).  The reaction mixture was heated to reflux for 16 hours. 
The reaction mixture was washed consecutively with water (60 mL) and brine (60 mL). 
The organics were dried over anhydrous magnesium sulphate and concentrated under 
vacuum to give the crude product as an orange solid (576 mg). Purification by flash 
chromatography (1:1 to 2:1 diethyl ether: pet. ether) to give the product as a yellow solid 
189 mg, 74%. 
The same experiment was conducted (scale x 1.45), with CHCl3 in the place of EtOAc; 
152 was furnished in 81% yield. 
1H-NMR: δH (500 MHz) (CDCl3): 5.31 (s, 2H, OCH2), 6.69 (s, 1H, CH-isoxazole) 7.05-
7.11 (m, 2H, H-3), 7.45-7.49 (m, 3H, m- & p-Ph), 7.79-7.82 (m, 2H, o-Ph), 8. 22-8.27 
(m, 2H, H-2). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
13C-NMR: δC (125 MHz) (CDCl3):  61.6 (OCH2), 101.0 (CH-isoxazole) 115.8 (C-3), 
126.1 (C-2), 126.9 (Ph), 128.5 (q-Ph), 129.0, 130.4 (Ph), 142.5 (C-1) 162.5 (C-4), 162.7 
(CN-isoxazole), 166.8 (CO-isoxazole). 
 The 13C-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
m.p.: 136-139 ˚C 
IR (KBr disc): 3116.3 (C-H), 1593.7(C=C), 1507.3 (C=N) 1442.5 (N=N), 1254.9 (C-O) 
cm-1 
HRMS (direct injection) [M+H]+, [C32H25N4O4]
+ calculated: 529.1870, found: 





Benzyl azide 155 (226 mg, 0.206 mL, 1.69 mmol) and the 4-propargylated azobenzene 
107 (200 mg, 0.85 mmol) were added to DMSO (30 mL). Distilled water (10 mL) was 
added followed by CuSO4.5H2O (88 mg, 0.17 mmol) and sodium ascorbate (68 mg, 0.17 
mmol). The reaction mixture was stirred overnight at room temperature. Distilled water 
(50 mL) was added, followed by extraction with ethyl acetate (2 X 30 mL). The organic 
layers were combined, washed sequentially with distilled water (50 mL) and saturated 
brine (50 mL), dried over anhydrous sodium sulphate and concentrated under vacuum 
to give an orange solid (346 mg). The material was loaded on to a silica plug. Diethyl 
ether (100 mL) was passed through to elute impurities, subsequent elution with acetone 
(100 mL) gave, after evaporation of the solvent, the pure compound as an orange solid 
227 mg, 89%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 5.27 (s, 2H, OCH2), 5.63 (s, 2H, NCH2), 7.25 (d, 
2H, H-7, J = 9.0 Hz), 7.31-7.41 (m, 5H, Ar-H), 7.52-7.61 (m, 3H, Ar-H), 7.85 (d, 2H, 
Ar-H, J = 7.5 Hz), 7.90 (d, 2H, H-6, J = 9.0 Hz), 8.34 (s, 1H, CH-triazole). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
13C-NMR: δC (125 MHz) (DMSO-d6): 53.4 (NCH2), 62.0 (OCH2), 115.9, 122.7, 125.0, 
125.4, 128.5, 128.7, 129.3, 129.9, 131.4 (Ar-H & CH-triazole), 136.4 (C-8), 143.0 
(triazole-qC), 146.8 (C-1a), 152.5 (C4/5), 161.3 (qC-Ph)      
The 13C-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
m.p.: 187-189 ˚C  
IR (KBr disc): 3133.6 (C-H), 3055.0 (C-H), 1601.4 (C=C), 1581.3 (C=C triazole), 
1495.1 (N=N), 1238.9 (C-N), 1224.7 (C-O) cm-1 
HRMS (direct injection) [M+H]+, [C22H20N5O]
+ calculated: 370.1662, found: 370.1662; 







Benzyl azide 155 (183 mg, 0.17 mL, 1.38 mmol) and the 4,4’-bispropargylated 
azobenzene 113 (100 mg, 0.34 mmol) were added to DMSO (30 mL). Distilled water 
(10 mL) was added followed by CuSO4.5H2O (69 mg, 0.28 mmol) and sodium ascorbate 
(55 mg, 0.28 mmol). The reaction mixture was stirred overnight at room temperature. 
Distilled water (50 mL) was added, extraction with ethyl acetate (2 x 30 mL) followed. 
The organic layers were combined, washed with distilled water (50 mL) and saturated 
brine (50 mL), dried over anhydrous sodium sulphate and concentrated under vacuum 
to give a yellow sticky solid (224 mg). The material was loaded on to a silica plug. 
Diethyl ether (150 mL) was passed through to elute impurities, a subsequent acetone 
(100 mL) elution gave, after evaporation of the solvent, the pure compound as a yellow 
solid 166 mg, 87%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 5.26 (s, 2H, OCH2), 5.65 (s, 2H, NCH2), 7.22 (d, 
2H, H-3, J = 8.5 Hz), 7.31-7.42 (m, 5H, Ph), 7.85 (d, 2H, H-2, J = 8.5 Hz), 8.34 (s, 1H, 
CH-triazole). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
13C-NMR: δC (125 MHz)( DMSO-d6): 53.4 (NCH2), 62.0 (OCH2 ), 115.8 (C-3), 124.6 
(C-2), 125.3(C-H triazole), 128.4 , 128.7, 129.3 (Ph) 136.5 (q-Ph), 143.1 (q-triazole), 
146.9 (C-1), 160.7 (C-4) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer 
m.p.: 190-192 ˚C  
IR (KBr disc): 3079.5, 2925.5 (C-H), 1603.2 (C=C), 1583.6 (C=C triazole), 1496.2 
(N=N), 1455.7 (C-N), 1248.4 (C-O) cm-1 
HRMS (direct injection) [M+H]+, [C34H29N8O2]
+ calculated: 557.2408, found:557.2404; 








4-(Phenylazo)benzyl alcohol, 159, (100 mg, 0.47 mmols) and NMM (83 mg, 0.71 mmol) 
were dissolved in DCM (3 mL). TPAP (8.3 mg, 0.023 mmols, 5 mol%) and 4Å 
molecular sieves were added. The reaction was stirred gently at room temperature for 2 
hours. The reaction mixture was then washed through a silica plug (diethyl ether 30 mL). 
The filtrate was concentrated under vacuum to give the desired product as an orange 
solid 77 mg, 78%. 
 








Route 1: 4-(Phenylazo)benzaldehyde, 160, (0.263 g, 1.25 mmol), hydroxylamine 
hydrochloride (0.139 g, 2.00 mmol) and pyridine (0.146 g, 0.15 mL, 1.85 mmol) were 
added to ethanol (10 mL) in a 35 mL microwave vessel. The sealed vessel was then 
heated by microwave irradiation (T = 125 ˚C, Pmax = 300 W) for 60 mins. Distilled 
water (10 mL) was added, the reaction mixture was left to stand for 5 mins while a 
precipitate formed. The precipitate was filtered and dried to give the desired product as 
an orange solid (0.242 g, 86%) which required no further purification.  
Route 2: 4-(Phenylazo)benzaldehyde, 160, (1.97 g, 9.4 mmol), hydroxylamine 
hydrochloride (0.97 g, 14.0 mmol) and pyridine (0.83 g, 0.85 mL, 10.5 mmol) were 
added to ethanol (80 mL). The reaction mixture was heated to reflux for 4 hours. 
Distilled water (80 mL) was added, the reaction mixture was left to stand for 25 mins 
while a precipitate formed. The precipitate was filtered and dried to give the desired 
product as an orange solid (1.50 g, 71%) which required no further purification. 









Route 1: Bis[4-(1,3-dioxolan-2-yl)phenyl]diazene, 166, (0.451 g, 1.38 mmol), 
hydroxylamine hydrochloride (0.64 g, 9.21 mmol) and pyridine (0.36 g, 0.37 mL, 4.6 
mmol) were added to ethanol (10 mL) in a microwave vessel. The sealed vessel was 
then heated by microwave irradiation (T = 125 ˚C, Pmax = 300 W) for 90 mins. Distilled 
water (15 mL) was added, the reaction mixture was left to stand for 10 mins while a 
precipitate formed. The precipitate was filtered and dried to give the desired product as 
an orange solid 0.198 g, 53%. 
Route 2: Bis[4-(1,3-dioxolan-2-yl)phenyl]diazene 166,  (3.02 g, 9.3 mmol), 
hydroxylamine hydrochloride (5.79 g, 55.5 mmol) and pyridine (2.20 g, 2.25 mL, 27.8 
mmol) were added to ethanol (75 mL). The reaction mixture was heated to reflux for 4 
hours. Distilled water (150 mL) was added, the reaction mixture was left to stand for 30 
mins while a precipitate formed. The precipitate was filtered and dried to give the desired 
product as an orange solid 1.1 g, 44%. 
1H-NMR: δH (300 MHz) (DMSO-d6): 7.86 (d, 4H, Ar-H, J = 7.0 Hz), 8.25 (d, 4H, Ar-
H, J = 7.0 Hz), 8.29 (s, 1H, CH=NOH), 11.85 (s, 1H, CH=NOH), 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer 
13C-NMR: δC (75 MHz) (DMSO-d6): 129.2, 132.9 (Ar-CH), 139.5 (CH=NOH), 143.4 
(C-4), 153.7 (C-1) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer 
r.f. 0.39 (pet. Ether: EtOAc 6:1) 
IR (KBr disc): 2982.1 (br.) (O-H), 1588.6 (C=C), 1467.1 (N=C), 1414.9 (N=N), 1011.4 
(N-O),  
HRMS (direct injection) [M+H]+, [C14H11Cl2N4O2]








The acetal protected azobenzene 169 (3.16 g, 9.7 mmol), hydroxylamine hydrochloride 
(3.38 g, 48.6 mmol) and pyridine (2.37 g, 2.43 mL, 30.0 mmol) were added to ethanol 
(80 mL). The reaction mixture was heated to reflux for 4 hours. Distilled water (150 mL) 
was added, and the mixture was extracted with diethyl ether (3 x 50 mL). The organics 
were combined, dried over anhydrous magnesium sulphate and concentrated under 
vacuum to give the crude product. Purification by flash chromatography (diethyl ether: 
pet. ether 1:2 > 1:1) gave the desired product as an orange solid 1.24 g, 48%. 










Route 1: To a solution of 4-(phenylazo)benzaldehyde oxime, 110, (150 mg, 0.66 mmol) 
in EtOH (3 mL) and H2O (1 mL) was added Ch-T (152 mg, 0.66 mmol). The reaction 
mixture was stirred at room temperature 10 min. a solution of propargyloxybenzene, 
173, (29 mg, 0.222 mmol) in EtOH/H2O (3:1, 2 mL). The reaction mixture was heated 
to 40 ˚C for 60 mins. H2O (30 mL) was added, followed by extraction with DCM (20 
mL). The combined organics were dried over anhydrous magnesium sulphate and 
concentrated under reduced pressure to give the crude product (244 mg). Purification by 
flash column chromatography (pet. ether:EtOAc, 4:1) yielded the desired product as an 
orange solid 209 mg, 89%.183 
 
Route 2: 4-(Phenylazo)benzaldehyde oxime 110 (30 mg, 0.133 mmol) was dissolved in 
DMF (1.0 mL) followed by cooling to 0 ˚C. NCS (34 mg, 0.26 mmol) was added 
portionwise to the reaction mixture over the course of an hour. The reaction mixture was 
stirred at room temperature for a further hour. Propargyloxybenzene, 173, (5.8 mg, 0.044 
mmol) and triethylamine (14 mg, 0.019 mL, 0.133 mmol) were added, followed by 
stirring overnight at room temperature. DCM (3 x 4 mL) was added and the organics 
were washed with water (10 mL) and brine (10 mL). The organics were then dried over 
magnesium sulphate and concentrated under vacuum to give the crude product as an 
orange solid (37.4 mg). Purification by flash chromatography (pet ether:EtOAc, 4:1)  
gave the yielded the desired product as an orange solid 11.4 mg, 73%. 
Route 3: Propargyloxybenzene 173 (9.7 mg, 0.075 mmol) and NEt3 (22 mg, 0.22 mmol) 
were dissolved in DMF (0.5 mL), to this a solution of the chlorooxime 174 (57 mg, 0.22 
mmol) in DMF (0.5 mL) was added. The reaction mixture was left to stir for 2 hours at 
room temperature. Distilled water was added (10 mL) followed by extraction with DCM 
(3 x 4 mL). The combined organics were dried over anhydrous magnesium sulphate and 
concentrated under vacuum to give the crude product (31 mg). Purification by flash 
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chromatography (pet ether:EtOAc, 4:1)  gave the yielded the desired product as an 
orange solid 19.6 mg, 76%. 
 









A solution of the oxime 110 (100 mg, 0.44 mmol) in DMF (0.45 mL) was cooled in an 
ice bath. To this N-chlorosuccinimide (72 mg, 0.54 mmol) was added in four portions 
over 1 hr. The resulting solution was stirred at room temperature for 4 hrs. The reaction 
was quenched with iced water (1.2 mL) followed by extraction with diethyl ether (4 x 
0.6 mL). The organic layers were combined, dried over anhydrous Na2SO4 and 
concentrated under vacuum pressure to give the product as a flaky orange solid 93 mg, 
81%.  
1H-NMR: δH (500 MHz) (CDCl3): 7.50-7.56 (m, 3H, Ar-H), 7.93-7.97 (m, 4H, Ar-H), 
8.00-8.03 (m, 2H, Ar-H) 8.13 (s, 1H, OH) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer; 5:1 trans to cis. 
13C-NMR: δC (125 MHz) (CDCl3): 122.9, 123.1, 128.1, 129.2, 131.6 (Ar-CH), 134.4 (C-
8), 139.4 (C-Cl), 152.6, 152.7 (C-4 & C-5) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer 
m.p.: 157-161 ˚C  
IR (KBr disc): 3453.2 (O-H), 1633.9 (C=C), 1439.9 (N=N), 998.3 (N-O), 681.3 (C-Cl) 
HRMS (direct injection) [M+H]+, [C13H11ClN3O]
+ calculated: 260.0585, found: 








N-Chlorosuccinimide (72 mg, 0.54 mmol) was added in 4 portions over 1 hr to a ice 
cooled solution of  the bis-oxime 116 (50 mg, 0.17 mmol) in DMF (0.5 mL). The 
reaction mixture was allowed to warm to room temperature and stirred for 4 hrs. Iced 
water (1.2 mL) was added, followed by extraction with diethyl ether (4 x 1.0 mL). The 
organic layers were washed with brine (2 x 1mL) and dried over magnesium sulphate. 
The solvent was removed under vacuum to give the product as an orange solid 41 mg, 
72%. 
1H-NMR: δH (300 MHz) (DMSO-d6): 8.09 (d, 2H, Ar-H, J = 3Hz), 8.09 (d, 2H, Ar-H, J 
= 3Hz), 12.80 (s, 1H, OH) 
13C-NMR: δC (75 MHz) (DMSO-d6): 129.2, 132.9 (Ar-CH), 139.5 (C-Cl), 143.4 (C-4), 
153.7 (C-1) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer 
m.p.: 157-160 ˚C  
IR (KBr disc): 2914.9 (br.) (O-H), 1595.0 (C=C), 1460.0 (N=C), 1404.1.9 (N=N), 
1003.3 (N-O), 685.4 (C-Cl) 
HRMS (direct injection) [M+H]+, [C14H11Cl2N4O2]
+ calculated: 337.0254, found: 






























EtOH 0.11 1:3 4 40 No 175 
A.2 Oxime 
116 
EtOH 0.11 1:6 4 40 No 175  
A.3 Oxime 
116 








EtOH 0.046 1:6 20* 
 








EtOH 0.046 1:6 20* 
 
83 175 - 46% yield 
ǂ Dipole precursor: alkyne ratio is interpreted as the number of mole equivalents 
of alkyne to each dipole precursor. Therefore, a 1:3 molar ratio of ratio implies 
a ratio of 2:3 alkyne to dipole precursor in terms of functional groups, since the 
oxime 116 or chlorooxime 176 potentially furnish 2 equivalents of nitrile oxide. 
*In these experiments a solution of NEt3 (total volume 1 mL) was added slowly 




Route A: Reaction temperatures, molar ratio of the reactants and concentration of the 
oxime are as per table E1. The bis-oxime 176 and Ch-T were added to ethanol (10 mL) 
and stirred for 10 minutes, propargyloxybenzene 173 was added. The reaction mixture 
was left to stir for four hours. Distilled water (50 mL) was added, followed by extraction 
with DCM (3 x 30 mL). The combined organics were dried over anhydrous sodium 
sulphate and concentrated under vaccum to give the crude mixture which did not contain 
any 175. 
 
Route B: Reaction temperatures, molar ratio of the reactants and concentration of the 
chlorooxime are as per table E1. Bis-chlorooxime 176 and propargyloxybenzene 173 
were dissolved in EtOH. NEt3 was added and the mixture was left to stir. The reaction 
mixture was partitioned between distilled water (100 mL) and DCM (50 mL). The 
organics were washed with distilled water (50 mL) and brine (50 mL), followed by 
drying over anhydrous sodium sulphate and concentrating under vaccum. Purification 
by flash chromatography (diethyl ether: pet ether, 1:4 > 1:2) gave the title compound 
175, yields shown in the table. 
 
Route C: Bis-chlorooxime 176 (160 mg, 0.47 mmol) and propargyloxybenzene 173 (393 
mg, 2.97 mmol) were dissolved in toluene (30 ml). NEt3 was added and the reaction was 
left to stir. The solvent was removed under vacuum and the residue was dispersed in 
DCM. The organics were washed with distilled water (2 x 50 mL) and brine (50 mL), 
followed by drying over anhydrous sodium sulphate and concentrating under vacuum. 
Purification by flash chromatography (diethyl ether: pet ether, 1:4 > 1:2) gave the title 
compound 175, yields shown in the table. 
 
1H-NMR: δH (300 MHz) (CDCl3): 5.25 (s, 2H, CH2), 6. 73 (s, 1H, isoxazole-CH), 6.99- 
7.06 (m, 3H, Ar-H),  7.31- 7.37 (m, 2H, Ar-H) 7.93-8.05 (m, 4H, Ar-H) 




13C-NMR: δC (75 MHz) (CDCl3): 61.4 (CH2) 101.43 (isoxazole-CH) 114.8, 122.0, 
123.6, 127.7 129.74 (Ar-CH) 131.4 (C-4), 153.4 (C-1), 157.8 (O-Ar-C), 161.8 
(isoxazole-CN), 169.0 (isoxazole-CO) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer 
R.f. (diethyl ether: pet. ether 1:2) 0.52 
IR (KBr disc): 3108.7, 2917.0, 2865.8 (C-H), 1616.8 (C=N), 1600.8 (C=C), 1434.4 
(N=N), 1247.0 (C-O). 
HRMS (direct injection) [M+H]+, [C32H25N4O4]
+ calculated: 529.1870, found: 








(i) Lithium aluminum hydride (0.49 g, 13 mmol) was added to diethyl ether (30 mL) 
which was cooled to -82 °C (N2(Lq)/ EtOAc slush bath). The suspension was vigorously 
stirred and the protected nitrobenzene, 196, (0.52 g, 2.7 mmol) in diethyl ether (50 ml) 
was added dropwise. The resulting reaction mixture was allowed to slowly warm to 
room temperature and was left to stir for 3 hours. The reaction cooled to -82 °C (N2(Lq)/ 
EtOAc slush bath) and quenched by the slow, dropwise consecutive addition of EtOAc 
(3 mL), MeOH (3 mL) and distilled water (3 mL). 5% H2SO4 solution was added until 
all the salts dissolved. EtOAc (50 mL) was added and the organics were separated from 
the aqueous phase and washed with distilled water (50 mL) and brine (50 mL).  The 
organics were dried over anhydrous magnesium sulphate and concentrated under 
vacuum to give the crude product was an orange solid (0.43 g). the crude material was 
dissolved in ethanol (20 ml) and hydroxylamine hydrochloride (0.38 g, 5.4 mmol) and 
pyridine (0.41 g, 5.3 mmol) were added. The mixture was heated to reflux for 14 hrs. 
The ethanol was removed under vacuum and the residue dissolved in diethyl ether (30 
mL), followed by washing with water and brine (30 mL each). The organics were dried 
over anhydrous sodium sulphate and concentrated under vacuum to give the crude 
product as an orange/brown solid (0.34g). The residue was triturated with ether/pet ether 
(1:1), and the title compound obtained as an off white solid 0.24g, 37%.  
(ii) Lithium aluminum hydride (1.51 g, 40 mmol) was added to diethyl ether (100 mL) 
which was cooled to -82 °C (N2(Lq)/ EtOAc slush bath). With vigorous stirring the 
protected nitrobenzene, 196, (1.47 g, 7.5 mmol) in diethyl ether (150 ml) was added 
dropwise. The resulting reaction mixture was allowed to slowly warm to room 
temperature and was left to stir for 3 hours. The reaction cooled to -82 °C (N2(Lq)/ 
EtOAc slush bath) and quenched by the slow, dropwise addition of distilled water (10 
ml), 10% NaOH solution (10 mL) and distilled water (20 mL). The organics were 
decanted from the precipitate, which were washed with further ether (50 mL). The 
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combined organics were dried over anhydrous sodium sulphate and concentrated under 
reduced vacuum to give the crude product was an off white solid (1.54 g). The crude 
material, hydroxylamine hydrochloride (2.30 g, 33 mmol) and pyridine (1.30 g, 1.30 
mL, 16.5 mmol) were added to ethanol (30 mL). The mixture was heated to reflux for 
14 hrs. The ethanol was removed under vacuum and the residue dissolved in diethyl 
ether (50 mL), followed by washing with water and brine (50 mL each). The organics 
were dried over anhydrous sodium sulphate and concentrated under vacuum to give the 
crude product as an orange/brown solid residue (1.39 g), which was triturated with  
diethyl ether (1:1) to give the title compound as an off white solid 0.82 g, 46%.  
1H-NMR: δH (500 MHz) (DMSO-d6): 7.14-7.18 (m, 1H, H-5/6), 7.34-7.38 (m, 1H, H-
5/6)  7.60-7.66 (m, 3H, Ar-CH ) 7.74 (dd, 1H, H-4/7, J = 9.0, 1.0 Hz), 7.79 (s, 1H, 
CH=NOH), 7.82 (dt, 1H, H-4/7, J = 8.5, 1.0 Hz) 8.00-8.02 (m, 1H, Ar-CH) 8.73 (s, 1H, 
H-3) 11.52 (s, 1H, CH=NOH) 
13C-NMR: δC (125 MHz) (DMSO-d6): 117.8 121.4 (Ar-CH) 122.4 (C-3a) 122.5, 126.5, 
126.8, 127.2, 127.2 (Ar-CH), 128.7 (C-2’) 129.8 (C-3), 130.5 (Ar-CH) 139.4 (C-1’) 
144.6 (CH=NOH) 149.4 (C-7a)  
m.p.: 229-233 ˚C.  
IR (KBr disc): 3169.2 (O-H), 3118.1, 3074.9 (C-H), 1629.0 (C=N), 1519.8, 1313.6 (N-
O), 982.2 (N-O) cm-1. 
HRMS (direct injection) [M+H]+, [C14H12N3O]
+ calculated: 238.0975; found: 238.0986. 









2-Nitrobenzaldehyde oxime 195 (0.20 g, 1.20 mmol) was added to a suspension of 
NaBH4 (0.27 g, 7.2 mmol) in DMSO (10 mL) with vigorous stirring. Reaction times are 
indicated in table E2. All experiments were carried out at 80 °C apart from experiment 
6 which was heated to 150 ˚C. After the indicated reaction duration the DMSO mixture 
was cooled and diluted with H2O (50 mL) and extracted with DCM (2 x 20 mL). The 
combined organics were washed with water (3 x 30 mL), dried over anhydrous 
magnesium sulphate and concentrated under vacuum to give the crude product mixture 
as summarised in table E2.  
Table E2: Experimental conditions explored for the synthesis of 118 
ǂ estimated by examining the relative integrations of key signals in 1H-NMR 
spectra of the crude products  
Experiment Time Outcomeǂ 
1 5 mins Starting material returned 73% 
2 1.5 hrs Starting material returned 76% 
3 6 hrs starting material returned, with benzaldehyde 
oxime and other minor impurities 71% (Crude) 
4 14 hrs Complex mixture, (84% crude) 
5 16 hrs Mixture of benzaldehyde oxime and 2-amino 
benzaldehyde oxime (0.25:1 ratio) 68% (crude) 
6 16 hrs Complex mixture, DMSO decomposition 
(reaction heated to 150 ˚C).  77% (crude) 
7 24 hrs Complex mixture, including 2-amino 








Protected nitrobenaldehyde 196 (0.50 g, 2.56 mmol) was added to EtOH (20 mL), 
followed by addition of Zn dust (1.71 g, 26.13 mmol) and NaOH (1.04 g, 26.11 mmol). 
The reaction mixture was heated to reflux for 3 hours. The residue was concentrated 
under vacuum and the residue partitioned between diethyl ether (50 mL) and distilled 
water (50 mL). The organics were dried over anhydrous sulphate and concentrated under 
vacuum. Purification by flash chromatography (diethyl ether: pet. ether, 1:2 > 1:1) gave 
the azoxybenzene product 200  as an off white solid (278 mg, 63%).*** Hydroxylamine 
hydrochloride (0.088 g, 1.27 mmol) was added to a solution of 200 (0.217 g, 0.64 mmol) 
in acetonitrile (20 mL) and water (20 mL). The resulting solution was stirred at 60 ˚C 
for 2 hours. Upon cooling to room temperature distilled water was added (50mL) 
followed by extraction with diethyl ether (2 X 25 mL). The organics layers were 
combined, dried over anhydrous magnesium sulphate and concentrated under vacuum 
to afford the title compound as a light orange solid 0.132 g, 72%.  
1H-NMR: δH (500 MHz) (DMSO-d6): 7.46 (t, 1H, Ar-H, J = 7.5 Hz), 7.55 (t, 1H, Ar-H, 
J = 8.0 Hz), 7.62- 7.68 (m, 2H, Ar-H), 7.86 (d, 1H, Ar-H, J = 8.0 Hz), 7.91 (d, 1H, Ar-
H, J = 7.0 Hz), 7.95 (d, 1H, Ar-H, J = 8.0 Hz), 8.03 (d, 1H, Ar-H, J = 8.0 Hz), 8.31 (s, 
1H, CH=NOH), 8.33 (s, 1H, CH=NOH),  11.47 (s, 1H, CH=NOH), 11.63 (s, 1H, 
CH=NOH), 
13C-NMR: δC (125 MHz) (DMSO-d6): 122.4, 124.6 (Ar-CH), 126.6, (C-2/2’) 127.2, 
127.9 (Ar-CH), 128.3 (C-2/2’), 129.4, 129.9, 130.6, 131.4 (Ar-CH), 141.6 (C-1/1’), 
144.6 (CH=NOH), 145.5 (CH=NOH), 147.8 (C-1/1’). 
m.p.: 186-188 ˚C.  
IR (KBr disc): 3253.1 (O-H), 1631.9 (C=N), 1440.9 (N=N), 975.1 (N-O) cm-1. 
                                                 
*** Canadian Journal of Chemistry, 1973, 51(23): 3827-3841 
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HRMS (direct injection) [M+H]+, [C14H13N4O3]
+ calculated: 285.0982; found: 
285.0971. Difference 3.79 ppm.  
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Isoxazole linked protected galactose azobenzene conjugate 214 
 
 
The chloro-oxime 174 (200 mg, 0.77 mmol) and the 1-O-propargyloxy galactose 209 
(100 mg, 0.26 mmol) were added to EtOAc (20 mL). To this, a solution of triethylamine 
(79 mg, 0.78 mmol) and EtOAc (1.0 Ll) was added over 4 hours with a syringe pump. 
The reaction mixture was heated to reflux for 24 hours. Water (50 mL) was added, 
followed by extraction with DCM (2 X 50 mL). The combined organic layers were 
washed sequentially with water, brine (30 mL each), and dried over anhydrous NaSO4. 
The organic phase was concentrated under reduced pressure to give the crude product 
as a sticky orange solid (172 mg). The crude material was subjected to flash 
chromatography (DCM/MeOH, 99:1) to give the desire product as an orange solid 125 
mg, 79 %, the furoxan byproduct 216 was also recovered from the chromatography 
franctions, (49 mg, 0.11 mmol). 
1H-NMR: δH (300 MHz) (CDCl3): 2.00, 2.07, 2.07, 2.18 [4 X (s, 3H, C(O)CH3)], 3.97 
(app. t, 1H, H5, J = 6.5 Hz), 4.13-4.25 (m, 2H, H6), 4.66 (d, 1H, H1, J = 8.0 Hz) 4.84 (d, 
1H, OCH2, J = 14.0 Hz), 4.97-5.07 (m, 2H, OCH2 & H
3), 5.29 (dd, 1H, H2, J = 8.0, 3.5 
Hz ), 5.43 (d, 1H, H4, J = 3.5 Hz) 6.65 (s, 1H, CH-isoxazole), 7.50-7.57 (m, 3H, Ar-H) 
7.50-7.57 (m, 6H, Ar-H).  
13C-NMR: δC (75 MHz) (CDCl3): 20.6, 20.6, 20.7, 20.8 (C(O)CH3), 61.3 (C
6), 61.6 
(OCH2), 66.9 (C
4), 68.6 (C2), 70.7 (C3), 71.0 (C5), 100.5 (C1), 101.7 (CH-isoxazole) 
123.0, 123.5, 127.6, 129.2 (Ar-CH), 129.7 (C-8), 131.4 (C-1), 152.6, 153.5 (C-4 & C-5) 
161.8 (CN-isoxazole) 168.8 (CO-isoxazole), 169.5, 170.1, 170.2, 170.4 (C(O)CH3) 
m.p.: 56-59 ˚C  
IR (KBr disc): 3135.6, 2956.9 (C-H), 1757.8 (C=0) 1614.8 (C=C triazole), 1431.3 
(N=N) 1369.8 (C-N), 1226.7 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C30H32N3O11]
+ calculated: 610.2031, found: 







1H-NMR: δH (500 MHz) (CDCl3): 7.43-7.50 (m, 6H, Ar-H), 7.65-7.69 (m, 4H, Ar-H), 




Isoxazole linked galactose azobenzene conjugate 215 
 
 
Isoxazole linked protected galactose azobenzene conjugate 214 (108 mg, 0.18 mmol) 
was added to THF (10ml) followed by methanol (50 mL) and water (10 mL). Sodium 
methoxide (catalytic amount) was added, the mixture was then allowed to stir overnight 
at room temperature. Acidic Dowex resin was added to adjust the pH to 6. The resulting 
mixture was then filtered under gravity. The solid collected, comprising of the 
precipitated product and the resin beads, was washed with DMF (50 mLs) the resulting 
solution was concentrated under reduced pressure to yield the product as an orange solid 
63 mg, 79%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.30-3.45 (m, 3H, H
2,3,5), 3.53-3.58 (m, 2H, H6) 
3.67 (dd, 1H, H4, J = 3.0, 1.0 Hz) 4.30 (d, 1H, H1, J = 7.5 Hz),  4.82 (d, 1H, OCH2, J = 
14.0 Hz) 4.96 (d, 1H, CH2, J = 14.0 Hz) 7.23 (s, 1H, CH-isoxazole) 7.59-7.66 (m, 3H, 
Ar-H) 7.93-7.97 (m, 2H, Ar-H)  8.02-8.06 (m, 2H, Ar-H) 8.10-8.13 (m, 2H, Ar-H) 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.9 (C
6) 61.0 (OCH2) 68.5 (C
4), 71.0, 73.8, 76.0 
(C2, C3 &C5) 102.6 (C1) 103.5 (CH-isoxazole) 123.2, 123.8, 128.3, 130.0, 132.4 (Ar-H), 
131.6, 153.2, 152.4 (Ar-q) 161.6 (CN-isoxazole), 170.8 (CO-isoxazole) 
m.p. 158- 163 ˚C  
IR (KBr disc): 3402.7 (OH), 2924.7  (CH) 1610.2 (C=N), 1433.4 (N=N), 1056.5 (C-O) 
cm-1. 
HRMS (direct injection) [M+Na]+, [C22H23N3O7Na]
+ calculated: 464.1428, found: 





Isoxazole linked protected mannose azobenzene conjugate 217 
 
 
A solution of the propargyl mannose 211 (0.250 g, 0.65 mmol) and the chlorooxime 174 
(0.049 g, 0.22 mmol) in ethyl acetate (10 mL) was heated to reflux. Triethlyamine (0.033 
g, 0.22 mmol) in ethyl acetate (1.0 mL) was added dropwise over 4 hours. The reaction 
mixture was heated to reflux overnight. Further ethyl acetate (20 mL) was added 
followed by consecutive washing with water (20 mL) and brine (20 mL). The organics 
were then dried over anhydrous magnesium sulphate and concentrated under vacuum to 
give the crude product as a sticky orange solid (309 mg). The crude material was purified 
by flash chromatography (DCM/MeOH 100:0 > 95:5) to give the title compound as an 
orange sticky solid 98 mg, 73 %. 
1H-NMR: δH (300 MHz) (CDCl3): 2.01, 2.05, 2.12, 2.16 [4 X (s, 3H, C(O)CH3)], 3.99-
4.17 (m, 2H, H5 & H6), 4.23-4.33 (m, 1H, H6), 4.78 (d, 1H, OCH2, J = 14.0 Hz), 4.85 (s, 
1H, OCH2, J = 14.0 Hz), 5.00 (s, 1H, H
1), 5.24-5.40 (m, 3H, H2 & H3 & H4), 6.71 (s, 1H, 
CH-isoxazole), 7.47-7.56 (m, 3H, Ar-H) 7.91-8.03 (m, 6H, Ar-H).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (75 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.8 (C(O)CH3), 60.3 (OCH2), 62.3 
(C6), 65.9, 68.9, 69.2, 69.3 (C2-C5), 97.4 (C1), 102.0 (CH-isoxazole) 123.0, 123.5, 127.7, 
129.2 (Ar-CH), 131.3 (C-1) 153.6, 153.5 (C-4 & C-5) 161.9 (CN-isoxazole) 168.2 (CO-
isoxazole), 169.7, 1169.9, 170.0, 170.6 (C(O)CH3) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.  174-179 ˚C  
IR (KBr disc): 3459.1 (C-H), 1721.0 (C=0) 1618.4 (C=C triazole), 1377.9 (C-N), 1209.9 
(C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C30H32N3O11]
+ calculated: 610.2031, 
found:610.2041; difference: 1.57 ppm 
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Isoxazole linked mannose azobenzene conjugate 218 
 
Isoxazole linked protected mannose azobenzene conjugate 217 (108 mg, 0.18 mmol) 
was added to THF (10ml) followed by methanol (40 mL) and water and (10 mL). 
Sodium methoxide (catalytic amount) was added, the mixture was then allowed to stir 
overnight. Acidic Dowex resin was added to adjust the pH to 6. The acidified solution 
was concentrated until an orange coloured precipitate formed. Following filtration the 
precipitate was separated from the resin beads by washing with DMF (50 mL). The 
resulting solution was concentrated under reduced pressure to yield the product as an 
orange solid 58 mg, 87 %. 
 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.07-3.83 (m, very broad, H
2-6 & H’2-6), 4.22-4.26 
(m, 1H, H’1),  4.41 (d, 1H, H1, J = 8.0 Hz) 4.84 (d, 1H, OCH2, J = 14.0 Hz) 4.97 (d, 1H, 
CH2, J = 14.0 Hz) 7.18 (s, 1H, CH-isoxazole), 7.58-7.65 (m, 3H, Ar-H), 7.93 (d, 2H, Ar-
H,  J= 6.5 Hz), 8.02 (d, 2H, Ar-H, J = 8.5 Hz) 8.07 (d, 2H, Ar-H, J = 8.5 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.8, 60.9. 61.2 (OCH2, C
6 & C’6), 68.6, 71.0, 
73.6, 73.7, 75.4, 75.5, 76.0, 81.1 (C2-5), 102.5 (CH-isoxazole), 102.7, 104.3 (C1 & C’2) 
123.2, 123.8, 128.3, 130.0, 132.4 (Ar-H), 152.4, 153.2 (Ar-q), 161.6 (CN-isoxazole), 
162.8 (Ar-q), 170.6 (CO-isoxazole). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
Rf: 0.2 (MeOH 
IR (KBr disc): 3390.0 (O-H), 2932.1, 2780.7 (C-H), 1617.5 (C=N), 1430.2 (N=N), 
1066.6 (C-O) cm-1 
HRMS (direct injection) [M+H]+, [C28H34N3O12]
+ calculated:, found: difference: ppm 






A solution of the propargylated lactose 213 (200 mg, 0.30 mmol) and the chlorooxime 
174 (231 mg, 0.89 mmol) in ethyl acetate (15 mL) was heated to reflux. Triethlyamine 
(0.10 g, 0.1 mmol) in ethyl acetate (1.0 mL) was added dropwise over 4 hours. The 
reaction mixture was heated to reflux overnight. Further ethyl acetate (20 mL) was added 
followed by consecutive washing with water (30 mL) and brine (30 mL). The organics 
were then dried over anhydrous magnesium sulphate and concentrated under vacuum to 
give the crude product as a sticky orange solid. The crude material was purified by flash 
chromatography (DCM/MeOH 100:0 > 95:5) to give the adduct as an orange solid which 
was deprotected without further characterisation.  
The protected adduct was added to THF (10 mL) followed by methanol  and water (40 
mL and 10 mL) in a 100 mL round bottom flask. Sodium methoxide (catalytic amount) 
was added, the mixture was then allowed to stir overnight. Acidic Dowex resin was 
added to adjust the pH to 6, whereupon an orange precipitate formed. The resulting 
mixture was filtered under gravity. The solids comprising of the precipitated product 
and the resin beads were washed with DMF (50 mL). The resulting solution was 
concentrated under reduced pressure to yield the product as an orange solid 99 mg, 55 
%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.07-3.83 (m, very broad, H
2-6 & H’2-6), 4.22-4.26 
(m, 1H, H’1),  4.41 (d, 1H, H1, J = 8.0 Hz) 4.84 (d, 1H, OCH2, J = 14.0 Hz) 4.97 (d, 1H, 
CH2, J = 14.0 Hz) 7.18 (s, 1H, CH-isoxazole), 7.58-7.65 (m, 3H, Ar-H), 7.93 (d, 2H, Ar-
H,  J= 6.5 Hz), 8.02 (d, 2H, Ar-H, J = 8.5 Hz) 8.07 (d, 2H, Ar-H, J = 8.5 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer; 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.8, 60.9. 61.2 (OCH2, C
6 & C’6), 68.6, 71.0, 
73.6, 73.7, 75.4, 75.5, 76.0, 81.1 (C2-5), 102.5 (CH-isoxazole), 102.7, 104.3 (C1 & C’2) 
123.2, 123.8, 128.3, 130.0, 132.4 (Ar-H), 152.4, 153.2 (Ar-q), 161.6 (CN-isoxazole), 
162.8 (Ar-q), 170.6 (CO-isoxazole). 
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The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer 
Rf: material failed to move in 100% MeOH 
IR (KBr disc): 3402.0 (O-H), 2921.9 (C-H), 1607.3 (C=N), 1431.8 (N=N), 1065.5 (C-
O) cm-1 
HRMS (direct injection) [M+Na]+, [C28H33N3O12Na]
+ calculated: 626.1956, found: 





Divalent isoxazole linked protected galactose azobenzene conjugate 221 
 
 
To a solution containing the bis-chlorooxime 176 (135 mg, 0.4 mmol) and the 
propargylated galactose 209 (308 mg, 0.80 mmol) in ethanol or EtOAc (25 mL) a 
solution of triethylamine (0.23 mL. 1.6 mmol) in ethanol or EtOAc (0.77 mL) was added 
over 4 hours. The resulting solution was heated to reflux for 16 hrs. Distilled water (25 
mL) was added, followed by extraction with  DCM (3 X 25 mL). The combined organic 
layers were washed with water and brine (25 mL each) and dried over anhydrous 
Na2SO4. Following concentration under vacuum the crude product was isolated as a 
sticky orange solid (452 mg EtOH; 463 mg EtOAc). The crude material was further 
purified by flash chromatography (DCM/MeOH, 99:1) to give the desired product as an 
orange solid; 141 mg 34% EtOH; 285 mg, 69% EtOAc 
1H-NMR: δH (300 MHz) (CDCl3): 2.00, 2.07, 2.07, 2.18 [4 X (s, 3H, C(O)CH3)], 3.98 
(t, 1H, H5, J = 6.5 Hz), 4.13-4.26 (m, 2H, H6), 4.67 (d, 1H, H1, J = 8.0 Hz) 4.85 (d, 1H, 
OCH2, J = 14.0 Hz), 4.97-50.8 (m, 2H, OCH2 & H
3), 5.30 (dd, 1H, H2, J = 8.0, 3.5 Hz ), 
5.43 (d, 1H, H4, J = 3.5 Hz) 6.66 (s, 1H, CH-isoxazole), 7.98 (d, 2H, Ar-H J= 9.0 Hz), 
8.06 (d, 2H, Ar-H J= 9.0 Hz). 
13C-NMR: δC (75 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.8 (C(O)CH3), 61.3 (C
6), 61.7 
(OCH2), 67.0.0 (C
4), 68.6 (C2), 70.7 (C5), 71.1 (C3), 100.6 (C1), 101.7 (CH-isoxazole) 
123.7, 127.7 (C-2/3), 131.3 (C-4), 153.5 (C-1) 161.8 (CN-isoxazole) 168.9 (CO-
isoxazole), 169.5, 170.1, 170.2, 170.4 (C(O)CH3). 
m.p. 98- 101 ˚̊C  
IR (KBr disc): 3132.5, 2980.2 (C-H), 1750.2 (C=0) 1611.4 (C=C triazole), 1433.9 
(N=N) 1370.6 (C-N), 1226.8, 1079.7 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C30H32N3O11]
+ calculated: 1037.3146, found: 
1037.3138; difference 0.79 ppm 
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Divalent isoxazole linked galactose azobenzene conjugate 222 
 
Divalent isoxazole linked protected galactose azobenzene conjugate 221 (104 mg, 0.10 
mmol) was added to THF (10 mL) followed by methanol/water (50 mL/10 mL). Sodium 
methoxide (catalytic amount) was added, the reaction mixture was allowed to stir 
overnight. Acidic Dowex resin was added to adjust the pH to 6. The resulting mixture 
was then filtered under gravity. The residue comprising of the precipitated product and 
the resin beads was washed with DMF (50 mL) the resulting solution was concentrated 
under reduced pressure to yield the product 38 mg, 56% yield. 
1H-NMR: δH (500 MHz) (DMSO-d6 (+ D2O ex.)): 3.30-3.39 (m, 2H, H
2 & H3), 3.40-
3.46 (m, 1H, H5) 3.54 (d, 1H, H6, J = 6.0 Hz) 3.66 (d, 1 H, H4, J = 2.0 Hz),  4.29 (d, 1H, 
H1, J = 7.0 Hz) 4.81 (d, 1H, OCH2, J = 14.0 Hz) 4.93 (d, 1H, CH2, J = 14.0 Hz) 7.14 (s, 
1H, CH-isoxazole) 8.03 (d, 2H, H-2/3, J = 8.5 Hz) 8.07 (d, 2H, H-2/3, J = 8.5 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.9 (C
6) 61.0 (OCH2) 68.5 (C
4), 70.8, 73.5 (C2 
& C3), 75.7 (C5) 102.6 (C1) 103.2 (CH-isoxazole) 128.3 (C-2 & C-3) 131.7 (C-4), 153.1 
(C-1), 161.7 (CN-isoxazole), 170.7 (CO-isoxazole). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 184- 206 ˚̊C (decomposition)  
IR (KBr disc): 3391.2 (O-H) 2929.7, 2780.4 (C-H) 1617.0 (C=N), 1430.0 (N=N), 1066.5 
(C-O) cm-1 
HRMS (direct injection) [M+H]+, [C32H37N4O14]
+ calculated: 701.2301, found: 
701.2326; difference: 3.57 ppm 
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Divalent isoxazole linked protected mannose azobenzene conjugate 223 
 
A solution of the propargylated galactose 209 (921 g, 2.4 mmol) and the bis-chlorooxime 
176 (0.100 g, 0.3 mmol) in ethyl acetate (20 mL) was heated to reflux. A solution 
triethylamine (0.045 g, 0.062 mL, 0.45 mmol) in ethyl acetate (0.95 mL) was added 
dropwise over 4 hours. The reaction mixture was heated to reflux overnight. DCM (50 
mL) was added followed by consecutive washing with water (75 mL) and brine (75 mL). 
The organics were dried over anhydrous magnesium sulphate and concentrated under 
vacuum to give the crude product as a sticky orange solid (879 mg). The crude material 
was purified by flash chromatography (DCM/MeOH 100:0 > 98:2) to give the title 
compound as an orange sticky solid 213 mg, 68 %. 
1H-NMR: δH (500 MHz) (CDCl3): 2.01, 2.06, 2.12, 2.17 [4 X (s, 3H, C(O)CH3)], 4.05-
4.10 (m, 1H, H5), 4.13 (dd, 1H, H6, J =12.5, 2.5 Hz) 4.32 (dd, 1H, H6, J = 12.5, 5.0 Hz) 
4.79 (d, 1H, OCH2, J = 13.5 Hz), 4.86 (d, 1H, OCH2, J = 13.5 Hz), 5.01 (s, 1H, H
1), 
5.30-5.40 (m, 3H, H2 & H3 & H4) 6.72 (s, 1H, CH-isoxazole), 7.98-8.02 (m, 2H, H-2/3), 
8.04-8.7 (m, 2H, H-2/3). 
Minor peaks at 6.71 (s), 6.725 (s), 7.95-7.98 (m) 8.31-8.33 (m) 8.44-8.46 (m) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.7, 20.7, 20.8, 20.9 (C(O)CH3), 60.3 (OCH2), 62.3 
(C6), 65.9, 68.8, 69.2, 69.3 (C2, C3, C4, C5), 97.5 (C1), 102.0 (CH-isoxazole), 123.7, 
127.8 (C-2/3), 131.2 (C-4), 153.9 (C-1) 161.9 (CN-isoxazole) 168.3 (CO-isoxazole), 
169.7, 169.9, 170.0, 170.6 (C(O)CH3) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
R.f.: (DCM: MeOH 99:1) 0.35 
HRMS (direct injection) [M+H]+, [C48H53N4O22]
+ calculated: 1037.3146, found: 
1037.3119; difference: 2.63 ppm 
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Divalent isoxazole linked mannose azobenzene conjugate 224 
 
 
Divalent isoxazole linked protected mannose azobenzene conjugate 223 (103 mg, 0.99 
mmol) was added to THF (10 mL) followed by methanol/water (50 mL/10 mL. Sodium 
methoxide (catalytic amounts) was added, the reaction mixture was allowed to stir 
overnight. Acidic Dowex resin was added to adjust the pH to 6. The resulting mixture 
was then filtered under gravity. The residue comprising of the precipitated product and 
the resin beads was washed with DMF (50 mL) the resulting solution was concentrated 
under reduced pressure to yield the product a sticky orange solid 57 mg 82%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.36-3.53 (m, 4H, H
3 H4, H5 & H6), 3.66-3.73 (m, 
2H, H2 & H6), 4.53 (t, 1H, OH, J = 6.0 Hz ), 4.62 (d, 1H, OH, J = 6.5 Hz), 4.72-4.86 (m, 
5H, OH x 2, H1 & OCH2) 7.23 (s, 1H, CH-isoxazole) 8.07-8.10 (m, 2H, H-2/3) 8.15-
8.18 (m, 2H, H-2/3). 
Minor peaks at 7.20 (s), 7.25 (s), 8.25-8.27 (m) 8.42-8.44 (m) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 58.9 (OCH2), 61.7 (C
6), 67.3, 70.5, 71.3, 75.0 
(C2-5) 100.1 (C1) 102.6 (CH-isoxazole) 124.0, 128.4 (C-2 & C-3) 131.8 (C-4), 153.2 (C-
1), 161.7 (CN-isoxazole), 170.6 (CO-isoxazole). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
Rf: compound does not move in 100% MeOH 
IR (KBr disc): 2923.1 (C-H), 1610.9 (C=C isoxazole), 1434.0 (N=N) 1295.6, 1055.0 (C-
O) cm-1. 
HRMS (direct injection) [M+Na]+, [C32.H36N4O14Na]
+ calculated: 723.212, found: 







The oxime 111 (1.852 g, 8.22 mmol) was dissolved in DMF (10 mL) and the reaction 
solution cooled in an ice bath for 5 minutes. Whilst still in the ice bath N-
chlorosuccinimide (1.65 g, 12.3 mmol) was added portion wise over 1 hr. The solution 
was stirred at room temperature for 3 hrs. Ice/water (50 mL) was added followed by 
extraction with diethyl ether (2 x 30 mL). The organics were combined, dried over 
anhydrous magnesium sulphate and concentrated under vacuum to give the desired 
product as an orange solid without the need for further purification 1.94 g, 91%. 
1H-NMR: δH (500 MHz) (CDCl3): 7.49-7.59 (m, 4H, Ar-H), 7.93-8.02 (m, 4H, Ar-H), 
8.06 (s, 1H, OH) 8.42 (br s, 1H, H-6) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 122.0 (C-6), 123.1, 124.7, 129.2, 129.2, 129.3, 131.5 
(Ar-CH), 133.6 (C-7), 139.4 (C-Cl), 152.5, 152.6 (C-4 & C-5) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 172-176 ˚C  
IR (KBr disc): 3233.1 (O-H) 3035.9, 2865.7 (C-H), 1613.6 (C=C), 1443.4 (N=N), 998.0 
(N-O), 682.5 (C-Cl) cm-1 
HRMS (direct injection) [M+H]+, [C13H11ClN3O]
+ calculated: 260.0585, found: 
260.0575; difference 4.08 ppm. 
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A solution of the propargylated galactose 209 (0.143 g, 0.37 mmol) and the chlorooxime 
225 (0.250 g, 1.11 mmol) in ethyl acetate (20 mL) was heated to reflux. Triethylamine 
(0.131 g, 0.18 mL, 1.3 mmol) in EtOAc (1.0 mL) was added dropwise over 4 hours. The 
reaction mixture maintained at reflux overnight. Further ethyl acetate (30 mL) was added 
followed by consecutive washing with water (50 mL) and brine (50 mL). The organics 
were dried over anhydrous magnesium sulphate and concentrated under vacuum to give 
the crude product as a sticky orange solid (367 mg). The crude material was purified by 
flash chromatography (diethyl ether: Pet ether: DCM 1:3:3) to give the title compound 
as an orange sticky solid 169 mg, 76%. 
1H-NMR: δH (500 MHz) (CDCl3): 2.00, 2.07, 2.08, 2.18 [4 X (s, 3H, C(O)CH3)], 3.98 
(app. t, 1H, H5, J = 6.5 Hz), 4.15-4.24 (m, 2H, H6), 4.66 (d, 1H, H1, J = 8.0 Hz) 4.86 (d, 
1H, OCH2, J = 13.5 Hz), 4.99 (d, 1H, OCH2, J = 13.5 Hz), 5.05 (dd, 1H, H
3, J = 10.5, 
3.5 Hz), 5.28 (dd, 1H, H2, J = 10.5, 8.0 Hz ), 5.43 (d, 1H, H4, J = 3.5 Hz) 6.69 (s, 1H, 
CH-isoxazole), 7.50-7.57 (m, 3H, Ar-H), 7.64 (t, 1H, Ar-H, J= 7.5 Hz), 7.94-7.97 (m, 
3H, Ar-H), 8.03 (d, 1H, Ar-H. J = 8.0 Hz), 8.32 (s, 1H, H-6).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.8 (C(O)CH3), 61.3 (C
6), 61.6 
(OCH2), 67.0 (C
4), 68.5 (C2), 70.7 (C3), 71.1 (C5), 100.4 (C1), 101.8 (CH-isoxazole) 
120.9 (C-6) 123.0, 124.9, 129.0, 129.2 (Ar-CH), 129.7 (C-7) 129.9, 131.4 (Ar-CH), 
152.5, 153.0 (C-4 & C-5) 162.0 (CN-isoxazole) 168.7 (CO-isoxazole), 169.5, 170.1, 
170.2, 170.4 (C(O)CH3) 




m.p. 56-58 ˚̊C  
IR (KBr disc): 2973.3 (C-H), 1752.2 (C=0) 1612.5 (C=C isoxazole), 1369.4 (C-N), 
1225.1 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C30H32N3O11]
+ calculated: 610.2031, 









A solution of the propargylated mannose 211 (0.144 g, 0.37 mmol) and the chlorooxime 
225 (0.251 g, 1.11 mmol) in ethyl acetate (20 mL) was heated to reflux. Triethylamine 
(0.132 g, 0.18 mL, 1.3 mmol) was added dropwise over 4 hours. The reaction mixture 
was maintained at reflux overnight Further ethyl acetate (30 mL) was added followed 
by consecutive washing with water (50 mL) and brine (50 mL). The organics were dried 
over anhydrous magnesium sulphate and concentrated under vacuum to give the crude 
product as a sticky orange solid (349 mg). The crude material was purified by flash 
chromatography (diethyl ether: Pet ether: DCM 1:3:3) to give the title compound as an 
orange sticky solid 153 mg, 68 %. 
1H-NMR: δH (500 MHz) (CDCl3): 2.01, 2.06, 2.12, 2.17 [4 X (s, 3H, C(O)CH3)], 4.05-
4.14 (m, 2H, H5 & H6), 4.33 (dd, 1H, H6, J = 12.5, 5.0 Hz) 4.79 (d, 1H, OCH2, J = 13.5 
Hz), 4.85 (d, 1H, OCH2, J = 13.5 Hz), 5.01 (d, 1H, H
1, J = 1.5 Hz), 5.30-5.40 (m, 3H, 
H2 & H3 & H4) 6.75 (s, 1H, CH-isoxazole), 7.49-7.57 (m, 3H, Ar-H), 7.64 (t, 1H, Ar-H, 
J = 8.0 Hz), 7.94-7.99 (m, 3H, Ar-H), 8.02 (ddd, 1H, Ar-H. J = 8.0, 2.0, 1.0 Hz), 8.34 (t, 
1H, H-6, J = 1.5 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.7, 20.7, 20.8, 20.9 (C(O)CH3), 60.3 (OCH2), 62.3 
(C6), 65.9, 68.9, 69.2, 69.2 (C2 & C3 & C4 & C5), 97.4 (C1), 102.1 (CH-isoxazole) 121.1 
(C-6) 123.0, 124.8, 129.0, 129.2 (Ar-CH), 129.7 (C-7) 129.8, 131.4 (Ar-CH), 152.5, 
153.0 (C-4 & C-5) 162.1 (CN-isoxazole) 168.2 (CO-isoxazole), 169.7, 169.9, 170.0, 
170.6 (C(O)CH3) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 57-59 ˚̊C  
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IR (KBr disc): 2958.8 (C-H), 1751.7 (C=0) 1612.1 (C=C isoxazole), 1370.9 (C-N), 
1226.3 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C30H32N3O11]
+ calculated: 610.2031, 





Isoxazole linked  mannose-azobenzene conjugate 229 
 
 
Isoxazole linked protected mannose-azobenzene conjugate 228 (98 mg, 1.61 mmol) in 
THF/MeOH/H2O (5 mL : 20 mL : 5 mL) was added sodium methoxide (catalytic 
amount). The reaction solution was allowed to stir at room temperature overnight. Acidic 
Dowex resin was added until the solution was pH 8. The resin was filtered off and the 
solution was concentrated under vacuum until a precipitate formed. The precipitate was 
filtered and washed with distilled water (50 mL) and dried to give the desired product 
as an orange solid 54 mg, 76%.  
1H-NMR: δH (500 MHz) (DMSO-d6): 3.40-3.62  (m, 4H, H
3, H4, H5 & H6), 3.70- 3.79 
(m, 2H, H2 and H6) 4.79 (d, 1H, OCH2, J = 13.5 Hz), 4.85-4.90 (m, 2H, OCH2 & H
1), 
7.31 (s, 1H, CH-isoxazole), 7.62-7.75 (m, 3H, Ar-H), 7.81 (t, 1H, Ar-H, J = 8.0 Hz), 
7.99 (d, 2H, Ar-H, J = 6.5 Hz), 8.06 (d, 1H, Ar-H. J = 8.0 Hz), 8.14 (t, 1H, Ar-H, J = 8.0 
Hz), 8.41(s, 1H, Ar-H) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 58.5 (OCH2), 61.6 (C
6), 67.3, 70.5, 71.3, 74.9 (C2 
& C3 & C4 & C5), 97.4 (C1), 100.1 (C1) 102.6 (CH-isoxazole) 120.8, 123.2, 124.6, 129.9, 
130.0, 130.9, 132.4 (Ar-CH), 152.3, 152.8 (Ar-q) 161.8 (CN-isoxazole) 170.5 (CO-
isoxazole). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
R.f.: (DCM : MeOH 3:1) 0.42 
IR (KBr disc): 3320.7 (O-H), 1611.4 (C=C isoxazole), 1419.9 (N=N), 1060.1 (C-O) cm-
1. 
HRMS (direct injection) [M+H]+, [C22H24N3O7]
+ calculated: 442.1609, found: 







The bis-oxime 112 (2.55 g, 9.5 mmol) was dissolved in DMF (15 mL) and the reaction 
solution was cooled in an ice bath for 5 minutes. Whilst still in the ice bath N-
chlorosuccinimide (3.80 g, 28.5 mmol) was added portion wise over 1 hour. The reaction 
mixture was stirred at room temperature for 3 hours. Ice/water (75 mL) was added 
followed by extraction with diethyl ether (2 x 50 mL). The organics were combined, 
dried over anhydrous magnesium sulphate and concentrated under vacuum to give the 
desired product as an orange solid without the need for further purification 2.98 g, 93% 
1H-NMR: δH (500 MHz) (DMSO-d6): 7.74 (app. t, 1H, H-5, J = 8.0 Hz), 8.03 (d, 1H, H-
4, J = 8.0 Hz), 8.08 (d, 1H, H-6, J = 8.0 Hz), 8.29 (s, 1H, H-2) 12.65 (s, 1H, OH)* 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 120.4 (C-2), 125.6, 129.9 (C-4 & C-6), 130.7 (C-
5), 134.4 (C-3), 135.2 (C-Cl), 152.2 (C-1)  
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 202-204 ˚C  
IR (KBr disc): 3276.7 (O-H) 3088.8 (C-H), 1631.3(C=C), 1461.4 (N=N), 995.22 (C-O), 
683.4 (C-Cl) cm-1 
HRMS (direct injection) [M+H]+, [C14H11Cl2N4O2]
+ calculated: 337.0254, found: 








A solution of the propargylated galactose 209 (1.208 g, 3.13 mmol) and the bis-
chlorooxime 230 (0.176 g, 0.521 mmol) in ethyl acetate (30 mL) was heated to reflux. 
Triethlyamine (0.116 g, 0.16 mL, 1.15 mmol) in EtOAc (1.0 mL) was added dropwise 
over 4 hours. The reaction mixture maintained at reflux overnight. Further ethyl acetate 
(50 mL) was added followed by consecutive washing with water (75 mL) and brine (75 
mL). The organics were dried over anhydrous magnesium sulphate and concentrated 
under vacuum to give the crude product as a sticky orange solid (1.43 g). Purification 
by flash chromatography (diethyl ether: Pet ether: DCM 1:1:3) gave the title compound 
as an orange sticky solid 389 mg, 72 %. 
1H-NMR: δH (500 MHz) (CDCl3): 1.99, 2.07, 2.08, 2.18 [4 X (s, 3H, C(O)CH3)], 3.98 
(app. t, 1H, H5, J = 6.5 Hz), 4.14-4.25 (m, 2H, H6), 4.67 (d, 1H, H1, J = 8.0 Hz) 4.87 (d, 
1H, OCH2, J = 14.0 Hz), 5.00 (d, 1H, OCH2, J = 14.0 Hz), 5.04-5.07 (m, 1H, H
3), 5.30 
(dd, 1H, H2, J = 10.5, 5.0 Hz ), 5.43 (d, 1H, H4, J = 2.5 Hz) 6.70 (s, 1H, CH-isoxazole), 
7.66 (t, 1H, H-5, J= 7.5 Hz), 7.98 (d, 1H, H-4/6, J = 7.5 Hz), 8.05 (d, 1H, H-4/6, J = 7.5 
Hz), 8.36 (s, 1H, H-2).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.5, 20.6, 20.7, 20.8 (C(O)CH3), 61.3 (C
6), 61.6 
(OCH2), 67.0 (C
4), 68.6 (C2), 70.7 (C3), 71.1 (C5), 100.5 (C1), 101.7 (CH-isoxazole) 
121.0 (C-2) 124.9, 129.3 (C-4 & C-6), 129.9 (C-3) 129.9, (C-5), 152.8 (C-1) 161.9 (CN-
isoxazole) 168.8 (CO-isoxazole), 169.5, 170.0, 170.2, 170.4 (C(O)CH3) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 71-74 ˚C  
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IR (KBr disc): 2980.5 (C-H), 1751.3 (C=0) 1612.3 (C=C isoxazole), 1423.6 (N=N) 
1370.0 (C-N), 1224.6 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C48H53N4O22]
+ calculated: 1037.3146, found: 
1037.3148; difference 0.20 ppm 
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Divalent isoxazole linked protected galactose azobenzene conjugate 231 (264 mg, 0.25 
mmol) was added to a  THF/MeOH/H2O mixture (5 mL: 20 mL: 5 mL) followed by 
sodium methoxide (catalytic amount). The reaction solution was allowed to stir at room 
temperature for 16 hrs. Acidic Dowex resin was added until the solution was pH 8. The 
resin was filtered off and the solution was concentrated under vacuum to give the desired 
product as an orange solid 149 mg, 83%.  
1H-NMR: δH (500 MHz) (DMSO-d6): 3.29-3.44 (m, 3H, H
2, H3 & H5), 3.52-3.57 (m, 
2H, H6), 4.30 (d, 1H, H1, J = 7.5 Hz) 4.82 (d, 1H, OCH2, J = 14.0 Hz), 4.96 (d, 1H, 
OCH2, J = 14.0 Hz), 7.25 (s, 1H, CH-isoxazole), 7.80 (t, 1H, H-5, J= 8.0 Hz), 8.07-8.10 
(m, 2H, H-4 & H-6), 8.40 (t, 1H, H-2, J = 2.0 Hz).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.8 (C
6), 61.0 (OCH2), 68.5 (C
4), 70.8, 73.6, 
75.8 (C2, C3 & C5), 102.6 (CH-isoxazole), 103.4 (C1), 120.9 (C-2) 124.9, 130.3 (C-4 & 
C-6), 130.2 (C-3) 131.1, (C-5), 152.7 (C-1) 161.7 (CN-isoxazole) 170.9 (CO-isoxazole),  
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 209-211 ˚C  
IR (KBr disc): 3380.4 (O-H) 2925.7 (C-H), 1613.8 (C=C isoxazole), 1450.4 (N=N) 
1369.5 (C-N), cm-1. 
HRMS (direct injection) [M+Na]+, [C32H36N4O14Na]
+ calculated: 723.2120, found: 








A solution of the propargylated mannose 211 (0.507 g, 1.31 mmol) and the bis-
chlorooxime 230 (0.073 g, 0.22 mmol) in ethyl acetate (20 mL) was heated to reflux. 
Triethlyamine (0.085 g, 0.062 mL, 0.48 mmol) in EtOAc (1.0 mL) was added dropwise 
over 4 hours. The reaction mixture was maintained at reflux overnight. Further ethyl 
acetate (30 mL) was added followed by consecutive washing with water (50 mL) and 
brine (50 mL). The organics were dried over anhydrous magnesium sulphate and 
concentrated under vacuum to give the crude product as a sticky orange solid (1.43 g). 
Purification by flash chromatography (diethyl ether: Pet ether: DCM 1:1:3) gave the title 
compound as an orange sticky solid 169 mg, 74 %. 
1H-NMR: δH (500 MHz) (CDCl3): 2.01, 2.06, 2.12, 2.17 [4 X (s, 3H, C(O)CH3)], 4.03-
4.17(m, 2H, H5 & H6), 4.32 (dd, 1H, H6, J = 12.0, 5.0 Hz) 4.80 (d, 1H, OCH2, J = 13.5 
Hz), 4.86 (d, 1H, OCH2, J = 13.5 Hz), 5.02 (d, 1H, H
1, J = 1.0 Hz), 5.29-5.40 (m, 3H, 
H2 & H3 & H4) 6.76 (s, 1H, CH-isoxazole), 7.66 (t, 1H, H-6, J = 8.0 Hz), 8.00 (d, 1H, 
H-4/6, J = 8.0 Hz), 8.06 (d, 1H, H-4/6, J = 8.0 Hz), 8.38 (s, 1H, H-2).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.8 (C(O)CH3), 60.2 (OCH2), 62.3 
(C6), 65.9, 68.9, 69.2, 69.3 (C2, C3, C4, C5), 97.4 (C1), 102.1 (CH-isoxazole) 121.2 (C-
2) 124.9, 129.4 (C-4/6), 129.8 (C-3) 129.9 (C-5), 152.8 (C-1) 162.0 (CN-isoxazole) 
168.2 (CO-isoxazole), 169.7, 169.8, 169.9, 170.6 (C(O)CH3) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 64-67 ˚C  
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IR (KBr disc): 2958.8 (C-H), 1751.8 (C=0) 1613.3 (C=C isoxaozle), 1423.3 (N=N) 
1371.6 (C-N), 1226.8 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C48H53N4O22]
+ calculated: 1037.3146, found: 








Divalent isoxazole linked protected mannose azobenzene conjugate 233 (188 mg, 0.18 
mmol) was added to a THF/MeOH/H2O mixture (5 mL: 20 mL: 5 mL) followed by 
sodium methoxide (catalytic amount). The reaction solution was allowed to stir at room 
temperature for 16 hrs. Acidic Dowex resin was added until the solution was pH 8. The 
resin was filtered off and the solution was concentrated under vacuum to give the desired 
product as an orange solid 103 mg, 81%.  
1H-NMR: δH (500 MHz) (DMSO-d6): 3.38-3.452 (m, 4H, H
2, H3, H4 & H6), 3.66-3.70 
(m, 2H, H5 & H6), 4.82 (d, 1H, OCH2, J = 13.5 Hz), 4.80 (d, 1H, H
1, J = 1.5 Hz), 4.83 
(d, 1H, OCH2, J = 13.5 Hz), 7.25 (s, 1H, CH-isoxazole), 7.80 (t, 1H, H-5, J= 7.5 Hz), 
8.07-8.13 (m, 2H, H-4 & H-6), 8.42 (t, 1H, H-2, J = 1.5 Hz).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 58.9 (OCH2), 61.5 (C
6), 67.2 70.4, 71.1, 74.9 (C2, 
C3 C4 & C5), 100.0 (C1), 102.6 (CH-isoxazole), 121.0 (C-2) 124.8, 130.2 (C-4 & C-6), 
130.2 (C-3) 131.0, (C-5), 152.7 (C-1) 161.8 (CN-isoxazole) 170.5 (CO-isoxazole),  
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 159-163 ˚C  
IR (KBr disc): 3380.4 (O-H) 2925.7 (C-H), 1617.1 (C=C isoxazole), 1422.4 (N=N) 
1385.5 (C-N), cm-1. 
HRMS (direct injection) [M+H]+, [C32H36N4O14]
+ calculated: 723.2120, found: 




Triazole linked protected galactose azobenzene conjugate 235 
 
To a solution of the propargylated galactose 209 (347 mg, 0.90 mmol) and the 4-azido 
azobenzene 171 (200 mg, 0.90 mmol) in DMSO (30 mL), copper sulphate pentahydrate 
(90 mg, 0.36 mmol) and sodium ascorbate (72 mg, 0.36 mmol) were added, followed by 
water (10 mL). The reaction mixture was allowed to stir overnight at room temperature. 
Distilled water (100 mL) was added, followed by extraction with DCM (2 x 50 mL). 
The organics were combined, washed consecutively with water (2 x 100 mL) and brine 
(100 mL), followed by concentration under vacuum to give the crude product as an 
orange sticky solid (484 mg). Purification by flash chromatography (DCM: MeOH 
100:0 to 98:2) gave the product as an orange foam 458 mg, 83% 
1H-NMR: δH (500 MHz) (CDCl3): 1.99, 2.02, 2.06, 2.17 [4 X (s, 3H, C(O)CH3)], 3.99 
(t, 1H, H5, J = 6.5 Hz), 4.15-4.24 (m, 2H, H6), 4.73 (d, 1H, H1, J = 8.0 Hz) 4.93 (d, 1H, 
OCH2, J = 13.0 Hz), 5.04 2-5.10 (m, 2H, H
3 + OCH2), 5.25-5.30 (m, 1H, H
2) 5.43 (d, 
1H, H4, J = 3.0 Hz) 7.51-7.57 (m, 3H, H-1 & H-2), 7.92 (d, 2H, H-6/7, J = 9.0 Hz) 7.96 
(dd, 2H, H-3, J = 8.0, 1.5 Hz), 8.06 (s, 1H, CH-triazole), 8.10 (d, 2H, H-6/7, J = 9.0 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.8 [4 x (C(O)CH3)], 61.4 (C
6), 
63.0 (OCH2), 67.1 (C
4), 68.8 (C2), 70.8 (C3), 71.0 (C5), 100.7 (C1), 120.8 (CH-triazole), 
120.9 (C-6/7), 123.1 (C-3), 124.4 (C-6/7), 129.2 (C-2), 131.6 (C-1), 138.3 (C-5/8), 145.4 
(q-triazole) 152.3, 152.5 (C-5/8 & C-4), 169.6, 170.1, 170.2, 170.4 [4 x (C(O)CH3)] 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 65-69 ˚C. 
IR (KBr disc): 2938.7 (C-H), 1750.3 (C=0) 1603.3 (C=C), 1509.5 (N=N), 1370.9 (C-
N), 1228.1 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C29H32N5O10]
+ calculated: 610.2144; found: 
610.2164; Difference: 3.35 ppm.  
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The triazole linked protected galactose azobenzene conjugate 235 (396 mg, 0.64 mmol) 
was dissolved in a THF/MeOH/H2O mixture (10 mL:30 mL:10 mL), sodium methoxide 
(catalytic amount) was added and the resulting solution was left to stir over night at room 
temperature. Acidic Dowex resin was used to neutralise the solution to pH 7. The resin 
was removed by filtration and the solution was concentrated under vacuum until a 
precipitate formed. The precipitate was filtered and washed with distilled water (100 
mL) to give the product as an orange solid, 247 mg 86%. 
1H-NMR: δH (500 MHz) (CDCl3): 3.30-3.39 (m, 2H, H
2 & H3), 3.44 (t, 1H, H5, J = 6.0 
Hz), 3.56-3.69 (Br H2O peak containing H4 & H6 (d, 1H, H6, J = 6.0 Hz) 4.30 (d, 1H, 
H1, J = 7.5 Hz), 4.77 (d, 1H, OCH2, J = 12.5 Hz) 4.95 (d, 1H, OCH2, J = 12. 5 Hz) 7.59-
7.65 (m, 3H, H-1 & H-2), 7.94 (dd, 2H, H-3, J = 8.0, 2.0 Hz) 8.11 (d, 2H, H-6/7, J = 9.0 
Hz), 8.15 (d, 2H, H-6/7, J = 9.0 Hz), 8.96 (s, 1H, CH-triazole). 
13C-NMR: δC (125 MHz) (CDCl3): 61.0 (C
6), 61.8 (OCH2), 68.6 (C
4), 70.9 73.7 (C2 & 
C3), 75.8 (C5) 103.4 (C1) 121.2 (C-6/7), 123.2, 123.2 (C-3 and CH-triazole), 124.6 (C-
6/7), 130.0 (C-2), 132.4 (C-1), 138.8 (C-5/8), 146.0 (q-triazole) 151.7 (C-5/8), 152.3 (C-
4). 
m.p.: 211-214 ˚C. 
IR (KBr disc): 3350.2(C-H), 2929.4 (C-H), 1597.0 (C=C), 1510.7 (N=N), 1383.7 (C-
N), 1235.1, 1064.4 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C21H24N5O6]
+ calculated: 442.1721; found: 








To a solution of the propargylated mannose 211 (0.250g, 0.65 mmol) and the 4-
azidoazobenzene 171 (0.072 g, 0.32 mmol) in DMSO (30 mL), copper sulphate 
pentahydrate (95 mg, 0.38 mmol) and sodium ascorbate (76mg, 0.38 mmol) were added, 
followed by water (10 mL). The reaction mixture was allowed to stir overnight at room 
temperature. Distilled water (100 mL) was added, followed by extraction with DCM (2 
x 50 mL). The organics were combined, washed consecutively with water (2 x 100 mL) 
and brine (100 mL), followed by concentration under vacuum to give the crude product 
as an orange sticky solid (319 mg). The crude material was incompletely purified by 
flash chromatography (DCM: MeOH 100:0 to 98:2). The resulting material was 
dissolved in a THF/MeOH/H2O mixture (10 mL: 30 mL: 10 mL), sodium methoxide 
was added (catalytic amounts) and the resulting solution was left to stir over night at 
room temperature. Acidic Dowex resin was used to neutralise the solution to pH 7. The 
resin was removed by filtration and the solution was concentrated under vacuum until a 
precipitate formed. The precipitate was filtered and washed with distilled water (100 
mL) to give the product as an orange solid, 117 mg, 80%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.43-3.56 (m, 2H, H
2 + H5) 3.50-3.55 (m, 2H, H4 
+ H6), 3.66 (br s, 1H, H3), 3.72 (d, 1H, H6, J = 1.5 Hz) 4.66 (d, 2H, OCH2, J = 11.0) 4.81 
(d, 1H, OCH2, J = 11.0 Hz), 4.82 (s, 1H, H
1)  7.55-7.62 (m, 3H, H-1 & H-2), 7.89 (d, 
2H, H-3, J = 7.5 Hz) 8.06 (d, 2H, H-6/7, J = 9.0 Hz), 8.11 (d, 2H, H-6/7, J = 9.0 Hz), 
8.88 (s, 1H, CH-triazole). 
Minor peaks at 8.72 (s), 8.83 (s), 8.90 (s). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
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13C-NMR: δC (125 MHz) (DMSO-d6): 59.5 (OCH2), 61.6 (C
6), 67.3 (C5), 70.5 (C4), 71.2 
(C3) 74.5 (C2), 99.7 (C1) 121.3 (C-6/7), 123.1 (C-3), 124.6 (C-6/7), 130.0 (C-2), 132.4 
(C-1), 138.6 (C-5/8), 145.5 (q-triazole) 151.7 (C-5/8), 152.3 (C-4).  
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 58-61 ˚C 
IR (KBr disc): 3380.6 (O-H), 2925.86 (C-H), 1448.6 (N=N), 1042.3 (C-O)   cm-1 
HRMS (direct injection) [M+H]+, [C21H24N5O6]
+ calculated: 442.1721, found: 










The propargylated azobenzene 113 (50 mg, 0.17 mmol) was dissolved in ethanol (5 mL) 
and the solution heated to reflux. Separately, the helicid oxime 241 (0.160, 0.34 mmol) 
and Ch-T (93 mg, 0.41 mmol) were added to ethanol (5 mL). After mixing for 10 
minutes the solution was added dropwise to the refluxing azobenzene solution. After 90 
minutes, a second freshly premixed solution of the oxime 241 (0.160, 0.34 mmol) and 
Ch-T (93 mg, 0.41 mmol) was added dropwise to the reaction mixture. The addition was 
repeated twice more on the same scale at 90 minutes intervals. The reaction mixture was 
heated to reflux overnight. It was then concentrated under vacuum before being 
dissolved in DCM (50 mL). The organics were washed with water (25 mL) aqueous 
NaOH (5% w/v, 25 mL) and brine (25 mL). the organics were dried over anhydrous 
magnesium sulphate, followed by concertation under vacuum to give the crude product 
(582 mg). Purification by flash chromatography (pet ether: EtOAc 3:1) gave the desired 
product as a yellow solid (124 mg, 59%) 
1H-NMR: δH (500 MHz) (CDCl3): 2.03, 2.06, 2.09, 2.17 (s, 3H, C(O)CH3), 4.23-4.29 
(m, 3H, H5 & H6) 5.06 (dd, 1H, H4, J = 9.5, 3.0 Hz) 5.18 (dd, 1H, H2, J = 8.0, 3.0 Hz) 
5.29 (s, 2H, OCH2) 5.42 (d, 1H, H
1, J = 8.0 Hz) 5.76 (app. t, 1H, H3, J = 3.0 Hz) 6.64 (s, 
1H, isoxazole-CH) 7.07-7.13(m, 4H, H-3’ & H-2/3) 7.77 ( d, 2H, H-2’, J = 9.0 Hz) 7.91 
(d, 2H, H-2/3, J = 9.0 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.5, 20.6 20.7 20.8 (CH3C(O)), 61.7 (OCH2), 62.3 
(C6), 66.2 (C4), 68.4 (C3), 68.8 (C2), 70.6 (C5), 96.9 (C1), 101.4 (isoxazole-CH), 115.1, 
117.3 (Ar-CH), 123.6 (C-1’) 124.6 128.3 (Ar-CH), 147.8 (C-1) 158.4 (C-4’) 159.7 (C-
4) 161.9 (isoxazole-CN) 168.0 (isoxazole-CO) 169.1, 169.1, 169.7, 170.7 (C(O)CH3) 
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The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
R.f.: (DCM) 0.38 
IR (ATR): 1744.9 (C=O), 1616.6, 1582.6 (C=C), 1530.0 (N=N), 1370.8 (C-N), 1223.2, 
1023.8, 1003.4 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C60H60N4O24Na]
+ calculated: 1243.3490; found: 









Divalent isoxazole linked protected helicid-azobenzene conjugate 242 (63 mg, 0.052 
mmol) was dissolved in THF (10 mL) followed by addition of MeOH (40 mL) and 
distilled water (10 mL). Catalytic amounts of NaOMe were added and the mixture was 
left to stir at room temperature overnight. Acidic Dowex resin was added until the 
reaction mixture reached pH ~5. The solids were then separated by filtration and were 
washed with aqueous methanol (1:1, 25 mL). The product was then washed away from 
the resin with DMF (50 mL). The solvent was removed under vacuum to give the desired 
product as a yellow solid (44 mg, 95%) 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.40-3.53 (v. br. m, H2O & OH, H
2 & H3 & H6), 
3.65-3.70 (m, 1H, H6), 3.71-3.76 (m, 1H, H5), 3.95 (t, 1H, H4, J = 3.0 Hz), 5.20 (d, 1H, 
H1, J = 8.0 Hz), 7.14 (d, 2H, H-3’, J = 9.0 Hz), 7.17 (s, 1H, isoxazole-CH), 7.27 (d, 2H, 
H-2/3, J = 9.0 Hz) 7.83 (d, 2H, H-2’, J = 9.0 Hz) 7.88 (d, 2H, H-2/3, J = 9.0 Hz) 
13C-NMR: δC (125 MHz) (DMSO-d6): 61.1, 61.3 (OCH2 & C
6), 67.4, 70.6 (C2 & C3), 
71.8 (C4), 75.1 (C5), 98.7 (C-1), 102.9 (isoxazole-CH), 115.9 (C-2/3), 117.1 (C-3’), 
122.1 (C-1’), 124.7 (C-2/3), 128.6 (C-2’), 147.2 (C-1) 159.6 (C-4’) 160.2 (C-4) 162.0 
(isoxazole-CN) 168.3 (isoxazole-CO)  
R.f.: (DCM: MeOH 4:1) 0.31 
IR (ATR): 1623.6, 1576.6 (C=C), 1499.7 (N=N), 1378.0 (C-N), 1224.4, 1014.8, (C-O) 
cm-1. 
HRMS (direct injection) [M+H]+, [C44H45N4O16]
+ calculated: 885.2825; found: 








The chlorooxime 253 (1.019 g, 3.31 mmol) and the propargylated azobenzene 113 
(0.246 g, 0.85 mmol) were dissolved in EtOAc (30 mL). Triethylamine (0.338 g, 3.34 
mmol) in EtOAc (1 mL) was added over four hours with a syringe pump. The reaction 
mixture was heated to reflux for 16 hours. The organics were washed with water and 
brine (50 mL each), followed by drying over anhydrous magnesium sulphate and finally 
concentration under vacuum to give the crude product a sticky yellow solid (1.399 g). 
Despite several attempts at purification by flash chromatography (1: DCM: MeOH 99:1; 
2: EtOAc: pet. ether 1:3; 3: EtOAc: cyclohexane: pet ether 1:1:2) the desired product 








The galactose azide 255 (408 mg, 1.10 mmol) and the propargylated azobenzene 107 
(1.5 eq., 387 mg, 1.65 mmol) were added to DMSO (30 mL) with vigorous stirring. 
Distilled water (10 mL) was added followed by copper sulphate pentahydrate (110 mg, 
0.88 mmol) and sodium ascorbate (90 mg, 0.88 mmol). The reaction solution was stirred 
at room temperature overnight. DCM (80 mL) was added, followed by washing with 
distilled water (100 mL) and brine (100 mL). The organics were dried over anhydrous 
magnesium sulphate and concentrated under vacuum to give the crude product as a 
sticky orange solid (743 mg). Purification by flash chromatography (SiO2, DCM: MeOH 
99:1) gave the title compound as an orange foam, 519 mg, 0.85 mmol, 77%. 
1H-NMR: δH (500 MHz) (CDCl3): 1.86, 2.01, 2.05, 2.22 [4 X (s, 3H, C(O)CH3)], 4.13-
4.25 (m, 3H, H5 + H6), 5.21 (dd, 1H, H3, J = 3.5 Hz, 10.0 Hz) 5.31 (s, 2H, OCH2), 5.52-
5.59 (m, 2H, H2 + H4) 5.82 (d, 1H, H1, J = 9.0 Hz) 7.12 (d, 2H, H-7, J = 9.0 Hz), 7.44 (t, 
1H, H-1, J = 7.5 Hz) 7.50 (t, 2H, H-2, J = 7.5 Hz), 7.88 (d, 2H, H-3, J = 7.5 Hz), 7.91-
7.96 (m, 3H, H-6 + C-H triazole. 
13C-NMR: δC (125 MHz) (CDCl3): 20.2, 20.5, 20.6, 20.7 [4 x (C(O)CH3)], 61.2 (C
6), 
62.0 (OCH2), 66.9, 67.9 (C
2 + C4), 70.8 (C3), 74.19 (C5) 86.4 (C1) 115.1 (C-7), 121.3 
(C-H triazole), 122.6 (C-3), 124.8 (C-6), 129.0 (C-2), 130.5 (C-1),  144.5 (q-triazole) 
147.4 (C-5) 152.8 (C-4) 160.5 (C-8) 169.1, 169.8, 169.9, 170.3 [4 x (C(O)CH3)] 
m.p.: 64-67 ˚C. 
IR (KBr disc): 2973.3 (C-H), 1754.1 (C=0) 1600.4 (C=C), 1583.6 (C=C triazole), 1500.0 
(N=N), 1370.9 (C-N), 1234.6 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C29H32N5O10]
+ calculated: 610.2144; found: 
610.2160. Difference 2.63 ppm. 
255 
 




The triazole linked protected galactose-azobenzene conjugate 257 (478 mg, 0.78 mmol) 
was dissolved in THF (10 mL). MeOH (30 mL), distilled water (10 mL) and sodium 
methoxide (cat.) were added sequentially. The reaction mixture was stirred overnight at 
room temperature. Acidic Dowex resin was added until pH 8 was reached. The resin 
was filtered off and the solvent removed under vacuum to give the product as an orange 
solid, 318 mg, 0.72 mmol, 92%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.46-3.59 (m, 3H, H
5 + 2xH6) 3.71-3.79 (m, 2H, 
H3 + H4), 4.04 (t, 1H, H2, J = 9.5 Hz), 5.28 (s, 2H, OCH2) 5.51 (d, 1H, H
1, J = 9.0 Hz,), 
7.26 (d, 2H, H-7, J = 9.0 Hz), 7.52 (t, 1H, H-1, J = 7.0 Hz) 7.57 (t, 2H, H-2, J = 7.0 Hz), 
7.84 (d, 2H, H-3, J = 7.5 Hz), 7.90 (d, 2H, H-6, J = 9.0 Hz), 8.42 (s, 1H, CH-triazole). 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.8 (C
6), 61.7 (OCH2), 68.8 (C
4), 69.7 (C2), 73.9 
(C3) 78.7 (C5), 88.5 (C1) 115.8 (C-7), 122.7 (C-3), 124.3 (C-H triazole), 125.1 (C-6), 
129.9 (C-2), 131.4 (C-1), 142.8 (q-triazole) 146.8 (C-5) 152.4 (C-4) 161.2 (C-8). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 141-143 ˚C.  
IR (KBr disc): 3393.2 (O-H), 2916.9 (C-H), 1600.5 (C=C triazole), 1500.2 (N=N), 
1372.7 (C-N), 1249.6 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C21H24N5O6]
+ calculated: 442.1721; found: 








The mannose azide 256 (359 mg, 0.96 mmol) and the propargylated azobenzene 107 
(1.5 eq., 342 mg, 1.44 mmol) were added to DMSO (30 mL) with vigorous stirring. 
Distilled water (10 mL) was added followed by copper sulphate pentahydrate (96 mg, 
0.77 mmol) and sodium ascorbate (76 mg, 0.77 mmol). The reaction solution was stirred 
at room temperature overnight. DCM (80 mL) was added, followed by washing with 
distilled water (100 mL) and brine (100 mL). The organics were dried over anhydrous 
magnesium sulphate and concentrated under vacuum to give the crude product (761 mg). 
Purification by flash chromatography (SiO2, DCM: MeOH 99:1) gave the title 
compound as an orange solid, 496 mg, 84%. 
1H-NMR: δH (500 MHz) (CDCl3): 2.05-2.08 (s, 9H, 3 X C(O)CH3) 2.17 (s, 3H, 
C(O)CH3), 3.90-3.95 (m, 1H, H
5), 4.07 (dd, 1H, H6, J = 2.5 Hz, 12.5 Hz), 4.07 (dd, 1H, 
H6, J = 5.5 Hz, 12.5 Hz), 5.33-5.39 (m, 3H, H4 + OCH2), 5.91 (dd, 1H, H
3, J = 3.5 Hz, 
8.5 Hz), 5.98 (t, 1H, H2, J = 3.5 Hz), 6.03 (d, 1H, H1, J = 3.5 Hz,), 7.12 (d, 2H, H-7, J = 
9.0 Hz), 7.44 (t, 1H, H-1, J = 7.0 Hz) 7.50 (t, 2H, H-2, J = 7.0 Hz), 7.85 (s, 1H, CH-
triazole), 7.88 (d, 2H, H-3, J = 7.5 Hz), 7.94 (d, 2H, H-6, J = 9.0 Hz). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.7 [4 X (C(O)CH3)] 61.5 (C
6), 
62.1 (OCH2), 66.1 (C
4), 68.3 (C2), 68.7 (C3) 72.4 (C5), 83.6 (C1) 115.0 (C-7), 122.6 (C-
3), 123.1 (CH-triazole), 124.8 (C-6), 129.1 (C-2), 130.5 (C-1), 144.6 (q-triazole) 147.5 
(C-5) 152.7 (C-4) 160.4 (C-8) 169.3, 169.6, 169.6, 170.5 [4 X (C(O)CH3)] 




m.p.: 62-64 ˚C. 
IR (KBr disc): 2990.2 (C-H), 1752.6 (C=0) 1600.4 (C=C triazole), 1500.4 (N=N), 
1370.8 (C-N), 1240.3 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C29H32N5O10]
+ calculated: 610.2144; found: 








The triazole linked protected mannose-azobenzene conjugate 259 (487 mg, 0.80 mmol) 
was dissolved in THF (10mL). MeOH (30 mL), distilled water (10 mL) and sodium 
methoxide (catalytic amounts) were added sequentially. The reaction mixture was stirred 
overnight at room temperature. Acidic Dowex resin was added until the pH remained 
acidic. The resin was filtered off and the solvent removed under vacuum to give the 
product an orange solid which required no further purification, 314 mg, 89%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.30-3.35 (s, 1H, H
5) 3.56-3.63 (m, 3H, H4 + H6), 
3.86 (dd, 1H, H3, J = 3.5 Hz, 7.5 Hz) 5.28 (t, 1H, H2, J = 3.5 Hz), 5.27 (s, 2H, OCH2) 
5.93 (d, 1H, H1, J = 4.0 Hz,), 7.23 (d, 2H, H-7, J = 9.0 Hz), 7.51 (t, 1H, H-1, J = 7.0 Hz) 
7.56 (t, 2H, H-2, J = 7.0 Hz), 7.82 (d, 2H, H-3, J = 7.5 Hz), 7.89 (d, 2H, H-6, J = 9.0 
Hz), 8.36 (s, 1H, C-H triazole). 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.8 (C
6), 61.6 (OCH2), 66.7 (C
4), 68.3 (C2), 71.2 
(C3) 78.4 (C5), 86.2 (C1) 115.9 (C-7), 122.7 (C-3), 125.0 (C-6) 125.1 (C-H triazole), 
129.9 (C-2), 131.5 (C-1), 142.9 (q-triazole) 146.8 (C-5) 152.4 (C-4) 161.1 (C-8)  
 (The 13C -NMR shows low intensity peaks for the cis isomer) 
m.p.: 135-138 ˚C.  
IR (KBr disc): 3401.7.2 (O-H), 1606.3 (C=C triazole), 1502.8 (N=N), 1253.3 (C-O) cm-
1. 
HRMS (direct injection) [M+H]+, [C21H24N5O6]
+ calculated: 442.1721; found: 




Divalent triazole linked protected galactose-azobenzene conjugate 261 
  
The galactose azide 255 (461 mg, 1.23 mmol) and the bis-propargylated azobenzene 113 
(0.5 eq., 180 mg, 0.62 mmol) were added to DMSO (30 mL) with vigorous stirring. 
Distilled water (10 mL) was added followed by copper sulphate pentahydrate (124 mg, 
0.50 mmol) and sodium ascorbate (98 mg, 0.50 mmol). The reaction solution was stirred 
at room temperature overnight. DCM (80 mL) was added, followed by washing with 
distilled water (100 mL) and brine (100 mL). The organics were dried over anhydrous 
magnesium sulphate and concentrated under vacuum to give the crude product as a 
sticky orange solid (690 mg). Purification by flash chromatography (SiO2, DCM: MeOH 
99:1) gave the title compound as a sticky orange solid, 471 mg, 74%. 
1H-NMR: δH (500 MHz) (CDCl3): 1.83, 2.01, 2.05, 2.22 [4 x (s, 3H, C(O)CH3)], 4.14-
4.26 (m, 3H, H5 + 2xH6), 5.19-5.30 (m, 3H, H3 & OCH2), 5.55-5.59 (m, 2H, H
2 + H4) 
5.87 (d, 1H, H1, J = 9.5 Hz) 7.10 (d, 2H, H-3, J = 9.0 Hz), 7.88 (d, 2H, H-2, J = 9.0 Hz), 
7.95 (s, 1H, C-H triazole). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.2, 20.5, 20.6, 20.6 [4 x (C(O)CH3)], 61.2 (C
6), 
62.1 (OCH2), 66.9, 67.9 (C
2 + C4), 70.8 (C3), 74.2 (C5) 86.4 (C1) 115.1 (C-3) 121.3 (C-
H triazole), 124.8 (C-2), 144.5 (q-triazole), 147.5 (C-1) 160.1 (C-4),  169.1, 169.8, 
169.9, 170.3 [4 x (C(O)CH3)] 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 207-210 ˚C. 
IR (KBr disc): 3164.0, 2968.5 (C-H), 1752.6 (C=0) 1599.9 (C=C triazole), 1501.4 
(N=N), 1372.1 (C-N), 1222.8 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C46H53N8O20]
+ calculated: 1037.3371; found: 








The divalent triazole linked protected galactose-azobenzene conjugate 261 (402 mg, 
0.39 mmol) was dissolved in THF (10mL). MeOH (30 mL), distilled water (10 mL) and 
sodium methoxide (cat.) were added sequentially. The reaction mixture was stirred 
overnight at room temperature. Acidic Dowex resin was added until the pH remained 
acidic. The resin was filtered off and the solvent removed under vacuum to give the 
product an orange solid, which crystallised from a water/ethanol mixture, 239 mg, 88%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.48-3.57 (m, 3H, H
5 + 2xH6) 3.72-3.77 (m, 2H, 
H3 + H4), 4.04 (t, 1H, H2, J = 9.5 Hz), 5.27 (s, 2H, OCH2) 5.51 (d, 1H, H
1, J = 9.0 Hz,), 
7.23 (d, 2H, H-3, J = 9.0 Hz), 7.86 (d, 2H, H-2, J = 7.5 Hz), 8.42 (s, 1H, C-H triazole). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 60.9 (C
6), 61.8 (OCH2), 68.9 (C
4), 69.8 (C2), 74.2 
(C3) 78.9 (C5), 88.6 (C1) 115.7 (C-3), 124.2 (CH-triazole), 124.6 (C-2), 142.8 (q-
triazole) 146.8 (C-1) 161.2 (C-4). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 198-202 ˚C.  
IR (KBr disc): 3380.5 (O-H), 2925.6 (C-H), 1598.3 (C=C triazole), 1498.4 (N=N), 
1240.5 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C21H24N5O6]
+ calculated: 723.2345; found: 








The mannose azide 256 (408 mg, 1.09 mmol) and  the bis-propargylated azobenzene 
113 (0.5 eq., 159 mg, 0.54 mmol) were added to DMSO (30 mL) with vigorous stirring. 
Distilled water (10 mL) was added followed by copper sulphate pentahydrate (108 mg, 
0.43 mmol) and sodium ascorbate (86 mg, 0.43 mmol). The reaction solution was stirred 
at room temperature overnight. DCM (100 mL) was added, followed by washing with 
distilled water (100 mL) and brine (120 mL). The organics were dried over anhydrous 
magnesium sulphate and concentrated under vacuum to give the crude product as a 
sticky orange solid (721 mg). Purification by flash chromatography (SiO2, DCM: MeOH 
99:1) gave the title compound as a sticky orange solid, 401 mg, 71%. 
1H-NMR: δH (500 MHz) (CDCl3): 2.06, 2.07, 2.07 (s, 3H, C(O)CH3) 2.17 (s, 3H, 
C(O)CH3), 3.91-3.92 (m, 1H, H
5), 4.07 (dd, 1H, H6, J = 2.5 Hz, 12.5 Hz), 4.37 (dd, 1H, 
H6, J = 5.5 Hz, 12.5 Hz), 5.33-5.39 (m, 3H, H4 + OCH2), 5.91 (dd, 1H, H
3, J = 3.5 Hz, 
8.5 Hz), 5.98 (t, 1H, H2, J = 3.5 Hz), 6.04 (d, 1H, H1, J = 3.5 Hz,), 7.10 (d, 2H, H-3, J = 
9.0 Hz), 7.86-7.89 (m, 3H, H-2 & CH-triazole),  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.6, 20.7, 20.7, 20.7 [4 x (C(O)CH3)] 61.5 (C
6), 
62.1 (OCH2), 66.1 (C
4), 68.2 (C2), 68.7 (C3) 72.4 (C5), 83.6 (C1) 115.0 (C-3), 123.1 (C-
H triazole), 124.5 (C-2), 144.6 (q-triazole) 147.5 (C-1), 160.0 (C-4), 169.3, 169.6, 169.6, 
170.5 [4 x (C(O)CH3)] 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 77-81 ˚C. 
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IR (KBr disc): 2962.5 (C-H), 1752.5 (C=0) 1598.8 (C=C triazole), 1499.8 (N=N), 
1371.6 (C-N), 1238.4 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C46H53N8O20]
+ calculated: 1037.3371; found: 








The divalent triazole linked protected mannose-azobenzene conjugate 263 (344 mg, 0.33 
mmol) was dissolved in THF (10mL). MeOH (30 mL), distilled water (10 mL) and 
sodium methoxide (cat.) were added sequentially. The reaction mixture was stirred 
overnight at room temperature. Acidic Dowex resin was added until the pH remained 
acidic. The resin was filtered off and the solvent removed under vacuum to give the 
product an orange solid, which was crystallised from a water/ethanol mixture, 211 mg, 
91%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 3.30-3.33 (m, 1H, H
5) 3.57-3.63 (m, 3H, H4 + H6), 
3.86 (s, 1H, H3) 4.43 (s, 1H, H2), 5.30 (s, 2H, OCH2) 5.95 (d, 1H, H
1, J = 4.0 Hz,), 7.26 
(d, 2H, H-3, J = 9.0 Hz), 7.87 (d, 2H, H-2, J = 9.0 Hz), 8.42 (s, 1H, CH-triazole). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 61.2 (C
6), 61.8 (OCH2), 66.1 (C
4), 68.6 (C2), 71.7 
(C3) 78.9 (C5), 86.2 (C1) 115.8 (C-3), 124.6 (C-2), 125.1 (C-H triazole), 142.8 (q-
triazole), 147.0(C-1) 161.0 (C-4)  
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: thermal degradation at 208-215˚C.  
IR (KBr disc): 3370.15 (O-H), 2924.0 (C-H), 1597.93.3 (C=C triazole), 1499.0 (N=N), 
1246.6 (C-O) cm-1. 
HRMS (direct injection) [M+Na]+, [C30H36N8O12Na]
+ calculated 700.2345, found: 




Triazole linked protected galactose-azobenzene conjugate 265 
 
The galactose azide 255 (0.333 g, 0.89 mmol) and  the propargylated azobenzene 144 
(0.223g, 0.89 mmol) were added to DMSO (30 mL), to this mixture was added a solution 
of copper sulphate (89 mg, 0.46 mmol) and sodium ascorbate (71 mg, 0.46 mmol) in 
distilled water (10 mL). The reaction mixture was then left to stir at room temperature 
overnight. DCM (50 mL) was added and the reaction was washed with water (3 x 150 
mL) and brine (150 mL). The organics were dried over magnesium sulphate and 
concentrated under vacuum to give the crude product as an orange oil. Flash 
chromatography (DCM/MeOH 99:1) gave the desired product as an orange foam, 0.487 
g, 85%.  
1H-NMR: δH (500 MHz) (CDCl3): 1.87, 2.01, 2.03, 2.137 (4 x s, 4 x 3H, C(O)CH3), 
2.35 (s, 3H, CH3), 4.08-4.24 (m, 3H, H
5 & H6), 5.24 (dd, 1H, H3, J = 9.5, 3.5 Hz), 5.45 
(s, 1H, OCH2) 5.53-5.59 (m, 2H, H
2 & H4), 5.84 (d, 1H, H1, J = 9.5 Hz), 7.10 (d, 1H, 
Ar-H, J = 8.5 Hz), 7.19-7.25 (m, 1H, Ar-H) 7.43-7.54 (m, 4H, Ar-H), 7.92-7.98 (m, 3H, 
Ar-H & triazole CH) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3): 20.2, 20.5, 20.6, 20.6, 20.6 (4 x C(O)CH3 & CH3), 
61.2 (C6) 64.6 (CH2), 66.9 (C
4), 67.9 (C2), 70.9 (C3), 74.0 (C5), 86.3 (C1), 116.2, 117.3 
(Ar C-H), 121.4 (triazole C-H) 123.0, 129.1, 130.8, 133.0 (Ar C-H), 131.7 (C-CH3) 
142.7 (Ar q-C), 145.3 (CH2-C-N) 153.2 (Ar q-C) 153.3 (C-O-CH2), 168.9, 169.8, 170.0, 
170.3 (4 x C(O)CH3) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: 66-60 ˚C  
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IR (KBr disc): 2963.9 (C-H), 1754.6 (C=0) 1502.2 (C=C triazole), 1463.6 (N=N) 1370.8 
(C-N), 1217.8 (C-O) cm-1. 
HRMS (direct injection) [M+H]+, [C30H34N5O10]
+ calculated: 624.2300, found: 




Triazole linked galactose-azobenzene conjugate 266 
 
 
The Triazole linked protected galactose-azobenzene conjugate 265 (0.411 g, 0.643 
mmol) was dissolved in a methanol/distilled water/THF mixture (40 mL: 10 mL: 10 
mL). Sodium methoxide (catalytic amounts) was added and the reaction mixture was 
allowed to stir 16 hrs. The solution adjusted to pH 8 with acidic Dowex resin. The resin 
was filtered off and the solution was concentrated under vacuum to give the desired 
product as a red solid (0.261 g, 0.553 mmol, 86%).  
1H-NMR: δH (500 MHz) (DMSO-d6): 2.32 (s, 3H, CH3), 3.45-3.81 (m, 5H, H
3, H4. H5 
& H6), 4.05 (t, 1H, H2, J = 9.5 Hz), 5.38 (s, 1H, OCH2) 5.52 (d, 1H, H
1, J = 9.5 Hz), 
7.34-7.42 (m, 3H, Ar-H) 7.52-7.62 (m, 3H, Ar-H), 7.81-7.84 (m, 2H, Ar-H), 8.40 (s, 1H, 
triazole CH) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 20.5, (CH3), 60.9 (C
6) 63.1 (OCH2), 68.9, 74.2, 
79.0 (C3, C4, C5), 69.8 (C2), 88.6 (C1), 116.0, 123.0 (Ar C-H), 124.1 (triazole C-H) 129.0, 
129.9, 131.6, 133.9 (Ar C-H), 130.8 (C-CH3) 142.0 (Ar q-C), 143.3 (CH2-C-N) 153.2 
(Ar q-C) 154.7 (C-O-CH2),  
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
R.F.: (DCM : MeOH 9:1) 0.45 
IR (ATR): 3412.5 (O-H) 2919.4 (C-H), 1503.5 (C=C triazole), 1455.1 (N=N) 1279.6 
(C-N), 1226.7, 1045.4 (C-O) cm-1. 
 
HRMS (direct injection) [M+H]+, [C22H26N5O6]
+ calculated: 456.1878, found: 
456.1888; difference 2.34 ppm  
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To solution of the propargylated thymidine 269 (0.514 g, 0.98 mmol) and the 
chlorooxime 174 (0.75 g, 2.94 mmol) in EtOAc (20 mL) triethylamine (0.38 g, 0.48 mL, 
3.43 mmol) in EtOAC (1.0 mL) was added over 40 mins by syringe pump. The reaction 
mixture was heated to reflux and left to stir overnight. Distilled water (50 mL) was 
added, followed by extraction with further EtOAc (2 X 30 mL). The combined organics 
were dried over anhydrous magnesium sulphate and concentrated under vacuum to give 
the crude product (1.21 g). Purification by flash chromatography (SiO2, Diethyl ether: 
DCM: Pet diethyl ether 4.5 : 4.5 : 1) gave the product as an orange foam, 0.42 g, 57%. 
1H-NMR: δH (500 MHz) (CDCl3): 1.53 (s, 3H, CH3), 2.22-2.31 (m, 1H, H-2’), 2.51-
2.59 (m, 1H, H-2’), 3.37 (d, 1H, H-5’, J= 11.5 Hz ), 3.52 (d, 1H, H-5’, J= 11.5 Hz), 4.20 
(br s, 1H, H-4’), 4.37 (br s, 1H, H-4’), 4.62 (d, 1H, O-CH2, J= 13.5 Hz), 4.67 (d, 1H, O-
CH2, J= 13.5 Hz), 6.38 (br t, 1H, H-1’, J= 6.0 Hz), 6.59 (s, 1H, CH-isoxazole), 7.22-7.34 
(m, 7H, Ar-H), 7.36-7.42 (m, 6H, Ar-H), 7.49-7.58 (m, 5H, Ar-H), 7.91-8.04 (m, 7H, 
Ar-H), 8.30 (s, 1H, NH). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3):  11.9 (CH3) ,37.8 (C-2’), 62.2 (O-CH2), 63.8 (C-
5’), 80.2 (C-3’), 83.8 (C-4’), 84.8 (C-1’)87.6 (OCPh3) 101.4 (CH-isoxazole) 111.4 (C-
5) 123.05, 123.2, 127.5, 127.6, 128.1, 128.6 128.9 (Ar-CH), 130.9 (C8) 129.2, 131.4 
(Ar-CH), 135.3 (CH-pyrimidine) 145.2, 150.1, 152.6, 153.5 (Ar-C) 161.8 (CN-
isoxazole) 163.4 (C-4) 169.3 (CO-isoxazole) 
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The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 111-115 ˚̊C  
IR (KBr disc): 3057.4 (N-H), 2923.2 (C-H), 1689.1 (C=O), 1594.2 (N=N) 1448.0 (N-
O), 1101.7 cm (C-O) -1 
HRMS (direct injection) [M+Na]+, [C45H39N5O6Na]
+ calculated: 768.2793, found: 








To a solution of the trityl protected isoxazole linked protected thymidine-azobenzene 
conjugate 270 (0.32 g, 0.43 mmol) in DCM (10 mL) was added DCA (4.0 mL, 6.25 g, 
48 mmol). The solution was left to stir for 3 hours at room temperature. Further DCM 
(20 mL) was added followed by washing with distilled water (25 mL), saturated 
NaHCO3 (25 mL), further distilled water (25 mL) and finally brine (25 mL). The 
organics were dried over anhydrous magnesium sulphate and concentrated under 
vacuum to give the crude product (182 mg, 84 %), which was purified by passing the 
material through a silica plug (elution with acetone, followed by diethyl ether). Followed 
evaporation, the pure product was obtained by precipitation from a methanol/chloroform 
solution to give the pure product as an orange sticky solid, 145 mg, 67%. 
1H-NMR: δH (500 MHz) (DMSO-d6): 1.79 (s, 3H, CH3), 2.17-2.25 (m, 1H, H-2’), 2.30-
2.38 (m, 1H, H-2’), 3.63 (s, 2H, H-5’), 4.05 (s, 1H, H-4’), 4.30 (s, 1H, H-3’), 4.80 (s, 
2H, O-CH2), 5.19(s, 1H, OH) 6.18 (t, 1H, H-1’, J= 7.0 Hz), 7.22 (s, 1H, CH isoxazole), 
7.59-7.67 (m, 3H, H1 & H2), 7.72 (s, 1H, CH-pyrimidine), 7.95 (d, 2H, H3, J= 6.0 Hz), 
8.04), 8.14 ( 2 X d, 2 X 2H, H6 & H7, J= 8.0 Hz), 11.33 (s, 1H, NH). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 12.7 (CH3) ,36.7 (C-2’), 61.7 (O-CH2), 61.9 (C-
5’), 80.4 (C-3’), 84.3 (C-4’), 85.0 (C-1’) 102.4 (CH-isoxazole) 110.1 (C-5) 123.2, 123.7, 
128.3, 130.0, (Ar-CH) 131.5 (C8) 132.4 (Ar-CH) 136.4 (C-6), 151.0 (NC(O)N), 152.4, 
153.2 (C4 & C5), 161.7 (CN-isoxazole), 164.2 (CC(O)N), 170.7 (CO-isoxazole) 
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The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 238-241 ˚C  
IR (KBr disc): 3354.9 (O-H) 3061.9 (N-H), 2907.9(C-H) 1696.4(C=O), 1474.7 (N-O), 
1282.1, 1110.1(C-O), 1092.04 (C-O-H) cm-1 
HRMS (direct injection) [M+H]+, [C26H26N5O6]
+ calculated: 504.1878, found: 








To solution of the  propargylated thymidine 269 (0.517 g, 0.98 mmol) and the 
chlorooxime 225 (0.75 g, 2.94 mmol) in EtOAc (20 mL) a solution of triethylamine 
(0.38 g, 0.48 mL, 3.43 mmol) in EtOAc (1.0 mL) was added over 40 mins by syringe 
pump. The reaction mixture was stirred overnight at room temperature. Distilled water 
(50 mL) was added, followed by extraction with further EtOAc (2 X 30 mL). The 
combined organics were dried over anhydrous magnesium sulphate and concentrated 
under vacuum to give the crude product as an orange sticky solid (1.16 g). The product 
was purified by flash chromatography (SiO2, Diethyl ether: DCM: Pet diethyl ether 4.5 
: 4.5 : 1) to give the product as an orange foam, 0.54 g, 73 % 
1H-NMR: δH (500 MHz) (CDCl3): 1.52 (s, 3H, CH3), 2.22-2.31 (m, 1H, H-2’), 2.51-
2.58 (m, 1H, H-2’), 3.36 (d, 1H, H-5’, J= 9.5 Hz), 3.52 (d, 1H, H-5’,J= 9.5 Hz), 4.19 (br 
s, 1H, H-4’), 4.37 (br s, 1H, H-3’), 4.64 (d, 1H, O-CH2, J= 13.5 Hz), 4.68 (d, 1H, O-
CH2, J= 13.5 Hz), 6.38 (t, 1H, H-1’, J= 6.5 Hz), 6.62 (s, 1H, CH-isoxazole), 7.22-7.33 
(m, 9H, Ar-H), 7.36-7.42 (m, 6H, Ar-H), 7.48-7.59 (m, 4H, Ar-H), 7.63 (t, 1H, Ar-H, 
J= 7.5 Hz), 7.92-7.98 (m, 2H, Ar-H),  8.03 (d, 1H, Ar-H, J= 7.5 Hz), 8.28 (s, 1H, NH), 
8.30 (s, 1H, H6). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3):  11.9 (CH3), 37.9 (C-2’), 62.3 (O-CH2), 63.8 (C-
5’), 80.1 (C-3’), 83.8 (C-4’), 84.8 (C-1’)87.6 (OCPh3) 101.5 (CH-isoxazole) 111.5 (C-
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CH3) 121.1, 123.0, 124.7, 127.5, 128.1, 128.6 129.0, 129.2 (Ar-CH), 129.8 (C-7), 131.4, 
135.3 (Ar-CH) 143.2 (q-Ph3), 150.1, 152.5, 153.0 (Ar-C) 162.0 (CN-isoxazole) 163.4 
(CC(O)N) 169.3 (CO-isoxazole) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 83-87 ˚̊C  
IR (KBr disc): 3059.0(N-H), 2925.7(C-H), 1692.9(C=O), 1449.0(N-O), 1274.4, 
1096.2(C-O) cm-1 
HRMS (direct injection) [M+Na]+, [C45H39N5O6Na]
+ calculated: 768.2793, found: 








To a solution of the propargylated thymidine 169 (0.495 g, 0.66 mmol) in DCM (20 
mL) was added DCA (3.0 mL, 4.69 g, 36 mmol), the solution was then left to stir 
overnight at room temperature. Further DCM (30 mL) was added followed by washing 
with distilled water (30 mL), saturated NaHCO3 (30 mL), further distilled water (30 mL) 
and finally brine (30 mL). The organics were then dried over anhydrous magnesium 
sulphate and concentrated under vacuum to give the crude product (311 mg, 94 %). 
Purification by flash chromatography (diethyl ether: DCM: methanol 30:70:2) gave the 
product as a sticky orange solid, 231 mg, 70 %. 
1H-NMR: δH (500 MHz) (CDCl3): 1.84 (s, 3H, CH3), 2.27-2.47 (m, 2H, H-2’),  3.59 (s, 
1H, OH), 3.82 (d, 1H, H-5’, J = 11 Hz), 3.82 (d, 1H, H-5’, J = 11 Hz),  4.16 (br s, 1H, 
H-4’), 4.41 (br s, 1H, H-3’), 4.63-4.73 (m, 2H, O-CH2), 6.18 (t, 1H, H-1’, J= 6.5 Hz), 
6.71 (s, 1H, CH isoxazole), 7.44-7.65, 7.89- 803 (2 X m, 5H & 4H, Ar-H and CH-
pyrimidine), 8.31 (s, 1H, H6), 9.65 (s, 1H, NH or OH).  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
Selected peaks for Z-isomer: 6.49 (s, 0.2H, CH isoxazole), 6.76 (d, 0.2H, Ar-H, J = 8.0 
Hz), 6.87 (d, 0.4H, Ar-H, J = 7.0 Hz), 7.15 (t, 0.2H, Ar-H, J = 7.0 Hz), 7.21- 7.31 (m, 
0.8H, Ar-H), 7.40 (s, 0.2H, Ar-H) 
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13C-NMR: δC (125 MHz) (CDCl3): 12.5 (CH3) ,37.2 (C-2’), 62.3 (O-CH2), 62.5 (C-5’), 
80.0 (C-3’), 85.1 (C-4’), 86.7 (C-1’), 101.6 (CH isoxazole) 111.1 (C-5) 121.0, 123.0, 
124.6, 129.0, 129.2 (Ar-CH) 129.7 (C7) 129.8 (Ar-CH) 131.4 (Ar-CH) 137.0 (CH-
pyrimidine), 150.6, 152.5, 152.9 (Ar-C) 162.0 (CN-isoxazole) 164.2 (CC(O)N), 169.5 
(CO-isoxazole) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 55-58˚̊C  
IR (KBr disc): 3418.3 (O-H) 3058.7 (N-H), 2925.7 (C-H), 1689.7 (C=O), 1472.7 (N-O), 
1275.1, 1096.4, 1063.5.0 (C-O)  cm-1 
HRMS (direct injection) [M+H]+, [C26H26N5O6]
+ calculated: 504.1878, found: 








To solution of the propargylated thymidine 169 (714 mg, 1.4 mmol) and bis-
chlorooxime 176 (81 mg, 0.24 mmol) in EtOAc (25 mL) a solution of triethylamine (49 
mg, 0.067 mL, 0.15 mmol) in EtOAc (1.0 mL) was added over 4 hours by syringe pump. 
The reaction mixture was stirred overnight at room temprature. Distilled water (50 mL) 
was added, followed by extraction with further EtOAc (2 X 30 mL). The combined 
organics were dried over anhydrous magnesium sulphate and concentrated under 
vaccum to give the crude product as an orange sticky solid (588 mg). The product was 
further purified by flash chromatography (SiO2, Diethyl ether: DCM: Pet diethyl ether 
2 : 2 : 1) to give the product as an orange foam, 123 mg, 65 %. 
1H-NMR: δH (500 MHz) (CDCl3): 1.52 (s, 3H, CH3), 2.22-2.32 (m, 1H, H-2’), 2.50-
2.61 (m, 1H, H-2’), 3.37 (d, 1H, H-5’, J= 10.0 Hz), 3.52 (d, 1H, H-5’ J= 10.0 Hz), 4.20 
(br s, 1H, H-4’), 4.37 (br s, 1H, H-3’) 4.64 (d, 1H, O-CH2, J= 13.5 Hz), 4.68 (d, 1H, O-
CH2, J= 13.5 Hz), 6.39 (t , 1H, H-1’, J= 6.5 Hz), 6.61 (s, 1H, CH isoxazole), 7.22-7.43 
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(m, 15H, Ar-H), 7.57 (s, 1H, H-6), 7.96 (d, 2H, H2, J= 7.5 Hz), 8.05 (d, 2H, H3, J= 7.5 
Hz), 8.48 (s, 1H, NH). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3):  11.9 (CH3) ,37.8 (C-2’), 62.3 (O-CH2), 63.8 (C-
5’), 80.2 (C-3’), 83.8 (C-4’), 84.8 (C-1’) 87.6 (0CPh3) 101.4 (CH isoxazole) 111.4 (C-
CH3) 123.7, 127.5, 127.8, 128.1, 128.6 (Ar-CH) 131.3 (C4)  135.3 (CH-pyrimidine) 
143.2 (q-Ph3) 150.2 (NC(O)N) 153.4 (C1) 161.8 (CN-isoxazole) 163.5 (CC(O)N)  169.4 
(CO-isoxazole) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
  m.p. 158-161 ˚̊C 
IR (KBr disc): 3057.8 (N-H), 2924.9 (C-H), 1689.0 (C=O), 1448.8 (N-O), 1274.1, 
1096.1 (C-O) cm-1 
HRMS (direct injection) [M+Na]+, [C78H68N8O12]
+ calculated: 1331.4849, found: 








A solution of the propargylated thymidine 169 (0.988 g, 1.89 mmol) and bis-
chlorooxime 230 (102 mg, 0.3 mmol) in ethyl acetate (15 mL) was heated to reflux. A 
solution of triethylamine (0.1 mL, 0.7 mmol), in a solution of ethyl acetate (0.9 mL), 
was slowly added over 4 hours with a syringe pump. The reaction mixture was left to 
heat at reflux overnight. Further ethyl acetate was added (30 mL) followed by 
consecutive washings with distilled water (50 mL) and brine (50 mL). The organics were 
dried over anhydrous sodium sulphate and concentrated under vacuum to give the crude 
product (1.03 g). Purification by flash chromatography (DCM:MeOH 100:0 to 98:2) 
gave the title compound as a sticky orange solid (180 mg, 0.14 mmol, 46%)  
1H-NMR: δH (500 MHz) (CDCl3): 1.54 (s, 3H, CH3), 2.20-2.27 (m, 1H, H-2’), 2.55-
2.61 (m, 1H, H-2’), 3.35-3.40 (m, 1H, H-5’), 3.46-3.55 (m, 1H, H-5’), 4.21 (br s, 1H, H-
4’), 4.32 (br s, 1H, H-3’), 4.60 (d, 1H, OCH2, J= 13.0 Hz), 4.66 (d, 1H, OCH2, J= 13.0 
Hz), 6.38-6.42 (m, 1H, H-1’), 6.71 (s, 1H, CH-isoxazole), 7.24-7.42 (m, 15H, trityl), 
7.58 (s, 1H, CH-pyrimidine)  7.64 (t, 1H, H-5, J= 7.5 Hz), 8.03-8.06 (m, 2H, H-4 & H-
6), 8.31 (s, 1H, H-2), 9.56 (s, 1H, NH). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3):  12.0 (CH3), 37.7 (C-2’), 62.4 (O-CH2), 64.0 (C-5’), 
80.9 (C-3’), 83.8 (C-4’), 84.9 (C-1’), 87.7 (OCPh3) 101.5 (CH-isoxazole) 111.5 (C-CH3) 
121.4 (C-2), 124.9(C-4/6), 127.6, 128.1, 128.6 (Ar-CH), 129.3 (C-4/6), 130.0 (C-5), 
130.0 (Ar-C) 135.2 (CH-pyrimidine) 143.2 (q-Ph3), 150.7 (NC(O)NH), 152.8 (Ar-C) 
162.0 (CN-isoxazole) 163.9 (CC(O)N) 169.3 (CO-isoxazole) 
278 
 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 148-152 ˚C  
IR (KBr disc): 3057.1 (N-H), 2924.5 (C-H), 1689.8 (C=O), 1449.0(N-O), 1273.7, 
1093.4 (C-O) cm-1 
HRMS (direct injection) [M+H]+, [C78H68N8O12Na]
+ calculated: 1331.4849, found: 








To a solution of the propargylated thymidine 169 (0.494g, 0.95 mmol) and the 4-azido 
azobenzene 171 (0.220 g, 0.95 mmol) in DMSO (30 mL), copper sulphate pentahydrate 
(95 mg, 0.38 mmol) and sodium ascorbate (78mg, 0.39 mmol) were added, followed by 
water (10 mL). The reaction mixture was allowed to stir overnight at room temperature. 
Distilled water (100 mL) was added, followed by extraction with DCM (2 x 50 mL). 
The organics were combined, washed consecutively with water (2 x 100 mL) and brine 
(100 mL), followed by concentration under vacuum to give the crude product (672 mg). 
Purification by flash chromatography (DCM: MeOH 100:0 to 98:2) followed by 
crystallisation from DCM/Pet ether (1:1) gave the product as an orange solid (0.595 g, 
0.80 mmol, 84%) 
 
1H-NMR: δH (500 MHz) (CDCl3): 1.50 (s, 3H, CH3), 2.24-2.31 (m, 1H, H-2’), 2.53-
2.59 (m, 1H, H-2’), 3.37 (dd, 1H, H-5’, J= 10.5, 2.5 Hz), 3.49 (dd, 1H, H-5’, J = 10.5, 
2.5 Hz ), 4.22 (br, 1H, H-4’), 4.44 (br, 1H, H-3’), 4.71 (d, 1H, O-CH2, J= 12.5 Hz), 4.76 
(d, 1H, O-CH2, J= 12.5 Hz), 6.39 (dd, 1H, H-1’, J = 8.0, 6.0 Hz), 7.24-7.43 (m, 15H, 
trityl), 7.50-7.60 (m, 4H, CH-pyrimidine & H-1 & H-2), 7.89 (d, 2H, H-6/7 , J = 9.0 Hz), 
7.96 (dd, 2H, H-3, J = 8.0, 1.5 Hz), 8.02 (s, 1H, CH-triazole), 8.09 (d, 2H, H-6/7, J = 9.0 
Hz)  
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (CDCl3):  11.9 (CH3), 37.9 (C-2’), 62.9 (O-CH2), 63.9 (C-5’), 
79.7 (C-3’), 83.9 (C-4’), 84.8 (C-1’), 87.6 (OCPh3) 101.5 (CH-isoxazole) 111.3 (C-CH3) 
120.1 (C-6/7) 123.1 (Ar-H), 124.4 (C-6/7), 127.5, 128.1, 129.8.6 (tritryl CH) 129.2, 
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131.6 (Ar-CH), 135.5 (CH-pyrimidine) 138.3 (C-5/8) 143.2 (qC-Ph3), 145.6 (q-triazole), 
150.1 (C-4), 152.3 (C-5/8), 152.5 (NC(O)NH), 163.3 (CC(O)N). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
m.p. 134-137 ˚̊C  
IR (KBr disc): 3057.6 (N-H), 2925.0 (C-H), 1689.1 (C=O), 1448.8 (N-N), 1274.0, 
1099.3 (C-O) cm-1 
HRMS (direct injection) [M+Na]+, [C44H39N7O5Na]
+ calculated: 768.2905, found: 








To a solution of the isoxazole linked protected thymidine-azobenzene conjugate 276 
(0.381g, 0.51 mmol) in DCM (10 mL), DCA (4.0 mL, 0.39 mmol) was added (10 mL). 
The reaction mixture was allowed to stir overnight at room temperature. Distilled water 
(50 mL) was added, followed by extraction with DCM (2 x 25 mL). The organics were 
combined, washed consecutively with water (100 mL) and brine (100 mL), followed by 
concentration under vacuum to give the crude product (274 mg). purification by flash 
chromatography (DCM: MeOH 98:2) followed by crystallisation from DCM/Pet. ether 
(1:1) gave the product as an orange solid (0.195 g, 0.39 mmol, 76%) 
1H-NMR: δH (500 MHz) (DMSO-d6): 1.80(s, 3H, CH3), 2.16-2.24 (m, 1H, H-2’), 2.30-
2.36 (m, 1H, H-2’), 3.63 (d, 1H, H-5’, J= 3.0 Hz), 4.05-4.06 (m, 1H, H-4’), 4.29-4.33 
(m, 1H, H-3’), 4.73 (s, 2H, O-CH2), 5.17 (br, 1H, OH), 6.18 (dd, 1H, H-1’, J = 8.5, 6.0 
Hz), 7.60-7.66 (m, 3H, & H-1 & H-2), 7.73 (d, 2H, CH-pyrimidine, J = 1.0 Hz), 7.95 
(dd, 2H, H-3, J = 8.5, 2.0 Hz), 8.10-8.13 (m, 2H, H-6/7), 8.17-8.20 (m, 2H, H-6/7), 8.99 
(s, 1H, triazole-CH) 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 12.7 (CH3), 36.8 (C-2’), 62.0 (O-CH2), 62.2(C-
5’), 79.7 (C-3’), 84.4 (C-1’), 85.1 (C-4’), 110.0 (C-CH3) 122.9 (triazole-CH) 123.2 (C-
2/3), 124.6 (C-6/7), 130.0 (C-2/3), 132.4 (C-1) 136.5 (CH-pyrimidine) 138.3 (C-5/8) 
145.8 (q-triazole), 151.0 (NC(O)NH), 151.7 (C-5/8), 152.4 (C-4), 164.2 (CC(O)N). 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p. 224-227 ˚C  
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IR (KBr disc): 3033.35.0 (N-H), 1688.9 (C=O), 1465.9 (N-N), 1280.9, 1094.2 (C-O) 
cm-1 
HRMS (direct injection) [M+Na]+, [C25H26N7O5]
+ calculated: 504.1990 found: 




4-[4-[(1E)-2-phenyldiazenyl]phenoxy]methyl]-1H-1,2,3-triazolo acetic acid 290 
 
 
2-Azidoacetic acid, 289, (0.202 g, 1.98 mmol) and the propargylated azobenzene 107  
(0.701 g, 2.97 mmol) were dissolved in DMSO (30 mL), distilled water (10 mL) was 
added, followed by copper sulphate (0.396 g, 1.58 mmol) and sodium ascorbate (0.314 
g, 1.58 mmol). The reaction mixture was stirred overnight. Distilled water (100 mL) was 
added, followed by extraction with diethyl ether (2 x 50 mL). The organics were 
combined, washed consecutively with water (2 x 100 mL) and brine (100 mL), and dried 
over anhydrous magnesium sulphate. After concentration under vacuum the crude 
product was obtained (706 mg). The crude material was passed through a silica plug 
(diethyl ether: pet. ether 1:1; followed by acetone) to give the title product 290 as an 
orange solid (408 mg, 1.20 mmol, 61%)  
1H-NMR: δH (500 MHz) (DMSO-d6): 4.72 (s, 2H, CH2-COOH), 5.26 (s, 2H, O-CH2) 
7.26 (d, 2H, H-7, J = 8.5) 7.48-7.64 (m, 3H, H-1 + H-2), 7.85 (d, 2H, H-3, J = 8.5), 7.91 
(d, 2H, H-6, J = 8.5) 8.11 (s, 1H, triazole). 
The 1H-NMR spectrum shows a series of low intensity peaks consistent with the 
presence of the cis isomer. 
13C-NMR: δC (125 MHz) (DMSO-d6): 54.2(CH2-CO2H), 62.1 (OCH2), 115.8 (C-7), 
122.7 (C-3), 125.0 (C-6), 126.2 (CH-triazole), 129.9 (C-2), 131.8 (H-1), 141.8 (q-
triazole), 146.7 (C-5), 152.5 (C-4), 161.4 (C-8) 
The 13C -NMR shows a series of low intensity peaks consistent with the presence of the 
cis isomer. 
m.p.: thermal degradation at 240 ˚C  
IR (KBr disc): 1624.2 (C=0), 1581.3 (C=C triazole), 1500.5 (N=N), 1404.2 (N-N), 
1253.8 (C-0) cm-1 
HRMS (direct injection) [M+H]+, [C17H16N5O3]
+ calculated: 338.1248, found: 








Method 1: The standard Fmoc SPPS protocol was used to manually synthesis H-Arg-
Gyl-Asp-Gly-Resin (0.31 mmol) on a rink amide resin. A solution of 290 (0.315 g, 0.933 
mmol, 3 eq.) PyBOP (486 mg, 0.933 mmol) and NMM (1.89 g, 0.205ml, 1.866 mmol, 
6 eq.) in DMF (5mL) was added to the resin suppoerted peptide chain. The SPPS vessel 
was agitated for 40 minutes. The vessel was drained of the reaction solution and the resin 
was washed with DMF (3 x 5 mL), DCM (3 x 5 mL), DMF (3x 5 mL) and DCM (3 x 5 
mL), the resin was dried under vacuum. The resin was then agitated in a solution of 
TFA, triisopropylsilane and water (95: 2.5: 2.5; 8 mL) for 1 hour. The solution 
containing the cleaved and deprotected peptide was then drained into a 15 mL falcon 
tube and air was blown over the solution until the volume was reduced to ~2 mL. Diethyl 
ether was added dropwise until no more precipitate formed. The precipitate was pelleted 
by centrifugation (5 mins, 2800 rpm) and the remaining liquid was decanted. Further 
ether was added to the pellet was dispersed through agitation and sonication. The pellet 
was regenerated from the suspension by centrifugation (5 mins, 2800 rpm) and removal 
of the liquid, this process was repeated once more. The pellet was then dissolved in 
distilled water (2 ml) and a minimum of acetonitrile, the resulting solution was 
lyophilised to give the crude product. which was subjected to semi-preparative HPLC. 
The seperated HPLC fractions were combined and lyophilised to give the product 295 
as an orange solid (64%). 
  
Method 2: The supported peptide H-GRGDG-resin 291 (0.1 mmol) was automatically 
synthesised using the standard Fmoc SPPS protocol on a rink amide resin. Imidazole-1-
sunfunyl azide260 280 (63 mg, 0.3 mmol) and DIEA (58 mg. 0.078 mL, 0.45 mmol) were 
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dissolved in DMF (8 mL), the solution added to the supported peptide H-GRGDG-resin 
(0.1 mmol) in a SPPS vessel. The reaction mixture was agitated for 1 hour. The liquid 
was drained from the SPPS vessel and the resin was washed with DMF (3 x 5 mL), DCM 
(3 x 5 mL) and DMF (3 x 5 mL). A second solution of imidazole-1-sunfunyl azide (63 
mg, 0.3 mmol) and DIEA (58 mg. 0.078 mL, 0.45 mmol) in DMF (8 mL) was added to 
the peptide and the reaction mixture was agitated over 1 hour. . The liquid was drained 
from the SPPS vessel and the resin was washed with DMF (3 x 5 mL), DCM (3 x 5 mL) 
and DMF (3 x 5 mL). The resin was agitated in a solution of TFA, triisopropylsilane and 
water (95: 2.5: 2.5; 6 mL) for 1 hour. The solution of containing the cleaved and 
deprotected peptide was then drained into a 15 mL falcon tube and air was blown over 
the solution until the volume was reduced to ~2 mL. Diethyl ether was added dropwise 
until no more precipitate formed. The precipitate was pelleted by centrifugation (5 mins, 
2800 rpm) and the remaining liquid was decanted. Further ether was added to the pellet 
was dispersed through agitation and sonication. The pellet was regenerated from the 
suspension by centrifugation (5 mins, 2800 rpm) and removal of the liquid, this process 
was repeated once more. To a mixtuere of N3-GRGDG-NH2  296 and propargylated 
azobenzene 107 (0.047 g, 0.2 mmol) in DMF (5mL) was added a solution of CuSO4. 
5H2O (0.013 g, 0.05 mmol and sodium ascorbate (0.010 g, 0.05 mmol) in distilled water 
(1 mL). The resulting reaction mixture was left to stir overnight at room temperature. 
The solvent was removed under vacuum without heating. The residue was dissolved in 
distilled water and acetonitrile (1:1, 2 mLs) and the resulting yellow solution was 
purified by semi-preparative HPLC. The HPLC fractions were combined and lyophilised 
to give the product 295 as an orange solid (51%).  
 
HRMS (direct injection) [M+H]+, [C31H40N13O8]
+ calculated: 722.3117, found: 





Figure 77:HRMS and HPLC data of the conjugate 295; 0-100% gradient of H2O/CH3CN, with 1% TFA, 













The supported peptide Ac-RGDS*TF-resin 297 (0.1 mmol) was automatically 
synthesised using the Fmoc SPPS protocol. A solution of 4-azidoazobenzene 171 (0.282 
g, 1.26 mmol), copper sulphate (0.125 g, 0.5 mmol) and sodium ascorbate (0.099 g, 
0.5mmol) in DMF/H2O (5:1, 6 mL) was added to a SPPS vessel containing the on-resin 
propargylated peptide 297 (Ac-RGDS*TF-resin). The reaction mixture was agitated for 
40 minutes, the solution was drained from the vessel and the resin was washed with 
DMF (3 x 5 mL), DCM (3 x 5 mL), DMF (3x 5 mL) and DCM (3 x 5 mL), the resin was 
dried under vacuum. The resin was agitated in a solution of TFA and water (95: 5; 8 
mL) for 1 hour. The solution of containing the cleaved  and deptroected peptide was 
then drained into a 15 mL falcon tube and air was blown over the solution until the 
volume was reduced to ~2 mL remained. Diethyl ether was added dropwise until no 
more precipitate formed. The precipitate was pelleted by centrifugation (5 mins, 2800 
rpm) and the remaining liquid was decanted. Further ether was added to the pellet was 
dispersed through agitation and sonication. The pellet was regenerated from the 
suspension by centrifugation (5 mins, 2800 rpm) and removal of the liquid, this process 
was repeated once more. The pellet was dissolved in distilled water (1 mL) and a 
minimum of acetonitrile (~2 mL), the resulting solution was lyophilised to give the crude 
product. The residue was then dissolved in distilled water and acetonitrile (1:1, 2.5 mL) 
and the resulting yellow solution was purified by semi-preparative HPLC. The HPLC 
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fractions were combined and lyophilised to give the product 300 as an orange solid 
(73%).  
HRMS (direct injection) [M+H]+, [C45H58N15O11]
+ calculated: 984.4435, found: 




Figure 78: HRMS and HPLC data of the conjugate 300; 0-100% gradient of H2O/CH3CN, with 1% TFA, 












Method 1: The supported peptide Ac-SRK(N3)RGDS-resin 302 (0.16 mmol) was 
manually synthesised using the Fmoc SPPS protocol on a rink amide resin. A solution 
of 4-propargylated azobenzene 107 (0.106 g, 0.45 mmol), copper sulphate (0.037 g, 0.15 
mmol) and sodium ascorbate (0.030 g, 0.15mmol) in DMF/H2O (5:1, 6 mL) was added 
to a SPPS vessel containing supported azido peptide 302 (Ac-SRK(N3)RGDS-resin) 
(0.16 mmol). The reaction mixture was agitated for 1 hour, the solution was then drained 
from the vessel and the resin was washed with DMF (3 x 5 mL), DCM (3 x 5 mL), DMF 
(3x 5 mL) and DCM (3 x 5 mL). The resin was agitated in a solution of TFA and water 
(9.5:5; 7 mL) for 1.5 hour. The solution containing the cleaved and deprotected peptide 
was drained into a 15 mL falcon tube and air was blown over the solution until the 
volume was reduced to 2 mL. Diethyl ether was added dropwise until no more 
precipitate formed. The precipitate was pelleted by centrifugation (5 mins, 2800 rpm) 
and the remaining liquid was decanted. Further ether was added to the pellet was 
dispersed through agitation and sonication. The pellet was regenerated from the 
suspension by centrifugation (5 mins, 2800 rpm) and removal of the liquid, this process 
was repeated once more. The pellet was then dissolved in distilled water (1.5 mL) and a 
minimum of acetonitrile (~1 mL), the resulting solution was lyophilised to give the crude 
product as a light yellow solid. The residue was dissolved in distilled water and 
acetonitrile (1:1, 2 mL) and the resulting yellow solution was purified by semi-
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preparative HPLC. The HPLC fractions were then combined and lyophilised to give the 
product 303 as an orange solid (56%).  
 
Method 2: The supported peptide Ac-SRK(N3)RGDS-resin 302 (0.16 mmol) was 
manually synthesised using the Fmoc SPPS protocol on a rink amide resin. The resin 
bound azidopeptide 302 (Ac-SRK(N3)RGDS-resin) (0.16 mmol) was agitated in a 
solution of TFA, TIS and water (95: 2.5: 2.5; 6 mL) for 1.5 hour. The solution of 
containing the cleaved and deprotected peptide was drained into a 15 mL falcon tube 
and air was blown over the solution until the volume was reduced to ~2 mL. Diethyl 
ether was added dropwise until no more precipitate formed. The precipitate was pelleted 
by centrifugation (5 mins, 2800 rpm) and the remaining liquid was decanted. Further 
ether was added to the pellet was dispersed through agitation and sonication. The pellet 
was regenerated from the suspension by centrifugation (5 mins, 2800 rpm) and removal 
of the liquid, this process was repeated once more. The resulting white solid was then 
dissolved in DMF (5 mL) and propargylated azobenzene 107 (0.106 g, 0.45 mmol) was 
added. To this as solution of CuSO4. 5H2O (0.111 g, 0.45 mmol) and sodium ascorbate 
(0.091 g, 0.45 mmol) in distilled water (1 mL) was added. The resulting reaction mixture 
was left to stir over night. The solvent was removed under vacuum without heating. The 
residue was dissolved in TFA (5 mL) and diethyl ether was added until no more 
precipitated formed. The precipitate was pelleted by centrifugation (5 mins, 2800 rpm) 
and the remaining liquid was decanted. Further ether was added to the pellet was 
dispersed through agitation and sonication. The pellet was regenerated from the 
suspension by centrifugation (5 mins, 2800 rpm) and removal of the liquid, this process 
was repeated once more.  The pellet was then dissolved in distilled water (1 mL) and a 
minimum of acetonitrile (~1 mL). The resulting solution was lyophilised to give the 
crude product as a light yellow solid. The material was dissolved in distilled water and 
acetonitrile (1:1, 2 mL) and the resulting yellow solution was purified by semi-
preparative HPLC. The HPLC fractions were combined and lyophilised to give the 
product 303 as an orange solid (14%).  
HRMS (direct injection) [M+H]+, [C47H70N19O13]
+ calculated: 1108.5395, found: 






Figure 79: HRMS and HPLC data for the conjugate 303; 0-100% gradient of H2O/CH3CN, with 1% TFA, 











The supported peptide Ac-RGDS*TF-resin 297 (0.31 mmol) was manually synthesised 
using the Fmoc SPPS protocol on a rink amide resin. A solution of the chlorooxime 174 
(241 mg, 0.93 mmol) and NEt3 (0.17 ml, 1.2 mmol) in DMF/H2O (7:1, 8 mL) was added 
to a SPPS vessel containing supported propargylated peptide 297 (RGDS*TF-resin). 
The reaction mixture was agitated for 30 minutes, the solution was drained from the 
vessel and the resin was washed with DMF (3 x 5 mL), DCM (3 x 5 mL) and DMF (3x 
5 mL). A second solution of the chlorooxime 174 (241 mg, 0.93 mmol) and NEt3 (0.17 
ml, 1.2 mmol) in DMF/H2O (7:1, 8 mL) was added to resin followed by a further 30 
minutes of agitation. The solution was drained from the vessel and the resin was washed 
with DMF (3 x 5 mL), DCM (3 x 5 mL), DMF (3x 5 mL) and DCM (3 x 5 mL). The 
resin was agitated in a solution of TFA and water (95: 5; 8 mL) for 1 hour. The solution 
of containing the cleaved and deprotected peptide was decanted into a 15 mL falcon tube 
and air was blown over the solution until the volume was reduce to ~2 mL. Diethyl ether 
was added dropwise until no more precipitate formed. The precipitate was pelleted by 
centrifugation (5 mins, 2800 rpm) and the remaining liquid was decanted. Further ether 
was added to the pellet was dispersed through agitation and sonication. The pellet was 
regenerated from the suspension by centrifugation (5 mins, 2800 rpm) and removal of 
the liquid, this process was repeated once more. The pellet was dissolved in distilled 
water (2 mL) and a minimum of acetonitrile (~0.5 mL), the resulting solution was 
lyophilised to give the crude product as a faintly orange solid. The residue was then 
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dissolved in distilled water and acetonitrile (1:1, 2.5 mLs) and the resulting a pale yellow 
solution was purified by semi-preparative HPLC. The HPLC fractions were combined 
and lyophilised to give the product 304 as an orange solid (13%).  
HRMS (direct injection) [M+H]+, [C46H58N13O12]
+ calculated: 984.4322, found: 




Figure 80: HRMS and HPLC data for the conjugate 304; 0-100% gradient of H2O/CH3CN, with 1% TFA, 











The supported peptide H-GRGDG-Resin 291 (0.31 mmol) was manually synthesised 
using the Fmoc SPPS protocol on a rink amide resin. A solution of the propargylated 
azobenzene 152 (0.315 g, 0.933 mmol, 3 eq.) PyBOP (486 mg, 0.933 mmol) and NMM 
(1.89 g, 0.205ml, 1.866 mmol, 6 eq.) in DMF (5mL) was added to a SPPS vessel 
containing the resin bound peptide 291. The SPPS vessel was agitated for 40 minutes. 
The vessel was drained of the reaction solution and the resin was washed with DMF (3 
x 5 mL), DCM (3 x 5 mL), DMF (3x 5 mL) and DCM (3 x 5 mL). A solution of 
azidogalactose 255 (347 mg, 0.93 mmol), copper sulphate (75 mg, 0.3 mmol) and 
sodium ascorbate (59 mg, 0.3 mmol) in DMF/H2O (7:1, 8 mL) was added to a SPPS 
vessel containing the on resin propargylated azobenzene peptide 305. The reaction 
mixture was agitated for 3 hours at room temprature. The solution was drained from the 
vessel and the resin was washed with DMF (3 x 5 mL), DCM (3 x 5 mL), DMF (3x 5 
mL) and DCM (3 x 5 mL). 
The resin was agitated in a solution of TFA, and water (9.5:5; 8 mL) for 1 hour. The 
solution of containing the cleaved peptide was then drained into a 15 mL falcon tube 
and air was blown over the solution until the volume was reduced to ~2 mL. Diethyl 
ether was added dropwise until no more precipitate formed. The precipitate was pelleted 
by centrifugation (5 mins, 2800 rpm) and the remaining liquid was decanted. Further 
ether was added to the pellet was dispersed through agitation and sonication. The pellet 
was regenerated from the suspension by centrifugation (5 mins, 2800 rpm) and removal 
of the liquid, this process was repeated once more. The pellet was then dissolved in 
distilled water (2 ml) and a minimum of acetonitrile (~2 mL), the resulting solution was 
lyophilised to give the crude product. The crude product was subjected to purifaction by 
semi-preparative HPLC. The HPLC fractions were combined and lyophilised to give the 
product as an orange solid (24%). 
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HRMS (direct injection) [M+H]+, [C47H60N12O19]
+ calculated: 1095.4014, found: 




Figure 81: HRMS and HPLC data for the conjugate 306; 0-100% gradient of H2O/CH3CN, with 1% TFA, 





Found: 1095.4191 (1.62 ppm) 
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Full NMR characterisation and assignment of 242 
 
 
1H-NMR: δH (500 MHz) (CDCl3): 2.03, 2.06, 2.09, 2.17 (s, 3H, C(O)CH3), 4.23-4.29 
(m, 3H, H5, H6 & H6’) 5.06 (dd, 1H, H4, J = 9.5, 3.0 Hz) 5.18 (dd, 1H H2, J = 8.0, 3.0 
Hz) 5.29 (s, 2H, OCH2) 5.42 (d, 1H, H
1, J = 8.0 Hz) 5.76 (t, 1H, H3, J = 3.0 Hz) 6.64 (s, 
1H, isoxazole-CH) 7.07-7.13(m, 4H, Ar-H) 7.77 ( d, 2H, H-2’) 7.91 (d, 2H, Ar-H) 
 
Figure 82:1H-NMR spectrum of 242. 
 
To assign these first the following assumptions where made: that the peak that 6.64 was 
the isoxazole CH due to it being a singlet in the region expected for such a shielded 
aromatic hydrogen. Also that the doublet at 5.42 is the H1 of the allose sugar unit, as H1 
311 
 
is the only carbohydrate proton expected to be a doublet. The acetyl hydrogen are also 
easily identified by their integration and shielded position from ~1.8-2.2 ppm.  
The remaining carbohydrate hydrogens where assigned with a COSY: showing a 
correlation between H1 and H2, H2 and H3, etc. The multiplicity for H2, H3 and H4 are 
all expected to be doublets of doublets, this is true of H2 and H4, H3 is an apparent 
triplet but this in fact just where the J values are equal for the doublet of doublets. H3 
also has low J-values because it is the epimeric hydrogen. H5 and H6 are overlapping 
and therefore cannot be differentiated from each other.  
 
Figure 83: COSY spectrum of 242. 
 
A weak correlation between the peak at 5.29 and 6.64 confirms at these are the CH2 next 
to the isoxazole and the CH in the ring. They are too far apart for coupling and therefore 
appear as singlets with the former integrating for twice of the later. The remaining peaks 
all feature in the aromatic region. The first doublet (7.11) integrates for 8 which indicates 
that it is in fact two sets of doublets in the same position. The COSY shows both the 
latter two doublet (7.76 & 7.91) coupling in the first peak (7.11) indicating that the 
superimposed doublets belong to belong to different rings. These will later be shown in 
the HMBC carbon correlation that the peak at 7.76 is from the helicid and 7.91 is from 




13C-NMR: δC (125 MHz) (CDCl3): 20.5, 20.6 20.7 20.8 (CH3C(O)), 61.7 (OCH2), 62.3 
(C6), 66.2 (C4), 68.4 (C3), 68.8 (C2), 70.6 (C5), 96.9 (C1), 101.4 (isoxazole-CH), 115.1, 
117.3 (Ar-CH), 123.6 (C-1’) 124.6 128.3 (Ar-CH), 147.8 (C-1) 158.4 (C-4’) 159.7 (C-
4) 161.9 (isoxazole-CN) 168.0 (isoxazole-CO) 169.1, 169.1, 169.7, 170.7 (C(O)CH3) 
 
 
Figure 84: 13C spectrum of 242. 
 
From the dept carbon experiments the following information can be gained: the peaks at 




Figure 85: Dept 135 spectrum of 242. 
 
The peaks at 123.6 and the 9 peaks between 147.8 and 170.7 are all quaternary. The 
remaining peaks are all CH. 
 




 The CH2 and CH peaks can all be assigned by direct correlation on the HSQC. The 
quaternary carbons can be assigned with the HMBC experiment.The last four peaks 
(169.1, 169.7 169.7, 170.7) all show a correlation with the CH3 of the acetyl groups 
indicating that that they represent the adjacent carbonyl carbons. The peak nearest these 
(168.0) correlates with CH of the isoxazole and the CH2 next to the isoxazole, this is 
therefore the carbon between these two also next to the oxygen in the isoxazole. The peak 
at 161.9 shows a correlation to the CH of the isoxazole and CH doublet of the aryl ring 
at 7.76 making this the other quaternary isoxazole carbon which is double bonded to the 
nitrogen. The peak at 159.7 correlates to the aryl hydrogen (7.91 and 7.11) and the CH2 
next to the isoxazole showing it to be the quaternary peak of the azobenzene aryl which 
is adjacent to the oxygen. This also shows that the doublet at 7.91 of the 1H NMR is from 
the azobenzene aryl, making the doublet at 7.76 from the helicid. The peak at 158.4 
correlates to the two aryl peaks from the helicid aryl (7.76 and 7.11) and C1 of the sugar, 
it is therefore the quaternary carbon of the helicid aryl nearest the allose sugar unit. 147.8 
correlates to 7.11 and 7.91 making it the azobenzene quaternary adjacent to the azo 
functionality. The peak at 123.6 is therefore the remaining quaternary carbon of the 
helicid aryl, connecting to the isoxazole unit 
 




Figure 88: HMBC spectrum of 242. 
 
